US5677132A
(en)
*
|
1971-05-20 |
1997-10-14 |
Strahilevitz; Meir |
Immunological assay reagent package
|
US6406920B1
(en)
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
EP0111762B1
(en)
*
|
1980-06-20 |
1987-11-19 |
Unilever Plc |
Processes and apparatus for carrying out specific binding assays
|
JPS57501147A
(ja)
*
|
1980-07-16 |
1982-07-01 |
|
|
NL185309C
(nl)
*
|
1980-07-28 |
1990-03-01 |
Akzo Nv |
Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
|
US4879219A
(en)
*
|
1980-09-19 |
1989-11-07 |
General Hospital Corporation |
Immunoassay utilizing monoclonal high affinity IgM antibodies
|
WO1982001773A1
(en)
*
|
1980-11-07 |
1982-05-27 |
Secher David S |
Assay for interferon
|
US4837167A
(en)
*
|
1981-01-30 |
1989-06-06 |
Centocor, Inc. |
Immunoassay for multi-determinant antigens using high-affinity
|
US4680258A
(en)
*
|
1981-03-24 |
1987-07-14 |
Sloan-Kettering Institute For Cancer Research |
Process for sex determination in man by use of monoclonal antibodies to the H-Y antigen
|
US4474893A
(en)
*
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
EP0072902B1
(de)
*
|
1981-08-21 |
1985-04-24 |
F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft |
Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
|
US4661586A
(en)
*
|
1981-11-17 |
1987-04-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Monoclonal anti-idiotype antibodies
|
EP0082636B2
(en)
*
|
1981-12-11 |
2006-10-18 |
The Welsh National School of Medicine |
Luminescent labelling materials and procedures
|
USRE32011E
(en)
*
|
1981-12-14 |
1985-10-22 |
Scripps Clinic And Research Foundation |
Ultrapurification of factor VIII using monoclonal antibodies
|
US4444878A
(en)
*
|
1981-12-21 |
1984-04-24 |
Boston Biomedical Research Institute, Inc. |
Bispecific antibody determinants
|
CA1213229A
(en)
*
|
1982-04-12 |
1986-10-28 |
Gary S. David |
Antibodies having dual specificities, their preparation and uses therefor
|
US4483929A
(en)
*
|
1982-05-03 |
1984-11-20 |
Liposome Technology Incorporated |
Liposomes with glycolipid-linked antibodies
|
US4792528A
(en)
*
|
1982-05-21 |
1988-12-20 |
The Trustees Of Columbia University In The City Of New York |
Methods for obtaining monoclonal antibodies useful in enhanced sensitivity immunoassays
|
US4514505A
(en)
*
|
1982-05-21 |
1985-04-30 |
The Trustees Of Columbia University In The City Of New York |
Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
|
US4443427A
(en)
*
|
1982-06-21 |
1984-04-17 |
Sidney Farber Cancer Institute, Inc. |
Monoclonal antibody
|
US4623621A
(en)
*
|
1982-06-24 |
1986-11-18 |
Hoffmann-La Roche Inc. |
Immunoassay for peptide and protein oligomers
|
DE3225027A1
(de)
*
|
1982-07-05 |
1984-01-05 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Immunchemisches messverfahren
|
US4471058A
(en)
*
|
1982-07-26 |
1984-09-11 |
Board Of Trustees Operating Michigan State University |
Method for the detection and/or determination of a polyvalent antigen using at least two different monoclonal antibodies
|
US4879218A
(en)
*
|
1982-09-13 |
1989-11-07 |
Virginia Tech Intellectual Properties, Inc. |
Antibody for C.difficile
|
US4596771A
(en)
*
|
1982-09-27 |
1986-06-24 |
Research Corporation |
Monoclonal antibodies to vitamin B-6 and immunossay method
|
US4659678A
(en)
*
|
1982-09-29 |
1987-04-21 |
Serono Diagnostics Limited |
Immunoassay of antigens
|
US4845027B1
(en)
*
|
1982-10-13 |
1994-05-10 |
Biowhittaker Inc |
Fluorometric assay of allergic reactions
|
US4844966A
(en)
*
|
1982-10-13 |
1989-07-04 |
Minnesota Mining And Manufacturing Company |
Assaying total IgE levels with fluorogenic enzyme labeled antibody
|
US4539292A
(en)
*
|
1982-12-29 |
1985-09-03 |
Reid Michael J |
Immunoassay technique for specific immunoglobulin E
|
AU582731B2
(en)
*
|
1983-01-21 |
1989-04-13 |
Milton David Goldenberg |
Specific cea-family antigens, antibodies specific thereto and their methods of use
|
US4818709A
(en)
*
|
1983-01-21 |
1989-04-04 |
Primus Frederick J |
CEA-family antigens, Anti-CEA antibodies and CEA immunoassay
|
US4525452A
(en)
*
|
1983-01-24 |
1985-06-25 |
Btc Diagnostics Limited Partnership |
Enzyme immunoassay with step of immersing sample in deionized water
|
US4994373A
(en)
|
1983-01-27 |
1991-02-19 |
Enzo Biochem, Inc. |
Method and structures employing chemically-labelled polynucleotide probes
|
US4849337A
(en)
*
|
1983-01-31 |
1989-07-18 |
Minnesota Mining And Manufacturing Company |
Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
|
US4558006A
(en)
*
|
1983-02-04 |
1985-12-10 |
Kirin-Amgen, Inc. |
A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
|
US5106760A
(en)
*
|
1983-02-04 |
1992-04-21 |
Kirin-Amgen |
ATCC HB8209, its monoclonal antibody to erythropoietin and assay using same
|
US4474892A
(en)
*
|
1983-02-16 |
1984-10-02 |
Board Of Trustees Of The Leland Stanford Junior University |
Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
|
FR2541304A1
(fr)
*
|
1983-02-21 |
1984-08-24 |
Centre Nat Rech Scient |
Anticorps monoclonaux anti-legionella, procede d'obtention et application au diagnostic de pneumonies
|
US5084379A
(en)
*
|
1983-04-29 |
1992-01-28 |
Biowhittaker, Inc. |
Fluorometric assay of chymopapain hypersensitivity and reagents therefor
|
US4851356A
(en)
*
|
1983-05-06 |
1989-07-25 |
The Trustees Of Columbia University In The City Of New York |
Immunoassay for human chorionic gonadotropin
|
JPS60501271A
(ja)
*
|
1983-05-06 |
1985-08-08 |
ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク |
ヒト絨毛性ゴナドトロピンのイムノアツセイ
|
US4642284A
(en)
*
|
1983-06-13 |
1987-02-10 |
Scripps Clinic And Research Foundation |
Method and system for detection of complement pathway activation
|
GB8317124D0
(en)
*
|
1983-06-23 |
1983-07-27 |
Ekins R P |
Free ligand assay
|
USRE34405E
(en)
*
|
1983-08-01 |
1993-10-12 |
Abbott Laboratories |
Determination of analytes in particle-containing medium
|
EP0154625A4
(en)
*
|
1983-08-18 |
1987-09-02 |
Quidel |
HYBRIDOME CELL LINE PRODUCING AN ALLERGY SUPPRESSOR FACTOR.
|
US4828981A
(en)
*
|
1983-08-24 |
1989-05-09 |
Synbiotics Corporation |
Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
|
JPS6060557A
(ja)
*
|
1983-09-13 |
1985-04-08 |
Eisai Co Ltd |
Pivka−2の測定方法および試薬
|
JPS6080768A
(ja)
*
|
1983-10-12 |
1985-05-08 |
Eisai Co Ltd |
塩基性胎児蛋白の測定方法および試薬
|
US4595661A
(en)
*
|
1983-11-18 |
1986-06-17 |
Beckman Instruments, Inc. |
Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect
|
US6846654B1
(en)
|
1983-11-29 |
2005-01-25 |
Igen International, Inc. |
Catalytic antibodies as chemical sensors
|
US5229272A
(en)
*
|
1989-04-25 |
1993-07-20 |
Igen, Inc. |
Catalytic antibody components
|
US6057121A
(en)
*
|
1983-11-29 |
2000-05-02 |
Igen International, Inc. |
Method of catalyzing stereochemical reactions
|
US4839275A
(en)
*
|
1983-12-01 |
1989-06-13 |
The Jewish Hospital |
Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
|
EP0168422A1
(en)
*
|
1983-12-12 |
1986-01-22 |
Meru, Inc. |
Method and materials for the identification of lipopolysaccharide producing microorganisms
|
US4683196A
(en)
*
|
1983-12-12 |
1987-07-28 |
Meru, Inc. |
Method and materials for the identification of lipopolysaccharide producing microorganisms
|
US4610960A
(en)
*
|
1983-12-21 |
1986-09-09 |
Wisconsin Alumni Research Foundation |
Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
|
US4666865A
(en)
*
|
1984-01-13 |
1987-05-19 |
Centocor, Inc. |
Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
|
US4757001A
(en)
*
|
1984-02-16 |
1988-07-12 |
Fujirebio Kabushiki Kaisha |
Method of measuring biological ligand by utilizing amylase
|
GB8404368D0
(en)
*
|
1984-02-20 |
1984-03-28 |
Cogent Ltd |
Monoclonal antibodies to human cytomegalovirus
|
US4865997A
(en)
*
|
1984-02-23 |
1989-09-12 |
Becton Dickinson And Company |
Assay for ligands by separating bound and free tracer from sample
|
US4690890A
(en)
*
|
1984-04-04 |
1987-09-01 |
Cetus Corporation |
Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
|
US4780401A
(en)
*
|
1984-04-09 |
1988-10-25 |
Ciba-Geigy Corporation |
Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
|
GR850899B
(ja)
*
|
1984-04-12 |
1985-11-25 |
Gen Hospital Corp |
|
US5011771A
(en)
*
|
1984-04-12 |
1991-04-30 |
The General Hospital Corporation |
Multiepitopic immunometric assay
|
CA1260372A
(en)
*
|
1984-04-27 |
1989-09-26 |
Elazar Rabbani |
Hybridization method for the detection of genetic materials
|
US4632901A
(en)
*
|
1984-05-11 |
1986-12-30 |
Hybritech Incorporated |
Method and apparatus for immunoassays
|
ZA853756B
(en)
*
|
1984-06-01 |
1986-01-29 |
Miles Lab |
Nucleic acid hybridization assay employing immobilized rna probes
|
US4731326A
(en)
*
|
1984-06-04 |
1988-03-15 |
Ortho Diagnostic Systems Inc. |
Disease diagnosis by detection of shed normal tissue antigens
|
US4636478A
(en)
*
|
1984-07-16 |
1987-01-13 |
Becton, Dickinson And Company |
Monoclonal antibodies recognizing L-thyroxine
|
AU4637185A
(en)
*
|
1984-08-01 |
1986-02-25 |
Advanced Biotechnology Associates Inc. |
A salmonella specific analysis reagent
|
US4707438A
(en)
*
|
1984-08-22 |
1987-11-17 |
Tel Aviv University |
Immunoassay for breast cancer employing monoclonal antibodies
|
IL76184A0
(en)
*
|
1984-08-28 |
1985-12-31 |
Hybritech Inc |
Article for diagnostic assays
|
US4745075A
(en)
*
|
1984-09-06 |
1988-05-17 |
Burroughs Wellcome Co. |
Diagnostic test methods
|
WO1986002736A1
(en)
*
|
1984-10-29 |
1986-05-09 |
Eks, Inc. |
Immunoassay method for small molecules
|
JPS62500686A
(ja)
*
|
1984-10-31 |
1987-03-19 |
アルコン ラボラトリ−ズ インコ−ポレイテツド |
抗原の定性試験、製品および方法
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
JPH0672893B2
(ja)
*
|
1985-08-16 |
1994-09-14 |
富士薬品工業株式会社 |
ヒト血中のヒトプロリルヒドロキシラーゼの放射性免疫学的測定法による定量法
|
DE3508384A1
(de)
*
|
1985-03-08 |
1986-11-06 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Hemmung humaner speichel- und pankreasamylase durch monoklonale antikoerper
|
DE3509958A1
(de)
*
|
1985-03-20 |
1986-09-25 |
Bayer Ag, 5090 Leverkusen |
Monoklonale antikoerper gegen atriale, natriuretische peptide vom menschen
|
US4722889A
(en)
*
|
1985-04-02 |
1988-02-02 |
Leeco Diagnostics, Inc. |
Immunoassays using multiple monoclonal antibodies and scavenger antibodies
|
US4707443A
(en)
*
|
1985-04-19 |
1987-11-17 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
|
US4935339A
(en)
*
|
1985-05-07 |
1990-06-19 |
Nichols Institute Diagnostics |
Delayed solid phase immunologic assay
|
US4737456A
(en)
*
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
US5273882A
(en)
*
|
1985-06-13 |
1993-12-28 |
Amgen |
Method and kit for performing nucleic acid hybridization assays
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
US5112738A
(en)
*
|
1985-07-03 |
1992-05-12 |
Miles Inc. |
Histamine derivatives, immunogen conjugates and antibodies raised thereto
|
US4910133A
(en)
*
|
1985-08-29 |
1990-03-20 |
Ube Industries, Limited |
Diagnostic test drug comprising monoclonal antibody to human copper.zinc-superoxide dismutase and diagnostic test method using the same
|
US5063151A
(en)
*
|
1985-09-20 |
1991-11-05 |
Biometallics, Inc. |
Immunoassay method and kit
|
US5595908A
(en)
*
|
1985-09-26 |
1997-01-21 |
University Of Southern Mississipi |
Piezoelectric device for detection of polynucleotide hybridization
|
US4933275A
(en)
*
|
1985-10-24 |
1990-06-12 |
The General Hospital Corporation |
Method for the detection of a polypeptide subunit in the presence of a quaternary protein containing the subunit
|
US6265176B1
(en)
|
1985-10-29 |
2001-07-24 |
Cordis Corporation |
Dot immunoassay on plastic sheets
|
US4770993A
(en)
*
|
1985-10-31 |
1988-09-13 |
Beatrice Companies, Inc. |
Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin
|
US5501949A
(en)
*
|
1985-12-10 |
1996-03-26 |
Murex Diagnostics Corporation |
Particle bound binding component immunoassay
|
US4868108A
(en)
*
|
1985-12-12 |
1989-09-19 |
Hygeia Sciences, Incorporated |
Multiple-antibody detection of antigen
|
US4810639A
(en)
*
|
1985-12-20 |
1989-03-07 |
E. I. Du Pont De Nemours And Company |
Immunoassay for CK-MB using bound and soluble antibodies
|
US4772551A
(en)
*
|
1985-12-26 |
1988-09-20 |
Neogen Corporation |
Method and test kit for detecting a trichothecene using novel monoclonal antibodies
|
US5175113A
(en)
*
|
1986-01-16 |
1992-12-29 |
Novo Nordisk A/S |
Modified β2 -microglobulin
|
US4741999A
(en)
*
|
1986-02-26 |
1988-05-03 |
The Research Foundation Of State University Of New York |
Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease
|
JPS62231168A
(ja)
|
1986-03-21 |
1987-10-09 |
ハイブリテツク・インコ−ポレイテツド |
アナライト−レセプタ−分析用内部標準を設けるための改良法
|
EP0266370A1
(en)
*
|
1986-03-26 |
1988-05-11 |
Murex Corporation |
Device and method for determining microbial resistance to antimicrobic agents
|
US5006459A
(en)
*
|
1986-03-31 |
1991-04-09 |
T Cell Sciences, Inc. |
Therapeutic and diagnostic methods using soluble T cell surface molecules
|
US5426029A
(en)
*
|
1986-03-31 |
1995-06-20 |
T Cell Diagnostics, Inc. |
Therapeutic and diagnostic methods using leukocyte surface antigens
|
US5292636A
(en)
*
|
1986-03-31 |
1994-03-08 |
T Cell Diagnostics, Inc. |
Therapeutic and diagnostic methods using soluble T cell surface molecules
|
US6881536B1
(en)
*
|
1986-04-30 |
2005-04-19 |
Bioveris Corporation |
Particle based electrochemiluminescent assays
|
US4963355A
(en)
*
|
1986-06-23 |
1990-10-16 |
Igen, Inc. |
Production of antibody catalysts
|
US5120504A
(en)
*
|
1986-07-14 |
1992-06-09 |
Hybritech Incorporated |
Apparatus for immunoassays with vent chennels in the container side wall
|
ATE120233T1
(de)
*
|
1986-08-06 |
1995-04-15 |
Scripps Clinic Res |
Monoklonale antikörper, b-spezifisch für apolipoprotein, die von zwei hybridomen erzeugt werden.
|
US4935343A
(en)
*
|
1986-08-08 |
1990-06-19 |
Syntex (U.S.A.) Inc. |
Monoclonal antibodies for interleukin-1β
|
US5316914A
(en)
*
|
1986-09-04 |
1994-05-31 |
Fuji Yakuhin Kogyo Kabushiki Kaisha |
Method for determining human collagen peptides by way of enzyme immunoassay
|
US5763262A
(en)
*
|
1986-09-18 |
1998-06-09 |
Quidel Corporation |
Immunodiagnostic device
|
US20010023075A1
(en)
*
|
1992-04-03 |
2001-09-20 |
Siu-Yin Wong |
A immunodiagnositc device having a dessicant incorporated therein
|
US4828986A
(en)
*
|
1986-09-29 |
1989-05-09 |
Scripps Clinic And Research Foundation |
Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
|
US4804626A
(en)
*
|
1986-10-22 |
1989-02-14 |
The General Hospital Corporation |
Immunometric assay for the detection of human chorionic gonadotropin
|
US4911909A
(en)
*
|
1987-01-02 |
1990-03-27 |
E. I. Du Pont De Nemours And Company |
Method of controlling hypertension using monoclonal antibodies to angiotensin-II
|
US4940659A
(en)
*
|
1987-02-20 |
1990-07-10 |
Monoclonetics International, Inc. |
Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome
|
US5789235A
(en)
*
|
1987-03-23 |
1998-08-04 |
Tackett; Scott E. |
Modifying cell metabolism via extra-cellular nucleases
|
DE3714147A1
(de)
*
|
1987-04-28 |
1988-11-17 |
Boehringer Mannheim Gmbh |
Immunchemisches verfahren und reagenz zur bestimmung eines polyvalenten antigens in einer fluessigen probe
|
US4788138A
(en)
*
|
1987-04-30 |
1988-11-29 |
Beckman Instruments, Inc. |
Method to achieve a linear standard curve in a sandwich immunoassay
|
US5474899A
(en)
*
|
1987-05-13 |
1995-12-12 |
Cistron Biotechnology, Inc. |
Selective immunoassay for IL-1 β
|
US5149626A
(en)
*
|
1987-05-14 |
1992-09-22 |
Mclean Hospital Corporation |
Multiple antigen immunoassay
|
FR2615622B1
(fr)
*
|
1987-05-19 |
1994-05-06 |
Ire Medgenix Sa |
Dosage plasmatique de monokines
|
US5009998A
(en)
*
|
1987-06-26 |
1991-04-23 |
E. I. Du Pont De Nemours And Company |
Method for performing heterogeneous immunoassay
|
US4971904A
(en)
*
|
1987-06-26 |
1990-11-20 |
E. I. Du Pont De Nemours And Company |
Heterogeneous immunoassay
|
US5179000A
(en)
*
|
1987-07-24 |
1993-01-12 |
Nippon Kayaku Kabushiki Kaisha |
Method for assaying basic fetoprotein in urine and assay kit therefor
|
US5447837A
(en)
*
|
1987-08-05 |
1995-09-05 |
Calypte, Inc. |
Multi-immunoassay diagnostic system for antigens or antibodies or both
|
EP0305870B1
(en)
*
|
1987-09-02 |
1994-04-13 |
Igen, Incorporated |
Production of immunoproximity catalysts
|
US6461825B1
(en)
*
|
1987-09-30 |
2002-10-08 |
Sanofi (Societe Anonyme) |
Immunometric assay kit and method applicable to whole cells
|
US4859612A
(en)
*
|
1987-10-07 |
1989-08-22 |
Hygeia Sciences, Inc. |
Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
|
DE3734015A1
(de)
*
|
1987-10-08 |
1989-04-20 |
Behringwerke Ag |
Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b
|
US5231000A
(en)
*
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
US5217869A
(en)
*
|
1987-10-13 |
1993-06-08 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
US5300425A
(en)
*
|
1987-10-13 |
1994-04-05 |
Terrapin Technologies, Inc. |
Method to produce immunodiagnostic reagents
|
US5256372A
(en)
*
|
1987-11-06 |
1993-10-26 |
Idexx Corporation |
Dipstick test device including a removable filter assembly
|
US5094941A
(en)
*
|
1987-12-31 |
1992-03-10 |
Zymogenetics, Inc. |
Monoclonal antibodies to PDGF
|
US4891313A
(en)
*
|
1988-01-21 |
1990-01-02 |
Boehringer Manheim Corporation |
Method for determination of a component of a sample
|
WO1989009393A1
(en)
*
|
1988-03-24 |
1989-10-05 |
Igen, Inc. |
Luminescent chimeric proteins
|
US5202267A
(en)
*
|
1988-04-04 |
1993-04-13 |
Hygeia Sciences, Inc. |
Sol capture immunoassay kit and procedure
|
US6702705B1
(en)
|
1988-05-04 |
2004-03-09 |
Igen International, Inc. |
Prodrugs activated by targeted catalytic proteins
|
US5620845A
(en)
*
|
1988-06-06 |
1997-04-15 |
Ampcor, Inc. |
Immunoassay diagnostic kit
|
US5173399A
(en)
*
|
1988-06-10 |
1992-12-22 |
Abbott Laboratories |
Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
|
AU2684488A
(en)
*
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
CA1335880C
(en)
|
1988-07-14 |
1995-06-13 |
Thomas P. O'connor |
Detection of an antibody and antigen in an immunoassay
|
US5096809A
(en)
*
|
1988-07-25 |
1992-03-17 |
Pacific Biotech, Inc. |
Whole blood assays using porous membrane support devices
|
US5059522A
(en)
*
|
1988-08-18 |
1991-10-22 |
Wayne Lawrence G |
Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
|
US5030555A
(en)
*
|
1988-09-12 |
1991-07-09 |
University Of Florida |
Membrane-strip reagent serodiagnostic apparatus and method
|
DE3836348A1
(de)
*
|
1988-10-25 |
1990-04-26 |
Boehringer Mannheim Gmbh |
Verfahren zur bestimmung von fuer ein antigen klassenspezifischen antikoerpern und dazu geeignetes reagenz
|
EP0368674A3
(en)
*
|
1988-11-11 |
1991-10-09 |
SANYO CHEMICAL INDUSTRIES, Ltd. |
Immunoassay and test kits therefor
|
US6306594B1
(en)
|
1988-11-14 |
2001-10-23 |
I-Stat Corporation |
Methods for microdispensing patterened layers
|
US5200051A
(en)
*
|
1988-11-14 |
1993-04-06 |
I-Stat Corporation |
Wholly microfabricated biosensors and process for the manufacture and use thereof
|
US5322838A
(en)
*
|
1988-11-16 |
1994-06-21 |
Brigham & Women's Hospital |
Use of INHIB (the C3 β-chain) in the detection and inhibition of inflammation
|
US5512657A
(en)
*
|
1988-12-12 |
1996-04-30 |
Bainbridge Sciences, Inc. |
Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
|
US5264370A
(en)
*
|
1988-12-12 |
1993-11-23 |
Bainbridge Laboratories, Inc. |
Detection of basement membrane components as diagnostic of cancer and other diseases
|
CA2008304C
(en)
*
|
1989-01-31 |
2001-03-27 |
Craig S. Hill |
Assay for bone alkaline phosphatase
|
CA2046661A1
(en)
*
|
1989-02-03 |
1990-08-04 |
John G. Steele |
Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
|
US5106761A
(en)
*
|
1989-03-13 |
1992-04-21 |
International Canine Genetics, Inc. |
Method for detecting molecules in a liquid medium
|
US5194585A
(en)
*
|
1989-04-25 |
1993-03-16 |
Igen, Inc. |
Inhibitors of catalytic antibodies
|
US5599538A
(en)
*
|
1989-04-25 |
1997-02-04 |
Igen, Inc. |
Autoantibodies which enhance the rate of a chemical reaction
|
US5658753A
(en)
*
|
1989-04-25 |
1997-08-19 |
Paul; Sudhir |
Catalytic antibody components
|
US6048717A
(en)
*
|
1989-04-25 |
2000-04-11 |
Igen International, Inc. |
Inhibitors of catalytic antibodies
|
US5318897A
(en)
*
|
1989-04-25 |
1994-06-07 |
Igen, Inc. |
Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state
|
US5236836A
(en)
*
|
1989-04-25 |
1993-08-17 |
Igen, Inc. |
Autoantibodies which enhance the rate of a chemical reaction
|
US6258360B1
(en)
|
1989-05-04 |
2001-07-10 |
Igen International, Inc. |
Prodrugs activated by targeted catalytic proteins
|
WO1990015153A1
(en)
*
|
1989-06-02 |
1990-12-13 |
Georgetown University |
A method for the detection of anti-streptokinase antibodies
|
AU643950B2
(en)
*
|
1989-06-06 |
1993-12-02 |
Martin Gould |
Immunoassay diagnostic kit
|
US5187068A
(en)
*
|
1989-06-09 |
1993-02-16 |
Nicolae Luca |
Method for determination of lipid moiety and apolipoprotein expressed epitope immunoreactivity on intact lipoprotein
|
US5484735A
(en)
*
|
1989-08-23 |
1996-01-16 |
Northwestern University |
Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids
|
US6008057A
(en)
*
|
1989-08-25 |
1999-12-28 |
Roche Diagnostics Corporation |
Immunoassay system
|
US5830709A
(en)
*
|
1989-10-27 |
1998-11-03 |
Benson; Roger E. |
Detection method for homologous portions of a class of substances
|
US5196311A
(en)
*
|
1989-10-27 |
1993-03-23 |
Health Research, Incorporated |
Elisa test for von willebrand factor
|
US5202264A
(en)
*
|
1989-10-27 |
1993-04-13 |
Health Research, Incorporated |
ELISA using multi-species antibodies for detection of von Willebrand factor in multiple species
|
EP0678744B1
(en)
*
|
1989-11-03 |
1999-09-15 |
MORTON, Donald L. |
Method for detecting urinary tumor associated antigens
|
US5624898A
(en)
|
1989-12-05 |
1997-04-29 |
Ramsey Foundation |
Method for administering neurologic agents to the brain
|
US6407061B1
(en)
*
|
1989-12-05 |
2002-06-18 |
Chiron Corporation |
Method for administering insulin-like growth factor to the brain
|
US5196324A
(en)
*
|
1989-12-15 |
1993-03-23 |
Eli Lilly And Company |
Monoclonal antibodies reactive with a human atheroma associated antigen
|
KR910014706A
(ko)
*
|
1990-01-10 |
1991-08-31 |
원본미기재 |
세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
|
JP2552047B2
(ja)
*
|
1990-01-26 |
1996-11-06 |
ワシントン リサーチ ファウンデーション |
悪性腫瘍の検査方法
|
US6190885B1
(en)
|
1990-02-02 |
2001-02-20 |
Cancer Research Fund Of Contra Costa |
Fusion protein containing HMFG Epitop E (S)
|
US5532135A
(en)
*
|
1990-02-02 |
1996-07-02 |
Cancer Research Fund Of Contra Costa |
Solid-phase competitive assay utilizing a fusion protein
|
EP0468056A4
(en)
*
|
1990-02-07 |
1992-07-08 |
Kanebo Ltd. |
Anti-procollagenase monoclonal antibodies and a method for the assay of procollagenase utilizing thereof
|
US5096837A
(en)
*
|
1990-02-08 |
1992-03-17 |
Pacific Biotech, Inc. |
Immunochromatographic assay and method of using same
|
US5922615A
(en)
|
1990-03-12 |
1999-07-13 |
Biosite Diagnostics Incorporated |
Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
|
US5223220A
(en)
*
|
1990-03-27 |
1993-06-29 |
Pacific Biotech, Inc. |
Solid phase immunoassay device and method of making same
|
DE69130536T2
(de)
*
|
1990-08-02 |
1999-04-22 |
Antex Biolog Inc |
Adhäsionsrezeptoren für pathogene oder opportunistische mikroorganismen
|
CA2072758A1
(en)
*
|
1990-09-14 |
1992-03-15 |
Kenneth Francis Buechler |
Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
|
JPH085920B2
(ja)
*
|
1991-01-21 |
1996-01-24 |
富士薬品工業株式会社 |
抗ヒトストロムライシンモノクローナル抗体及び酵素免疫測定法
|
US5997878A
(en)
|
1991-03-07 |
1999-12-07 |
Connaught Laboratories |
Recombinant poxvirus-cytomegalovirus, compositions and uses
|
AU657102B2
(en)
*
|
1991-04-12 |
1995-03-02 |
Bio-Rad Laboratories, Inc. |
CA 195-like immunoreactive antigen from human amniotic fluid
|
US5223396A
(en)
*
|
1991-05-03 |
1993-06-29 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Method for detecting organ transplant rejection
|
WO1992020820A1
(en)
*
|
1991-05-15 |
1992-11-26 |
Vanderbilt University |
Method to determine metastatic potential of tumor cells
|
US6168956B1
(en)
|
1991-05-29 |
2001-01-02 |
Beckman Coulter, Inc. |
Multiple component chromatographic assay device
|
US5877028A
(en)
|
1991-05-29 |
1999-03-02 |
Smithkline Diagnostics, Inc. |
Immunochromatographic assay device
|
US5869345A
(en)
*
|
1991-05-29 |
1999-02-09 |
Smithkline Diagnostics, Inc. |
Opposable-element assay device employing conductive barrier
|
US5998220A
(en)
|
1991-05-29 |
1999-12-07 |
Beckman Coulter, Inc. |
Opposable-element assay devices, kits, and methods employing them
|
US5607863A
(en)
*
|
1991-05-29 |
1997-03-04 |
Smithkline Diagnostics, Inc. |
Barrier-controlled assay device
|
US5468648A
(en)
*
|
1991-05-29 |
1995-11-21 |
Smithkline Diagnostics, Inc. |
Interrupted-flow assay device
|
WO1992022668A1
(en)
*
|
1991-06-14 |
1992-12-23 |
Vanderbilt University |
Method and compositions to assess oxidative stress in vivo
|
US5338660A
(en)
*
|
1991-07-12 |
1994-08-16 |
Board Of Supervisors Of Louisiana State University And Agricutural And Mechanical College |
Diagnosis of Fasciola infections by detection of antigens in feces or intestinal content
|
WO1993002359A1
(en)
*
|
1991-07-19 |
1993-02-04 |
Assay Research, Inc. |
Method and kit for measuring endogenous cytokines
|
US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
US5726010A
(en)
*
|
1991-07-31 |
1998-03-10 |
Idexx Laboratories, Inc. |
Reversible flow chromatographic binding assay
|
US6007999A
(en)
*
|
1991-07-31 |
1999-12-28 |
Idexx Laboratories, Inc. |
Reversible flow chromatographic binding assay
|
US5369006A
(en)
*
|
1991-08-20 |
1994-11-29 |
E. I. Du Pont De Nemours And Company |
Determination of CK isoenzymes and CK isoforms
|
CA2116453A1
(en)
|
1991-08-28 |
1993-03-18 |
Basil Rapoport |
Disease associated human autoantibodies specific for human thyroid peroxidase
|
DE4134297A1
(de)
*
|
1991-10-17 |
1993-04-22 |
Behringwerke Ag |
Monoclonale antikoerper gegen mycoplasma pneumoniae, diese produzierende hybridome, verfahren zu deren herstellung sowie deren verwendung
|
DE69230502T3
(de)
*
|
1991-10-23 |
2006-05-24 |
Thomas Jefferson University |
Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen
|
AU2874292A
(en)
*
|
1991-10-24 |
1993-05-21 |
Beth Israel Hospital Association, The |
Assay for malignant effusions
|
US5525461A
(en)
*
|
1991-11-01 |
1996-06-11 |
T Cell Diagnostics, Inc. |
Therapeutic and diagnostic methods using total leukocyte surface antigens
|
US5616503A
(en)
*
|
1992-01-17 |
1997-04-01 |
Self; Colin H. |
Determination of haptens
|
ATE138478T1
(de)
*
|
1992-02-17 |
1996-06-15 |
Akzo Nobel Nv |
Kalibrator und verwendung davon in einer immuntest
|
US5851787A
(en)
*
|
1992-04-20 |
1998-12-22 |
The General Hospital Corporation |
Nucleic acid encoding amyloid precursor-like protein and uses thereof
|
US5708141A
(en)
*
|
1992-05-11 |
1998-01-13 |
Corvas International, Inc. |
Neutrophil inhibitors
|
DE4218257A1
(de)
*
|
1992-06-03 |
1993-12-09 |
Behringwerke Ag |
Verfahren zur immunchemischen Bestimmung eines Analyten
|
US5688936A
(en)
*
|
1992-06-11 |
1997-11-18 |
The Regents Of The University Of California |
Vesicle membrane transport proteins
|
US5395754A
(en)
*
|
1992-07-31 |
1995-03-07 |
Hybritech Incorporated |
Membrane-based immunoassay method
|
US5447838A
(en)
*
|
1992-08-05 |
1995-09-05 |
Hybritech Incorporated |
Protein-dye conjugate for confirmation of correct dilution of calibrators
|
US5789183A
(en)
*
|
1992-08-14 |
1998-08-04 |
University Of Arkansas |
Serological detection and identification of rice blast
|
US5354692A
(en)
*
|
1992-09-08 |
1994-10-11 |
Pacific Biotech, Inc. |
Analyte detection device including a hydrophobic barrier for improved fluid flow
|
RU2137131C1
(ru)
*
|
1992-12-18 |
1999-09-10 |
Молекьюлар Ар-Экс, Инк. |
Гибридная клеточная линия (варианты), препарат антител (варианты), способ диагностики рассеянного склероза у человека (варианты), способ лечения человека, полипептид
|
EP0606516B1
(en)
*
|
1993-01-13 |
1998-12-30 |
Idemitsu Kosan Company Limited |
Anti-human ceruloplasmin monoclonal antibody
|
US5914241A
(en)
*
|
1993-01-19 |
1999-06-22 |
Biosite Diagnostics, Inc. |
Assays and kits for detecting analytes in the presence of cross-reacting substances
|
FR2700855B1
(fr)
*
|
1993-01-28 |
1995-03-03 |
Commissariat Energie Atomique |
Dosage immunométrique d'un antigène ou d'un haptène.
|
US7713528B1
(en)
|
1993-02-18 |
2010-05-11 |
Enzo Therapeutics, Inc. |
Method for in vivo delivery of active compounds using reagent conjugate
|
US5374531A
(en)
*
|
1993-03-22 |
1994-12-20 |
Zynaxis, Inc. |
Immunoassay for determination of cells
|
DE4314254A1
(de)
*
|
1993-04-30 |
1994-11-03 |
Boehringer Mannheim Gmbh |
Monoklonale Antikörper gegen CK-MB
|
CA2164725A1
(en)
*
|
1993-06-08 |
1994-12-22 |
Alexander Saunders |
Two-phase optical assay method and apparatus
|
JPH09501767A
(ja)
*
|
1993-07-29 |
1997-02-18 |
コア セラピューティクス,インコーポレイティド |
レセプター機能検定
|
US5837546A
(en)
*
|
1993-08-24 |
1998-11-17 |
Metrika, Inc. |
Electronic assay device and method
|
WO1995008336A1
(en)
*
|
1993-09-22 |
1995-03-30 |
Nichols Institute Diagnostics |
Graves' ophthalmopathy associated antibodies, graves' ophthalmopathy orbital antigen, and methods of use thereof
|
JP3356556B2
(ja)
*
|
1993-10-22 |
2002-12-16 |
第一化学薬品株式会社 |
変性リポプロテイン類の測定法
|
US7312052B1
(en)
|
1993-12-08 |
2007-12-25 |
Stratagene California |
Polymerase compositions and uses thereof
|
US5695928A
(en)
|
1993-12-10 |
1997-12-09 |
Novartis Corporation |
Rapid immunoassay for detection of antibodies or antigens incorporating simultaneous sample extraction and immunogenic reaction
|
US6045797A
(en)
*
|
1994-03-14 |
2000-04-04 |
New York University Medical Center |
Treatment or diagnosis of diseases or conditions associated with a BLM domain
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US6660842B1
(en)
*
|
1994-04-28 |
2003-12-09 |
Tripep Ab |
Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
|
US6040137A
(en)
*
|
1995-04-27 |
2000-03-21 |
Tripep Ab |
Antigen/antibody specification exchanger
|
US6417324B1
(en)
*
|
2000-04-21 |
2002-07-09 |
Tripep Ab |
Synthetic peptides that bind to the hepatitis B virus core and e antigens
|
US6933366B2
(en)
*
|
1996-12-27 |
2005-08-23 |
Tripep Ab |
Specificity exchangers that redirect antibodies to bacterial adhesion receptors
|
US6140099A
(en)
*
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US6107045A
(en)
|
1994-06-30 |
2000-08-22 |
Oklahoma Medical Research Foundation |
Antibodies to lipoproteins and apolipoproteins and methods of use thereof
|
ATE209660T1
(de)
|
1994-08-12 |
2001-12-15 |
Myriad Genetics Inc |
17q-verbundenes ovarial- und brustkrebs empfindlichkeitsgen
|
CA2196797C
(en)
|
1994-08-12 |
2000-10-10 |
Donna M. Shattuck-Eidens |
In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
|
US6974666B1
(en)
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
JP2729159B2
(ja)
*
|
1994-10-31 |
1998-03-18 |
日清製粉株式会社 |
ヒトグリセンチンのモノクローナル抗体、この抗体を産生するハイブリドーマおよびそれを用いるヒトグリセンチンの定量法
|
JP2000503521A
(ja)
|
1994-11-02 |
2000-03-28 |
トロフィックス ファーマシューティカルズ,インコーポレイテッド |
末梢神経系特異的ナトリウムチャンネル、それをコードするdna、結晶化、x線回折、コンピューター分子モデリング、合理的薬物設計、薬物スクリーニング、ならびにその製造法および使用法
|
US5837815A
(en)
*
|
1994-12-15 |
1998-11-17 |
Sugen, Inc. |
PYK2 related polypeptide products
|
IL114615A0
(en)
|
1995-07-16 |
1995-11-27 |
Yeda Res & Dev |
Modulators of the function of fas receptors and other proteins
|
US5837524A
(en)
*
|
1994-12-15 |
1998-11-17 |
Sugen, Inc. |
PYK2 related polynucleotide products
|
US5807989A
(en)
*
|
1994-12-23 |
1998-09-15 |
New York University |
Methods for treatment or diagnosis of diseases or disorders associated with an APB domain
|
US6300482B1
(en)
|
1995-01-03 |
2001-10-09 |
Max-Flanck-Gesellschaft Zuer For{Overscore (D)}Erung Der |
MDKI, a novel receptor tyrosine kinase
|
US5569608A
(en)
*
|
1995-01-30 |
1996-10-29 |
Bayer Corporation |
Quantitative detection of analytes on immunochromatographic strips
|
US5783387A
(en)
*
|
1995-02-06 |
1998-07-21 |
The Regents Of The University Of California |
Method for identifying and quantifying nucleic acid sequence aberrations
|
US5731153A
(en)
*
|
1996-08-26 |
1998-03-24 |
The Regents Of The University Of California |
Identification of random nucleic acid sequence aberrations using dual capture probes which hybridize to different chromosome regions
|
US5874214A
(en)
*
|
1995-04-25 |
1999-02-23 |
Irori |
Remotely programmable matrices with memories
|
US6416714B1
(en)
*
|
1995-04-25 |
2002-07-09 |
Discovery Partners International, Inc. |
Remotely programmable matrices with memories
|
US5751629A
(en)
*
|
1995-04-25 |
1998-05-12 |
Irori |
Remotely programmable matrices with memories
|
US5741462A
(en)
*
|
1995-04-25 |
1998-04-21 |
Irori |
Remotely programmable matrices with memories
|
US6017496A
(en)
*
|
1995-06-07 |
2000-01-25 |
Irori |
Matrices with memories and uses thereof
|
US6331273B1
(en)
|
1995-04-25 |
2001-12-18 |
Discovery Partners International |
Remotely programmable matrices with memories
|
US6329139B1
(en)
|
1995-04-25 |
2001-12-11 |
Discovery Partners International |
Automated sorting system for matrices with memory
|
US5686257A
(en)
*
|
1995-04-26 |
1997-11-11 |
Schering Corporation |
Binding compositions for mammalian T cell antigens and related reagents
|
US6147106A
(en)
*
|
1997-08-20 |
2000-11-14 |
Sugen, Inc. |
Indolinone combinatorial libraries and related products and methods for the treatment of disease
|
CA2245835A1
(en)
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
US6027879A
(en)
*
|
1995-08-09 |
2000-02-22 |
The Regents Of The University Of California |
Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe
|
US7635597B2
(en)
*
|
1995-08-09 |
2009-12-22 |
Bayer Healthcare Llc |
Dry reagent particle assay and device having multiple test zones and method therefor
|
US5616465A
(en)
|
1995-08-09 |
1997-04-01 |
The Regents Of The University Of California |
Detection and isolation of nucleic acid sequences using competitive hybridization probes
|
US5733728A
(en)
*
|
1995-08-18 |
1998-03-31 |
Regents Of The University Of Colorado |
Detecting and treating heart failure
|
US5660990A
(en)
*
|
1995-08-18 |
1997-08-26 |
Immunivest Corporation |
Surface immobilization of magnetically collected materials
|
US7455964B1
(en)
|
1996-07-15 |
2008-11-25 |
The Hospital For Sick Children |
Genes from the 20q13 amplicon and their uses
|
US7119174B2
(en)
*
|
1995-12-18 |
2006-10-10 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
US6716575B2
(en)
|
1995-12-18 |
2004-04-06 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
JP3449419B2
(ja)
|
1995-12-22 |
2003-09-22 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
KVLQT1をコードするQT延長症候群遺伝子およびそのminKとの関連
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US5770086A
(en)
*
|
1996-01-25 |
1998-06-23 |
Eureka| Science Corp. |
Methods and apparatus using hydrogels
|
US5942385A
(en)
*
|
1996-03-21 |
1999-08-24 |
Sugen, Inc. |
Method for molecular diagnosis of tumor angiogenesis and metastasis
|
US6531578B1
(en)
|
1996-04-12 |
2003-03-11 |
Robert Webber |
Immunoassay method employing monoclonal antibody reactive to human iNOS
|
US5968839A
(en)
*
|
1996-05-13 |
1999-10-19 |
Metrika, Inc. |
Method and device producing a predetermined distribution of detectable change in assays
|
EP0979101B1
(en)
|
1996-07-03 |
2010-10-27 |
Merial, Inc. |
Recombinant canine adenovirus 2 (cav2) containing exogenous dna
|
US6524578B1
(en)
|
1996-07-10 |
2003-02-25 |
Scott E. Tackett |
Use of nuclease to reduce wrinkles and discolorations in humans
|
DE19629444A1
(de)
*
|
1996-07-22 |
1998-01-29 |
Behringwerke Ag |
Sensitivitätssteigerung bei der immunchemischen Bestimmung eines Analyten
|
US6297027B1
(en)
|
1996-07-31 |
2001-10-02 |
Purina Mills, Inc. |
Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
|
US6277592B1
(en)
|
1996-07-31 |
2001-08-21 |
Purina Mills, Inc. |
Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US5945345A
(en)
*
|
1996-08-27 |
1999-08-31 |
Metrika, Inc. |
Device for preventing assay interference using silver or lead to remove the interferant
|
US6001658A
(en)
*
|
1996-09-13 |
1999-12-14 |
Diagnostic Chemicals Limited |
Test strip apparatus and method for determining presence of analyte in a fluid sample
|
US5856194A
(en)
|
1996-09-19 |
1999-01-05 |
Abbott Laboratories |
Method for determination of item of interest in a sample
|
US5795784A
(en)
|
1996-09-19 |
1998-08-18 |
Abbott Laboratories |
Method of performing a process for determining an item of interest in a sample
|
EP0954585B1
(en)
|
1996-10-01 |
2009-11-25 |
Geron Corporation |
Human telomerase reverse transcriptase promoter
|
US6004791A
(en)
|
1996-11-13 |
1999-12-21 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Protein tyrosine phosphatase PTP20 and related products and methods
|
EP0944833B1
(en)
*
|
1996-12-09 |
2001-06-27 |
Osteometer Biotech AS |
Sandwich assays for collagen fragments
|
SI1019500T1
(sl)
|
1997-01-15 |
2007-02-28 |
Yeda Res & Dev |
Proteini, ki vezejo receptor 1 za ifn, dna, ki jih kodira, in postopki za regulacijo celicnega odziva na interferone
|
US5879951A
(en)
*
|
1997-01-29 |
1999-03-09 |
Smithkline Diagnostics, Inc. |
Opposable-element assay device employing unidirectional flow
|
DE69737457T2
(de)
|
1997-01-31 |
2007-11-29 |
Genentech, Inc., South San Francisco |
O-fukosyltransferase
|
US20040241645A1
(en)
*
|
1997-01-31 |
2004-12-02 |
Genentech, Inc. |
O-fucosyltransferase
|
EP0966533B1
(en)
|
1997-02-07 |
2009-09-16 |
The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services |
Activity dependent neurotrophic factor iii (adnf iii)
|
US20050101032A1
(en)
*
|
1997-02-10 |
2005-05-12 |
Metrika, Inc. |
Assay device, composition, and method of optimizing assay sensitivity
|
JP4245084B2
(ja)
*
|
1997-03-21 |
2009-03-25 |
ストラタジーン |
ポリメラーゼ増強因子(pef)抽出物、pefタンパク質複合体、単離されたpefタンパク質、並びに精製及び単離方法
|
US5939316A
(en)
*
|
1997-03-27 |
1999-08-17 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
US5955355A
(en)
*
|
1997-03-27 |
1999-09-21 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
US5866412A
(en)
*
|
1997-03-27 |
1999-02-02 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
US5914394A
(en)
*
|
1997-03-27 |
1999-06-22 |
Millenium Pharmaceuticals, Inc. |
Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
|
BRPI9809387B8
(pt)
|
1997-04-07 |
2021-05-25 |
Genentech Inc |
anticorpo humanizado anti-fator de crescimento endotelial vascular humano e composição que o compreende
|
NZ500077A
(en)
|
1997-04-07 |
2001-10-26 |
Genentech Inc |
Humanized antibodies to vascular endothelial growth factor (VEGF) and methods for their preparation.
|
SI0994728T1
(sl)
|
1997-04-09 |
2009-02-28 |
Intellect Neurosciences Inc |
Rekombinantna protitelesa, specifična za beta-amiloidne konce, kodirana z DNA ter postopki za njihovo uporabo
|
US6818440B2
(en)
*
|
1997-04-28 |
2004-11-16 |
Sugen, Inc. |
Diagnosis and treatment of alk-7 related disorders
|
US6103536A
(en)
|
1997-05-02 |
2000-08-15 |
Silver Lake Research Corporation |
Internally referenced competitive assays
|
US5939252A
(en)
*
|
1997-05-09 |
1999-08-17 |
Lennon; Donald J. |
Detachable-element assay device
|
US6228641B1
(en)
|
1997-05-20 |
2001-05-08 |
Sugen, Inc. |
Diagnosis and treatment of PTP04 related disorders
|
JP5264026B2
(ja)
|
1997-06-10 |
2013-08-14 |
エルパス・インコーポレイテッド |
心疾患の早期発見のための方法
|
US7115710B2
(en)
*
|
1997-06-11 |
2006-10-03 |
Sugen, Inc. |
Diagnosis and treatment of PTP related disorders
|
WO1998056892A1
(en)
|
1997-06-11 |
1998-12-17 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr9
|
US6342593B1
(en)
|
1997-06-11 |
2002-01-29 |
Sugen, Inc. |
Diagnosis and treatment of ALP related disorders
|
US6388063B1
(en)
|
1997-06-18 |
2002-05-14 |
Sugen, Inc. |
Diagnosis and treatment of SAD related disorders
|
US6235769B1
(en)
|
1997-07-03 |
2001-05-22 |
Sugen, Inc. |
Methods of preventing and treating neurological disorders with compounds that modulate the function of the C-RET receptor protein tyrosine kinase
|
US7087420B1
(en)
|
1997-07-17 |
2006-08-08 |
Cambia |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US6391547B1
(en)
*
|
1997-09-09 |
2002-05-21 |
Center For The Application Of Molecular Biology To International Agriculture |
Microbial β-glucuronidase genes, gene products and uses thereof
|
US20040067531A1
(en)
*
|
1997-08-20 |
2004-04-08 |
Sugen, Inc. |
Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
US20140080177A1
(en)
*
|
1997-09-26 |
2014-03-20 |
Pieris Ag |
Anticalins
|
AU750082B2
(en)
*
|
1997-09-29 |
2002-07-11 |
University Of Maryland At Baltimore |
Altered DNA synthesome components as biomarkers for malignancy
|
DE69838483T2
(de)
|
1997-10-14 |
2008-07-03 |
Darwin Molecular Corp. |
Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
|
DK1029046T3
(da)
|
1997-10-29 |
2009-02-02 |
Genentech Inc |
WNT-1 inducerbare gener
|
EP1027437B8
(en)
|
1997-10-29 |
2008-10-29 |
Genentech, Inc. |
Uses of the wnt-1 induced secreted polypeptide wisp-1
|
AU753157B2
(en)
|
1997-11-03 |
2002-10-10 |
Georgetown University Medical Center |
VEGI, an inhibitor of angiogenesis and tumor growth
|
US6224882B1
(en)
|
1997-11-07 |
2001-05-01 |
Protein Science Corp. |
Insect cells or fractions as adjuvant for antigens
|
DE69840105D1
(de)
|
1997-11-21 |
2008-11-20 |
Genentech Inc |
Plättchen-spezifische antigene und deren pharmazeutische verwendung
|
US7192589B2
(en)
|
1998-09-16 |
2007-03-20 |
Genentech, Inc. |
Treatment of inflammatory disorders with STIgMA immunoadhesins
|
US6437563B1
(en)
|
1997-11-21 |
2002-08-20 |
Quantum Design, Inc. |
Method and apparatus for making measurements of accumulations of magnetically susceptible particles combined with analytes
|
US6221585B1
(en)
|
1998-01-15 |
2001-04-24 |
Valigen, Inc. |
Method for identifying genes underlying defined phenotypes
|
CA2318403A1
(en)
*
|
1998-01-21 |
1999-07-29 |
Sugen, Inc. |
Human orthologues of wart
|
US6531502B1
(en)
*
|
1998-01-21 |
2003-03-11 |
Sugen, Inc. |
3-Methylidenyl-2-indolinone modulators of protein kinase
|
US6764830B1
(en)
|
1998-01-23 |
2004-07-20 |
The Regents Of The University Of California |
Thermomyces lanuginosus kinesin motor protein and methods of screening for modulators of kinesin proteins
|
WO1999047535A1
(en)
|
1998-03-16 |
1999-09-23 |
Millennium Pharmaceuticals, Inc. |
METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS
|
US20040176572A1
(en)
*
|
1998-03-16 |
2004-09-09 |
Freimer Nelson B. |
Methods of compositions for diagnosing and treating chromosome-18p related disorders
|
AU758353B2
(en)
|
1998-03-17 |
2003-03-20 |
Genentech Inc. |
Polypeptides homologous to VEGF and BMP1
|
US6274314B1
(en)
*
|
1998-04-02 |
2001-08-14 |
Nyxis Neurotherapies, Inc. |
Diagnostic assay for the modified nucleosides pseudouridine, 7-methyladenosine, or 1-methyladenosine
|
US6514981B1
(en)
|
1998-04-02 |
2003-02-04 |
Sugen, Inc. |
Methods of modulating tyrosine protein kinase function with indolinone compounds
|
WO1999053036A2
(en)
|
1998-04-14 |
1999-10-21 |
Sugen, Inc. |
Ste20-related protein kinases
|
US7157083B2
(en)
*
|
1998-04-17 |
2007-01-02 |
Surrogate Pharmaceutical Pathways, Llc |
Compositions and methods for treating retroviral infections
|
US20060019404A1
(en)
*
|
1998-05-06 |
2006-01-26 |
Blatt Joel M |
Quantitative assay with extended dynamic range
|
ATE522220T1
(de)
|
1998-05-19 |
2011-09-15 |
Res Dev Foundation |
Triterpenzusammensetzungen und deren verwendungsmethoden
|
JP5138844B2
(ja)
|
1998-06-12 |
2013-02-06 |
ザ・ヘンリー・エム・ジャクソン・ファンデイション・フォー・ジ・アドヴァンスメント・オヴ・ミリタリー・メディシン、インコーポレイテッド |
抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強
|
US7402400B2
(en)
|
2001-07-03 |
2008-07-22 |
Regents Of The University Of California |
Mammalian sweet taste receptors
|
EP1806362B1
(en)
|
1998-07-28 |
2010-07-21 |
The Regents of the University of California |
Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction
|
NZ510497A
(en)
*
|
1998-08-21 |
2003-09-26 |
Immunex Corp |
Human IL-1 epsilon DNA and polypeptides
|
KR20010024603A
(ko)
|
1998-09-09 |
2001-03-26 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
필수 세균 유전자 및 그의 용도
|
US20070178475A1
(en)
*
|
1998-09-17 |
2007-08-02 |
Nehls Michael C |
Novel human polynucleotides and polypeptides encoded thereby
|
US6680335B2
(en)
|
1998-09-28 |
2004-01-20 |
Sugen, Inc. |
Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
|
US6368793B1
(en)
|
1998-10-14 |
2002-04-09 |
Microgenomics, Inc. |
Metabolic selection methods
|
US7091324B2
(en)
|
1998-11-05 |
2006-08-15 |
Board Of Trustees Of Leland Stanford Junior University |
Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
|
EP1950300A3
(en)
|
1998-11-18 |
2011-03-23 |
Genentech, Inc. |
Antibody variants with higher binding affinity compared to parent antibodies
|
DE69942782D1
(de)
|
1998-11-27 |
2010-10-28 |
Ucb Sa |
Zusammensetzungen und Verfahren zur Erhöhung der Knochenmineralisierung
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
US7273618B2
(en)
*
|
1998-12-09 |
2007-09-25 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
JP4731016B2
(ja)
|
1998-12-22 |
2011-07-20 |
ジェネンテック, インコーポレイテッド |
血管内皮細胞増殖因子アンタゴニストとその用途
|
US6861442B1
(en)
|
1998-12-30 |
2005-03-01 |
Sugen, Inc. |
PYK2 and inflammation
|
US20020055626A1
(en)
*
|
2000-06-09 |
2002-05-09 |
Turner C. Alexander |
Novel human seven transmembrane proteins and polynucleotides encoding the same
|
US20020031802A1
(en)
*
|
2000-05-12 |
2002-03-14 |
Yi Hu |
Novel seven transmembrane proteins and polynucleotides encoding the same
|
US6570003B1
(en)
*
|
2001-01-09 |
2003-05-27 |
Lexion Genetics Incorporated |
Human 7TM proteins and polynucleotides encoding the same
|
AU777909B2
(en)
|
1999-01-19 |
2004-11-04 |
Lexicon Genetics Incorporated |
Mammalian cortexin-like proteins and polynucleotides encoding the same
|
US7393823B1
(en)
|
1999-01-20 |
2008-07-01 |
Oregon Health And Science University |
HER-2 binding antagonists
|
US7625859B1
(en)
|
2000-02-16 |
2009-12-01 |
Oregon Health & Science University |
HER-2 binding antagonists
|
US7396810B1
(en)
|
2000-08-14 |
2008-07-08 |
Oregon Health Sciences University |
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
|
US6303749B1
(en)
|
1999-01-29 |
2001-10-16 |
Amgen Inc. |
Agouti and agouti-related peptide analogs
|
WO2000047617A1
(en)
|
1999-02-09 |
2000-08-17 |
Lexicon Genetics Incorporated |
Human uncoupling proteins and polynucleotides encoding the same
|
US20020015957A1
(en)
|
2000-04-29 |
2002-02-07 |
Hageman Gregory S. |
Diagnostics and therapeutics for macular degeneration-related disorders
|
GB9903841D0
(en)
*
|
1999-02-20 |
1999-04-14 |
Imp College Innovations Ltd |
Diagnosis and treatment of cancer
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
CA2366523C
(en)
|
1999-04-12 |
2008-10-14 |
Yuji Matsuzawa |
Method for analyzing the amount of intraabdominal adipose tissue
|
US20080145347A1
(en)
*
|
1999-04-29 |
2008-06-19 |
Steiner Mitchell S |
p-Hyde sequences in the Rat
|
US20020110809A1
(en)
*
|
1999-04-30 |
2002-08-15 |
Nehls Michael C. |
Novel human polynucleotides and polypeptides encoded thereby
|
US20020095031A1
(en)
*
|
1999-05-04 |
2002-07-18 |
Nehls Michael C. |
Novel human polynucleotides and polypeptides encoded thereby
|
US7566452B1
(en)
|
1999-05-04 |
2009-07-28 |
New York University |
Cancer treatment with endothelin receptor antagonists
|
US20030186311A1
(en)
*
|
1999-05-21 |
2003-10-02 |
Bioforce Nanosciences, Inc. |
Parallel analysis of molecular interactions
|
IL130225A0
(en)
|
1999-05-31 |
2000-06-01 |
Yissum Res Dev Co |
Novel uses of antibodies against ache and peptides thereof
|
JP2003507055A
(ja)
*
|
1999-08-24 |
2003-02-25 |
レキシコン・ジェネティクス・インコーポレーテッド |
ヒト乳腺cDNAライブラリーから得られた配列
|
KR20050004240A
(ko)
*
|
1999-08-31 |
2005-01-12 |
제넨테크, 인크. |
종양 치료용 조성물 및 방법
|
US20030050464A1
(en)
*
|
2000-07-28 |
2003-03-13 |
Yi Hu |
Novel human proteases and polynucleotides encoding the same
|
US20080003673A1
(en)
*
|
1999-09-02 |
2008-01-03 |
Alejandro Abuin |
Novel human proteases and polynucleotides encoding the same
|
US20050153323A1
(en)
*
|
2000-07-28 |
2005-07-14 |
Yi Hu |
Novel human proteases and polynucleotides encoding the same
|
US6448388B1
(en)
|
2000-08-16 |
2002-09-10 |
Lexicon Genetics Incorporated |
Human proteases and polynucleotides encoding the same
|
US6716614B1
(en)
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6433153B1
(en)
|
1999-09-02 |
2002-08-13 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases and polynucleotides encoding the same
|
US20020165376A1
(en)
*
|
1999-12-22 |
2002-11-07 |
Walke D. Wade |
Novel human proteases and polynucleotides encoding the same
|
US20030166902A1
(en)
*
|
2001-02-20 |
2003-09-04 |
Yi Hu |
Novel human protease and polynucleotides encoding the same
|
US7459540B1
(en)
*
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
US7408047B1
(en)
*
|
1999-09-07 |
2008-08-05 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
AU783968B2
(en)
*
|
1999-09-08 |
2006-01-05 |
Lexicon Genetics Incorporated |
Human G-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
|
AU780935B2
(en)
|
1999-09-13 |
2005-04-28 |
Equitech Laboratories, Inc. |
Materials and methods for the determination of an analyte
|
US6900043B1
(en)
|
1999-09-21 |
2005-05-31 |
Amgen Inc. |
Phosphatases which activate map kinase pathways
|
US6524840B1
(en)
|
1999-09-24 |
2003-02-25 |
Lexicon Genetics Incorporated |
Human endothelin converting enzyme-like proteins and polynucleotides encoding the same
|
US6867291B1
(en)
*
|
2000-09-15 |
2005-03-15 |
Lexicon Genetics Incorporated |
Human hemicentin proteins and polynucleotides encoding the same
|
US6790660B1
(en)
|
2001-09-18 |
2004-09-14 |
Lexicon Genetics Incorporated |
Human kielin-like proteins and polynucleotides encoding the same
|
EP1633872A2
(en)
*
|
1999-09-24 |
2006-03-15 |
Lexicon Genetics Incorporated |
Novel human protease inhibitor-like proteins and polynucleotides encoding the same
|
US6586230B1
(en)
*
|
2000-10-27 |
2003-07-01 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US20080050809A1
(en)
*
|
1999-09-28 |
2008-02-28 |
Alejandro Abuin |
Novel human kinases and polynucleotides encoding the same
|
US6777545B2
(en)
|
2001-04-06 |
2004-08-17 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6734010B2
(en)
*
|
2001-05-09 |
2004-05-11 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6444456B1
(en)
|
2000-03-10 |
2002-09-03 |
Lexicon Genetics Incorporated |
Human G-coupled protein receptor kinases and polynucleotides encoding the same
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6720173B1
(en)
|
1999-11-08 |
2004-04-13 |
Lexicon Genetics Incorporated |
Human kinase protein and polynucleotides encoding the same
|
US6841377B1
(en)
|
2001-06-13 |
2005-01-11 |
Lexicon Genetics Incorporated |
Human kinase and polynucleotides encoding the same
|
US6511840B1
(en)
|
2000-06-15 |
2003-01-28 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
US6476210B2
(en)
|
2000-10-12 |
2002-11-05 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6797510B1
(en)
*
|
2001-05-24 |
2004-09-28 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6734009B2
(en)
|
2000-12-27 |
2004-05-11 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6716616B1
(en)
*
|
1999-09-28 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
JP2003512027A
(ja)
*
|
1999-09-29 |
2003-04-02 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトカルボキシペプチダーゼおよびそれをコードするポリヌクレオチド
|
US6794132B2
(en)
|
1999-10-02 |
2004-09-21 |
Biosite, Inc. |
Human antibodies
|
US20070111259A1
(en)
*
|
1999-10-02 |
2007-05-17 |
Medarex, Inc. |
Human antibodies
|
US7135287B1
(en)
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
WO2001027274A1
(en)
|
1999-10-12 |
2001-04-19 |
Lexicon Genetics Incorporated |
Human ldl receptor family proteins and polynucleotides encoding the same
|
AU1198701A
(en)
*
|
1999-10-13 |
2001-04-23 |
Lexicon Genetics Incorporated |
Novel human membrane proteins
|
JP2004500045A
(ja)
*
|
1999-10-18 |
2004-01-08 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトタンパクおよびそれをコードするポリヌクレオチド
|
US6743907B1
(en)
*
|
1999-10-19 |
2004-06-01 |
Lexicon Genetics Incorporated |
Human proteins and polynucleotides encoding the same
|
US6750054B2
(en)
|
2000-05-18 |
2004-06-15 |
Lexicon Genetics Incorporated |
Human semaphorin homologs and polynucleotides encoding the same
|
US20080213878A1
(en)
*
|
1999-10-19 |
2008-09-04 |
Gregory Donoho |
Novel human membrane proteins and polynucleotides encoding the same
|
JP2003529338A
(ja)
|
1999-11-02 |
2003-10-07 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト輸送体タンパク質及び該タンパク質をコードするポリヌクレオチド
|
EP1230366A2
(en)
*
|
1999-11-10 |
2002-08-14 |
Lexicon Genetics Incorporated |
Human atpases and polynucleotides encoding the same
|
WO2001034779A2
(en)
|
1999-11-12 |
2001-05-17 |
Lexicon Genetics Incorporated |
Human proteins with homology to carboxypeptidases and polynucleotides encoding the same
|
CA2387390C
(en)
*
|
1999-11-16 |
2009-01-06 |
Genentech, Inc. |
Elisa for vegf
|
US6943010B1
(en)
*
|
1999-11-19 |
2005-09-13 |
Hortense W. Dodo |
Down-regulation and silencing of allergen genes in transgenic peanut seeds
|
ES2629683T3
(es)
|
1999-11-30 |
2017-08-14 |
Mayo Foundation For Medical Education And Research |
B7-H1, una nueva molécula inmunorreguladora
|
US6680209B1
(en)
*
|
1999-12-06 |
2004-01-20 |
Biosite, Incorporated |
Human antibodies as diagnostic reagents
|
EP1240187A2
(en)
*
|
1999-12-07 |
2002-09-18 |
Lexicon Genetics Incorporated |
Novel human kinase proteins and polynucleotides encoding the same
|
CA2393447A1
(en)
*
|
1999-12-07 |
2001-06-14 |
Lexicon Genetics Incorporated |
Novel human membrane proteins and polynucleotides encoding the same
|
WO2001042468A1
(en)
|
1999-12-09 |
2001-06-14 |
Lexicon Genetics Incorporated |
Human adam-ts proteases and polynucleotides encoding the same
|
JP2003516154A
(ja)
*
|
1999-12-13 |
2003-05-13 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトトランスフェラーゼタンパク質及び該タンパク質をコードするポリヌクレオチド
|
DE60029138T2
(de)
|
1999-12-22 |
2007-06-06 |
Sugen, Inc., San Francisco |
Verwendung von Indolinonverbindungen zur Herstellung von Pharmazeutika für die Modulation der Funktion c-kit Proteintyrosinkinase
|
WO2001046417A2
(en)
*
|
1999-12-22 |
2001-06-28 |
Lexicon Genetics Incorporated |
Human membrane proteins and polynucleotides encoding the same having homology to cd20 proteins and ige receptors
|
DK1897945T3
(da)
|
1999-12-23 |
2012-05-07 |
Genentech Inc |
IL-17 homologe polypeptider og terapeutiske anvendelser deraf.
|
AU783923B2
(en)
*
|
2000-01-06 |
2005-12-22 |
Lexicon Genetics Incorporated |
Novel human proteases and polynucleotides encoding the same
|
WO2001053493A2
(en)
*
|
2000-01-18 |
2001-07-26 |
Lexicon Genetics Incorporated |
Human kinase protein and polynucleotides encoding the same
|
DE60118703T2
(de)
*
|
2000-01-26 |
2006-12-14 |
Lexicon Genetics Inc., The Woodlands |
Menschliche neurexin-ähnliche proteine und dafür kodierende polynukleotide
|
WO2001055394A1
(en)
*
|
2000-01-28 |
2001-08-02 |
Lexicon Genetics Incorporated |
Human membrane proteins and polynucleotides encoding the same
|
JP2003535588A
(ja)
*
|
2000-01-28 |
2003-12-02 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト酵素及び該酵素をコードするポリヌクレオチド
|
JP2003529348A
(ja)
*
|
2000-02-04 |
2003-10-07 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒト膜タンパクおよびそれをコードするポリヌクレオチド
|
CA2399663A1
(en)
*
|
2000-02-04 |
2001-08-09 |
Lexicon Genetics Incorporated |
Novel human enzymes and polynucleotides encoding the same
|
AU3690801A
(en)
|
2000-02-11 |
2001-08-20 |
Lexicon Genetics Incorporated |
Human proteases and polynucleotides encoding the same
|
WO2001060814A2
(en)
*
|
2000-02-15 |
2001-08-23 |
Sugen, Inc. |
Pyrrole substituted 2-indolinone protein kinase inhibitors
|
AU2001238503A1
(en)
*
|
2000-02-17 |
2001-08-27 |
Lexicon Genetics Incorporated |
Novel human thrombospondin repeat proteins and polynucleotides encoding the same
|
EP1259610A2
(en)
*
|
2000-02-29 |
2002-11-27 |
Lexicon Genetics Incorporated |
Human transporter proteins and polynucleotides encoding the same
|
US6555669B2
(en)
|
2000-02-29 |
2003-04-29 |
Lexicon Genetics Incorporated |
Human transferase proteins and polynucleotides encoding the same
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US20020082405A1
(en)
*
|
2000-03-06 |
2002-06-27 |
Gregory Donoho |
Novel human transporter proteins and polynucleotides encoding the same
|
TW201006846A
(en)
|
2000-03-07 |
2010-02-16 |
Senomyx Inc |
T1R taste receptor and genes encidung same
|
WO2001068871A2
(en)
*
|
2000-03-13 |
2001-09-20 |
Lexicon Genetics Incorporated |
Human phospholipases and polynucleotides encoding the same
|
AU2001250898A1
(en)
*
|
2000-03-17 |
2001-10-03 |
The Salk Institute For Biological Studies |
Compositions associated with complex formation
|
AU4587101A
(en)
*
|
2000-03-20 |
2001-10-03 |
Lexicon Genetics Inc |
Novel human secreted proteins and polynucleotides encoding the same
|
AU2001218871A1
(en)
*
|
2000-03-21 |
2001-10-03 |
Takao Arai |
Monoclonal antibody and method and kit for the immunoassay of soluble human st2 with the use of the same
|
US7514239B2
(en)
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
WO2001074404A2
(en)
|
2000-03-31 |
2001-10-11 |
Novarx |
Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor
|
EP1272634A1
(en)
|
2000-04-03 |
2003-01-08 |
Lexicon Genetics Incorporated |
Human ion channel protein and polynucleotides encoding the same
|
WO2001079509A1
(en)
*
|
2000-04-12 |
2001-10-25 |
Lexicon Genetics Incorporated |
Human metalloprotease and polynucleotides encoding the same
|
US7364867B2
(en)
*
|
2000-04-17 |
2008-04-29 |
The Mount Sinai School Of Medicine |
Method of identifying bitter compounds by employing TRP8, a transient receptor potential channel expressed in taste receptor cells
|
JP2004511205A
(ja)
|
2000-04-25 |
2004-04-15 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトキナーゼプロテインおよびそれをコードするポリヌクレオチド
|
AU2001259156A1
(en)
*
|
2000-04-27 |
2001-11-07 |
Lexicon Genetics Incorporated |
Novel membrane proteins and polynucleotides encoding the same
|
US7030219B2
(en)
*
|
2000-04-28 |
2006-04-18 |
Johns Hopkins University |
B7-DC, Dendritic cell co-stimulatory molecules
|
JP2003533205A
(ja)
*
|
2000-05-12 |
2003-11-11 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトリポカリン相同体およびそれをコードするポリヌクレオチド
|
EP1290162A4
(en)
*
|
2000-05-17 |
2005-08-17 |
Univ Oregon Health Sciences |
INDUCTION OF APOPTOSIS AND INHIBITION OF CELL GROWTH BY PROTEIN 4.33 (P4.33)
|
WO2001090179A2
(en)
*
|
2000-05-23 |
2001-11-29 |
Lexicon Genetics Incorporated |
Novel human thrombospondin-like proteins and polynucleotides encoding the same
|
US6790667B1
(en)
*
|
2000-05-30 |
2004-09-14 |
Lexicon Genetics Incorporated |
Human mitochondrial proteins and polynucleotides encoding the same
|
US6703495B2
(en)
*
|
2000-06-07 |
2004-03-09 |
Lexicon Genetics Incorporated |
Polynucleotides encoding human transporter protein
|
US6465632B1
(en)
|
2000-06-09 |
2002-10-15 |
Lexicon Genetics Incorporated |
Human phosphatases and polynucleotides encoding the same
|
US20040168209A1
(en)
*
|
2000-06-12 |
2004-08-26 |
Alejandro Abuin |
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
|
EP2431054A3
(en)
|
2000-06-15 |
2013-03-06 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
JP2004504064A
(ja)
|
2000-06-22 |
2004-02-12 |
アムジエン・インコーポレーテツド |
Il−17分子およびその用途
|
EP2275549A1
(en)
|
2000-06-23 |
2011-01-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
CA2648046A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
US6528321B1
(en)
|
2000-06-26 |
2003-03-04 |
Beckman Coulter, Inc. |
Opposable-element chromatographic assay device for detection of analytes in whole blood samples
|
US20030032791A1
(en)
*
|
2000-06-26 |
2003-02-13 |
Alan Robertson Scott |
Novel melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
|
JP2004510412A
(ja)
*
|
2000-06-27 |
2004-04-08 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトgaba受容体及び該受容体をコードするポリヌクレオチド
|
US20060257399A1
(en)
*
|
2000-06-28 |
2006-11-16 |
Glycofi, Inc. |
Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoform
|
US20060034830A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform
|
US20060029604A1
(en)
*
|
2000-06-28 |
2006-02-09 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAc2Man3GlcNAc2 glycoform
|
US20060024304A1
(en)
*
|
2000-06-28 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Man5GlcNAc2 glycoform
|
JP2004519205A
(ja)
|
2000-06-28 |
2004-07-02 |
アムジェン インコーポレイテッド |
胸腺間質リンホポイエチンレセプター分子およびその使用
|
US20060034828A1
(en)
*
|
2000-06-28 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a GlcNAcMAN5GLCNAC2 glycoform
|
JP2004515220A
(ja)
*
|
2000-07-21 |
2004-05-27 |
インサイト・ゲノミックス・インコーポレイテッド |
プロテアーゼ
|
US6632681B1
(en)
|
2000-07-24 |
2003-10-14 |
Ey Laboratories |
Reagent delivery device and method of use
|
US6887685B1
(en)
|
2000-07-25 |
2005-05-03 |
Lexicon Genetics Incorporated |
Human thymosin protein and polynucleotides encoding the same
|
US20020076780A1
(en)
*
|
2000-08-16 |
2002-06-20 |
Turner C. Alexander |
Novel human ion channel proteins and polynucleotides encoding the same
|
US6858590B2
(en)
*
|
2000-08-17 |
2005-02-22 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US6680059B2
(en)
*
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
*
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
AU2001292151B2
(en)
|
2000-08-17 |
2006-05-04 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
EP1311690B1
(en)
*
|
2000-08-22 |
2006-07-26 |
Lexicon Genetics Incorporated |
Human proteases and polynucleotides encoding the same
|
CA2420036A1
(en)
*
|
2000-08-22 |
2002-02-28 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding the same
|
JP4932125B2
(ja)
|
2000-08-25 |
2012-05-16 |
ビーエーエスエフ プラント サイエンス ゲーエムベーハー |
新規プレニルプロテアーゼをコードする植物ポリヌクレオチド
|
EP1197550A3
(en)
*
|
2000-08-25 |
2002-11-20 |
Pfizer Products Inc. |
Methods and compositions for diagnosing and treating disorders involving angiogenesis
|
EP1191036A3
(en)
*
|
2000-08-25 |
2002-07-03 |
Pfizer Products Inc. |
Methods and compositions for diagnosing and treating disorders involving angiogenesis
|
AU2001285326A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Lexicon Genetics Incorporated |
Human kinase proteins and polynucleotides encoding the same
|
AU2001285327A1
(en)
*
|
2000-09-01 |
2002-03-22 |
Lexicon Genetics Incorporated |
Human gaba transporter protein and polynucleotides encoding the same
|
CA2421070A1
(en)
*
|
2000-09-01 |
2002-03-14 |
International Bioimmune Systems, Inc. |
The identification and development of specific monoclonal antibodies to squamous cell carcinoma
|
US20030176344A1
(en)
*
|
2000-09-14 |
2003-09-18 |
Decode Genetics Ehf. |
Human osteoporosis gene
|
AU2001294654A1
(en)
*
|
2000-09-25 |
2002-04-08 |
The Regents Of The University Of California |
Model for neurodegenerative diseases involving amyloid accumulation
|
WO2002026980A2
(en)
|
2000-09-27 |
2002-04-04 |
Lexicon Genetics Incorporated |
Human ion-exchanger proteins and polynucleotides encoding t he same
|
WO2002026981A2
(en)
*
|
2000-09-27 |
2002-04-04 |
Lexicon Genetics Incorporated |
Human protease inhibitor proteins and polynucleotides encoding the same
|
US6777232B1
(en)
|
2000-10-02 |
2004-08-17 |
Lexicon Genetics Incorporated |
Human membrane proteins and polynucleotides encoding the same
|
WO2002033089A2
(en)
*
|
2000-10-05 |
2002-04-25 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Ixodes scapularis tissue factor pathway inhibitor
|
WO2002033408A1
(en)
*
|
2000-10-17 |
2002-04-25 |
Besst-Test Aps |
Assay for directly detecting an inflammatory indicator in a body fluid sample
|
US7001763B1
(en)
|
2000-10-17 |
2006-02-21 |
Lexicon Genetics Incorporated |
Human semaphorin proteins and polynucleotides encoding the same
|
US7232880B2
(en)
*
|
2000-10-27 |
2007-06-19 |
Oregon Health & Science University |
Mutant IGFBP-3 molecules that do not bind to IGFS, but retain their ability to functionally bind IGFBP-3 receptor
|
EP1409674A2
(en)
*
|
2000-10-27 |
2004-04-21 |
Lexicon Genetics Incorporated |
Human 7tm proteins and polynucleotides encoding them
|
AU2002232936A1
(en)
*
|
2000-10-30 |
2002-05-15 |
Lexicon Genetics Incorporated |
Human 7TM proteins and polynucleotides encoding the same
|
AU2002230875B2
(en)
*
|
2000-11-01 |
2007-03-01 |
Lexicon Pharmaceuticals, Inc. |
Novel human proteases and polynucleotides encoding the same
|
AU2002245170A1
(en)
*
|
2000-11-15 |
2002-07-01 |
Lexicon Genetics Incorporated |
Novel human secreted proteins and polynucleotides encoding the same
|
US20060148732A1
(en)
*
|
2000-11-17 |
2006-07-06 |
Gutterman Jordan U |
Inhibition of NF-kappaB by triterpene compositions
|
AU2002228633A1
(en)
|
2000-11-20 |
2002-06-03 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6989247B2
(en)
|
2000-11-28 |
2006-01-24 |
Celltech R & D, Inc. |
Compositions and methods for diagnosing or treating psoriasis
|
US7393921B2
(en)
*
|
2000-12-04 |
2008-07-01 |
Institute For Systems Biology |
Prostate-specific polypeptide pamp and encoding nucleic acid molecules
|
US20060057651A1
(en)
*
|
2000-12-08 |
2006-03-16 |
Bowdish Katherine S |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
|
US20040198661A1
(en)
*
|
2000-12-08 |
2004-10-07 |
Bowdish Katherine S. |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
|
EP1341902A2
(en)
*
|
2000-12-08 |
2003-09-10 |
Alexion Pharmaceuticals, Inc. |
Chronic lymphocytic leukemia cell line and its use for producing an antibody
|
US9249229B2
(en)
*
|
2000-12-08 |
2016-02-02 |
Alexion Pharmaceuticals, Inc. |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
|
US7408041B2
(en)
*
|
2000-12-08 |
2008-08-05 |
Alexion Pharmaceuticals, Inc. |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
|
EP1341906A2
(en)
*
|
2000-12-11 |
2003-09-10 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
JP2004530417A
(ja)
*
|
2000-12-12 |
2004-10-07 |
レキシコン・ジェネティクス・インコーポレーテッド |
新規ヒトキナーゼおよびそれをコードするポリヌクレオチド
|
US6583269B1
(en)
|
2000-12-18 |
2003-06-24 |
Lexicon Genetics Incorporated |
Human protease inhibitor and polynucleotides encoding the same
|
AU2002227377A1
(en)
*
|
2000-12-20 |
2002-07-01 |
Lexicon Pharmaceuticals, Inc. |
Human ion channel protein and polynucleotides encoding the same
|
US6852844B1
(en)
*
|
2000-12-20 |
2005-02-08 |
Lexicon Genetics Incorporated |
Human protocadherin proteins and polynucleotides encoding the same
|
IL140537A0
(en)
*
|
2000-12-25 |
2002-02-10 |
Hadasit Med Res Service |
Educated nk t cells and their uses in the treatment of immune-related disorders
|
US7445802B2
(en)
*
|
2000-12-26 |
2008-11-04 |
Yeda Research And Development Co. Ltd |
Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases
|
AU2001297533A1
(en)
*
|
2000-12-28 |
2002-09-12 |
Lexicon Genetics Incorporated |
Novel human ion channel-related proteins and polynucleotides encoding the same
|
TW201022287A
(en)
|
2001-01-03 |
2010-06-16 |
Senomyx Inc |
T1R taste receptors and genes encoding same
|
WO2002053753A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Lexicon Genetics Incorporated |
Novel human lipase and polynucleotides encoding the same
|
WO2002053754A2
(en)
*
|
2001-01-08 |
2002-07-11 |
Lexicon Genetics Incorporated |
Human protease and polynucleotides encoding the same
|
WO2002059287A2
(en)
*
|
2001-01-23 |
2002-08-01 |
Lexicon Genetics Incorporated |
Novel human kinases and polynucleotides encoding the same
|
US20020115846A1
(en)
*
|
2001-01-24 |
2002-08-22 |
Xuanchuan (Sean) Yu |
Novel human lipase and polynucleotides encoding the same
|
US20020127674A1
(en)
*
|
2001-02-02 |
2002-09-12 |
Xuanchuan Yu |
Novel human transporter protein and polynucleotides encoding the same
|
CA3046566A1
(en)
|
2001-02-14 |
2002-08-22 |
Anthrogenesis Corporation |
Post-partum mammalian placental stem cells for use in the treatment of neurological or renal diseases and disorders
|
AR042586A1
(es)
|
2001-02-15 |
2005-06-29 |
Sugen Inc |
3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
|
US20020117169A1
(en)
|
2001-02-27 |
2002-08-29 |
Kurz Daniel R. |
Cover and applicator for a portion of a mammalian body
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
EP1578770A2
(en)
*
|
2001-03-12 |
2005-09-28 |
Lexicon Genetics Incorporated |
Novel human egf-family proteins and polynucleotides encoding the same
|
US20020164627A1
(en)
*
|
2001-03-12 |
2002-11-07 |
Wilganowski Nathaniel L. |
Novel human transporter proteins and polynucleotides encoding the same
|
WO2002072603A2
(en)
*
|
2001-03-12 |
2002-09-19 |
Lexicon Genetics Incorporated |
Novel human dectin proteins and polynucleotides encoding the same
|
ES2358977T3
(es)
|
2001-03-15 |
2011-05-17 |
Neogenix Oncology, Inc. |
Terapia con anticuerpos monoclonales para el cáncer de páncreas.
|
US6994995B1
(en)
*
|
2001-03-16 |
2006-02-07 |
Lexicon Genetics Incorporated |
Human synaptotagmin and polynucleotides encoding the same
|
US20030228639A1
(en)
*
|
2001-03-19 |
2003-12-11 |
Wright George L |
Prostate cancer markers
|
WO2002074932A2
(en)
|
2001-03-20 |
2002-09-26 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
US6613534B2
(en)
|
2001-03-20 |
2003-09-02 |
Wake Forest University Health Sciences |
MAP-2 as a determinant of metastatic potential
|
US7071303B2
(en)
|
2001-03-28 |
2006-07-04 |
Institute For Systems Biology |
Androgen regulated prostate specific nucleic acids
|
WO2002081671A1
(en)
*
|
2001-04-06 |
2002-10-17 |
Lexicon Genetics Incorporated |
Novel human kinase and polynucleotides encoding the same
|
CA2443968A1
(en)
|
2001-04-12 |
2002-10-24 |
Imperial College Innovations Limited |
Diagnosis and treatment of cancer: i
|
JP2004533236A
(ja)
*
|
2001-04-13 |
2004-11-04 |
ワイエス |
化膿性連鎖球菌(Streptococcuspyogenes)の表面タンパク質
|
US20070128229A1
(en)
*
|
2002-04-12 |
2007-06-07 |
Wyeth |
Surface proteins of Streptococcus pyogenes
|
WO2002083706A1
(en)
*
|
2001-04-16 |
2002-10-24 |
Lexicon Genetics Incorporated |
Nucleic acid encoding a human adenylosuccinate synthetase
|
US7803982B2
(en)
|
2001-04-20 |
2010-09-28 |
The Mount Sinai School Of Medicine Of New York University |
T1R3 transgenic animals, cells and related methods
|
US20040219632A1
(en)
*
|
2001-04-20 |
2004-11-04 |
Robert Margolskee |
T1r3 a novel taste receptor
|
WO2002088313A2
(en)
*
|
2001-04-30 |
2002-11-07 |
Lexicon Genetics Incorporated |
Novel human nuclear transporters and polynucleotides encoding the same
|
US20030211464A1
(en)
*
|
2001-05-02 |
2003-11-13 |
Charles Pidgeon |
Method and compositions for drug discovery
|
JP4353701B2
(ja)
|
2001-05-08 |
2009-10-28 |
ダーウィン モレキュラー コーポレイション |
Foxp3蛋白質を用いた霊長類における免疫機能の調節方法
|
US20020193585A1
(en)
*
|
2001-05-25 |
2002-12-19 |
Walke D. Wade |
Novel human transporter proteins and polynucleotides encoding the same
|
DE60225064T2
(de)
|
2001-05-29 |
2009-01-29 |
Lexicon Pharmaceuticals, Inc., The Woodlands |
Neue menschliche hydroxylasen und diese codierende polynukleotide
|
ATE535258T1
(de)
|
2001-06-01 |
2011-12-15 |
Cornell Res Foundation Inc |
Modifizierte antikörper gegen prostata- spezifisches membranantigen und ihre verwendungen
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US7026121B1
(en)
*
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
US6905827B2
(en)
*
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
EP1406645A4
(en)
*
|
2001-06-14 |
2005-02-16 |
Lexicon Genetics Inc |
NOVEL HUMAN TRANSPORTER PROTEINS AND POLYNUCLEOTIDES ENCODING THESE PROTEINS
|
WO2003000176A2
(en)
*
|
2001-06-20 |
2003-01-03 |
Molecular Staging, Inc. |
Conjugates of reduced antibodies and biomolecules
|
US20030018009A1
(en)
*
|
2001-06-20 |
2003-01-23 |
Collins Douglas A. |
Adenosyl-cobalamin fortified compositions
|
WO2002102972A2
(en)
*
|
2001-06-20 |
2002-12-27 |
Prochon Biotech Ltd. |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
WO2003001876A2
(en)
|
2001-06-26 |
2003-01-09 |
Senomyx, Inc. |
T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
|
AU2002318186A1
(en)
*
|
2001-07-03 |
2003-01-21 |
Lexicon Genetics Incorporated |
Novel human kielin-like proteins and polynucleotides encoding the same
|
US7270959B2
(en)
|
2001-07-25 |
2007-09-18 |
Oakville Hong Kong Company Limited |
Specimen collection container
|
JP4265149B2
(ja)
*
|
2001-07-25 |
2009-05-20 |
セイコーエプソン株式会社 |
電気光学装置、電気光学装置の製造方法
|
US7300633B2
(en)
*
|
2001-07-25 |
2007-11-27 |
Oakville Hong Kong Company Limited |
Specimen collection container
|
AUPR673001A0
(en)
|
2001-07-31 |
2001-08-23 |
Prince Henry's Institute Of Medical Research |
Pregnancy-related enzyme activity
|
US7744888B2
(en)
|
2001-08-03 |
2010-06-29 |
Abgenomics Cooperatief U.A. |
Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
|
ES2320639T3
(es)
|
2001-08-09 |
2009-05-27 |
Idexx Laboratories, Inc. |
Deteccion del virus de la diarrea viral bobina en muestras de pelo.
|
WO2003016481A2
(en)
*
|
2001-08-14 |
2003-02-27 |
Lexicon Genetics Incorporated |
Novel human collagen proteins and polynucleotides encoding the same
|
WO2003018631A2
(en)
*
|
2001-08-27 |
2003-03-06 |
Novartis Ag |
Nogo receptor homologues and their use
|
AU2002324792A1
(en)
*
|
2001-08-27 |
2003-03-10 |
Tularik Inc. |
Amplified gene involved in cancer
|
CA2459183A1
(en)
*
|
2001-08-27 |
2003-03-06 |
Tularik Inc. |
Amplified oncogenes and their involvement in cancer
|
JP2003076656A
(ja)
*
|
2001-09-05 |
2003-03-14 |
Sony Corp |
情報処理システム、情報処理装置および方法、記録媒体、並びにプログラム
|
EP1434993B1
(en)
|
2001-09-18 |
2013-04-24 |
Fibrogen, Inc. |
Methods of assaying connective tissue growth factor
|
JP4424987B2
(ja)
*
|
2001-09-20 |
2010-03-03 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム |
Elisaアッセイを用いた循環する治療抗体、抗原および抗原/抗体複合体の測定
|
US6896882B2
(en)
*
|
2001-09-27 |
2005-05-24 |
Gangagen, Inc. |
Lysin-deficient bacteriophages having reduced immunogenicity
|
WO2003026690A1
(en)
*
|
2001-09-27 |
2003-04-03 |
Gangagen, Inc. |
Incapacitated whole-cell immunogenic bacterial compositions
|
WO2003027243A2
(en)
|
2001-09-27 |
2003-04-03 |
Pioneer Hi-Bred International, Inc. |
Phytate polynucleotides and methods of use
|
WO2003028582A2
(en)
*
|
2001-09-28 |
2003-04-10 |
Aspenbio, Inc. |
Bovine pregnancy test
|
US20030110518A1
(en)
*
|
2001-09-28 |
2003-06-12 |
Houseknecht Karen L. |
Melanocortin-5 receptor sequences and uses thereof
|
PL373594A1
(en)
|
2001-10-04 |
2005-09-05 |
Immunex Corporation |
Ul16 binding protein 4
|
US6642232B2
(en)
|
2001-10-10 |
2003-11-04 |
Sugen, Inc. |
3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
DE10151511A1
(de)
|
2001-10-18 |
2003-05-08 |
Basf Lynx Bioscience Ag |
ee3-Proteinfamilie und zugrundeliegende DNA-Sequenzen
|
EP1440091A1
(en)
*
|
2001-10-22 |
2004-07-28 |
Novartis AG |
Nogo receptor homologues and their use
|
GB0126378D0
(en)
|
2001-11-02 |
2002-01-02 |
Oxford Biomedica Ltd |
Antigen
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
IL161863A0
(en)
*
|
2001-11-09 |
2005-11-20 |
Neopharm Inc |
Selective treatment of il-13 expressing tumors
|
AU2002364894A1
(en)
*
|
2001-11-09 |
2003-06-30 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
|
US20030148341A1
(en)
*
|
2001-11-15 |
2003-08-07 |
Sin Wun Chey |
Gene amplification and overexpression in cancer
|
US20030099621A1
(en)
|
2001-11-29 |
2003-05-29 |
Robert Chow |
Stem cell screening and transplantation therapy for HIV infection
|
EP1542719A4
(en)
|
2001-12-05 |
2006-06-21 |
Baylor College Medicine |
METHODS AND COMPOSITIONS FOR REGULATING OS FORMATION BY MODULATING THE SYMPATHETIC TONUS
|
JP2005512576A
(ja)
*
|
2001-12-10 |
2005-05-12 |
ノバルティス アクチエンゲゼルシャフト |
Cntf遺伝子多型に基づく、精神病および統合失調症の処置方法
|
CA2470088A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Tularik Inc. |
Identification of an amplified gene and target for drug intervention
|
US20060024292A1
(en)
*
|
2001-12-27 |
2006-02-02 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform
|
US20060034829A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Gerngross Tillman U |
Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform
|
US20040137440A1
(en)
*
|
2002-01-15 |
2004-07-15 |
Biaoyang Lin |
Androgen regulated nucleic acid molecules and encoded proteins
|
US7462491B2
(en)
*
|
2002-01-31 |
2008-12-09 |
Baylor College Of Medicine |
Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin
|
US7704700B2
(en)
*
|
2002-02-12 |
2010-04-27 |
Burnham Institute For Medical Research |
Methods for determining the prognosis for patients with a prostate neoplastic condition using inhibitor of apoptosis polypeptides
|
EP1563302B1
(en)
|
2002-02-13 |
2011-09-14 |
American Diagnostica, Inc. |
Methods for selecting treatment regimens and predicting outcomes in cancer patients
|
WO2003072710A2
(en)
*
|
2002-02-21 |
2003-09-04 |
Eastern Virginia Medical School |
Protein biomarkers that distinguish prostate cancer from non-malignant cells
|
AU2003217693A1
(en)
*
|
2002-02-22 |
2003-09-09 |
Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
US7662924B2
(en)
*
|
2002-02-22 |
2010-02-16 |
The Board Of Trustees Of The University Of Illinois |
Beta chain-associated regulator of apoptosis
|
CA2476518A1
(en)
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7294471B2
(en)
*
|
2002-02-27 |
2007-11-13 |
Cskeys, Llc |
Method for purifying cancer-specific proliferating cell nuclear antigen
|
AU2003225636A1
(en)
|
2002-03-05 |
2003-09-22 |
Ramot At Tel-Aviv University Ltd. |
Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
|
EP1497642A2
(en)
*
|
2002-03-19 |
2005-01-19 |
Tularik, Inc. |
Gene amplification in cancer
|
WO2003079025A2
(en)
|
2002-03-19 |
2003-09-25 |
Novartis Ag |
Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
|
AU2003221841A1
(en)
|
2002-04-03 |
2003-10-27 |
Celltech R And D, Inc. |
Association of polymorphisms in the sost gene region with bone mineral density
|
US20060052320A1
(en)
*
|
2002-05-06 |
2006-03-09 |
Limin Li |
Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
|
WO2004040398A2
(en)
*
|
2002-05-06 |
2004-05-13 |
Dana-Farber Cancer Institute, Inc. |
Use of a computer to design a molecule
|
US20040005615A1
(en)
*
|
2002-05-24 |
2004-01-08 |
Jing Li |
Amplification and overexpression of oncogenes
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
GB0213745D0
(en)
|
2002-06-14 |
2002-07-24 |
Univ Edinburgh |
Enzyme
|
WO2004004649A2
(en)
|
2002-07-08 |
2004-01-15 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20040219609A1
(en)
*
|
2002-07-12 |
2004-11-04 |
Day Anthony G. |
Methods for modulating proteins not previously known as proteases
|
JP2005533256A
(ja)
*
|
2002-07-17 |
2005-11-04 |
ユー.エス. ジェノミクス, インコーポレイテッド |
キメラタグを用いるポリマーを分析するための方法と組成物
|
AU2003304411A1
(en)
|
2002-08-01 |
2005-03-07 |
The Regents Of The University Of California |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
|
US20050059011A1
(en)
*
|
2002-08-07 |
2005-03-17 |
Sin Wun Chey |
Amplification and overexpression of oncogenes
|
SI1535068T1
(sl)
*
|
2002-08-13 |
2010-07-30 |
N Dia Inc |
Naprave in postopki za odkrivanje amnijske tekočine v vaginalnih izločkih
|
US20060099676A1
(en)
*
|
2002-08-15 |
2006-05-11 |
Limin Li |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
|
AU2003265525A1
(en)
*
|
2002-08-15 |
2004-03-19 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
|
AU2003256912A1
(en)
|
2002-08-16 |
2004-03-03 |
Yeda Research And Development Co. Ltd. |
Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
|
DE60333608D1
(de)
|
2002-08-23 |
2010-09-09 |
Bayer Schering Pharma Ag |
Biomarker zur Diagnose von Alzheimer
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
NZ538384A
(en)
|
2002-09-06 |
2009-04-30 |
Alexion Pharma Inc |
Treatment for asthma using a compound which binds to or otherwise blocks the generation and/or activity of one or more complement components reptors, such as, C5a receptors
|
CA2498008C
(en)
|
2002-09-11 |
2014-02-04 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
EP2116616A3
(en)
|
2002-09-11 |
2010-03-17 |
Genentech, Inc. |
Genes differentially expressed in activated T cells and uses thereof
|
EP2116551A1
(en)
|
2002-09-11 |
2009-11-11 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
JP2006515165A
(ja)
|
2002-09-16 |
2006-05-25 |
ジェネンテック・インコーポレーテッド |
免疫関連疾患の治療のための新規組成物と方法
|
US7094551B2
(en)
*
|
2002-09-17 |
2006-08-22 |
Zahradnik Richard J |
Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
|
WO2004028479A2
(en)
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Nouvelles compositions et methodes de traitement du psoriasis
|
CN101260154A
(zh)
*
|
2002-10-02 |
2008-09-10 |
霍夫曼-拉罗奇有限公司 |
新mhc ii相关肽
|
US7432351B1
(en)
|
2002-10-04 |
2008-10-07 |
Mayo Foundation For Medical Education And Research |
B7-H1 variants
|
EP1554584B1
(en)
*
|
2002-10-11 |
2008-05-07 |
Sentina Biotechnology Incorporated |
Methods for detection of breast cancer
|
US20080293750A1
(en)
*
|
2002-10-17 |
2008-11-27 |
Anna Helgadottir |
Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
|
EP2322200A3
(en)
|
2002-10-29 |
2011-07-27 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
JP3447009B1
(ja)
*
|
2002-10-29 |
2003-09-16 |
實 平垣 |
構築物用構成体およびその製造方法
|
ES2463420T3
(es)
|
2002-11-01 |
2014-05-27 |
Iris International, Inc. |
Inmuno-PCR sándwich por desplazamiento
|
CA2503748A1
(en)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
US20050129711A1
(en)
*
|
2002-11-14 |
2005-06-16 |
Janakiraman Ramachandran |
Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
|
EP1572971B1
(en)
|
2002-11-15 |
2009-09-30 |
Morphotek Inc. |
Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
|
EP2179742A1
(en)
|
2002-11-26 |
2010-04-28 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20040101860A1
(en)
*
|
2002-11-27 |
2004-05-27 |
Jones Alison M. |
Predicting animal performance
|
US20040259226A1
(en)
*
|
2003-05-30 |
2004-12-23 |
Robey W. Wade |
Monitoring for and detecting microbes used in bioterrorism
|
WO2004050873A1
(en)
*
|
2002-11-29 |
2004-06-17 |
The University Of Hong Kong |
Genetically modified plants expressing proteinase inhibitors, sapina2a or sapin2b, and methods of use thereof for the inhibition of trypsin-and chymotrypsin-like activities
|
US20060275764A1
(en)
*
|
2002-12-03 |
2006-12-07 |
Aarhus Universitet |
Method for determining predisposition to manifestation of immune system related diseases
|
WO2004058938A2
(en)
*
|
2002-12-31 |
2004-07-15 |
Pharmacia & Upjohn Company Llc |
Canine l-pbe sequences
|
WO2004058957A2
(en)
*
|
2002-12-31 |
2004-07-15 |
Pharmacia & Upjohn Company Llc |
Canine cyp1a2 sequences
|
JP2006518989A
(ja)
*
|
2002-12-31 |
2006-08-24 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
イヌのダイオキシン/アリール炭化水素受容体配列
|
US7560272B2
(en)
*
|
2003-01-04 |
2009-07-14 |
Inverness Medical Switzerland Gmbh |
Specimen collection and assay container
|
US7259002B2
(en)
*
|
2003-01-21 |
2007-08-21 |
Bristol-Myers Squibb Company |
Polynucleotide encoding a novel acyl coenzyme A, monoacylglycerol acyltransferase-3 (MGAT3), and uses thereof
|
US7449321B2
(en)
*
|
2003-01-22 |
2008-11-11 |
National University Of Singapore |
Molecules, compositions, methods and kits for applications associated with flaviviruses
|
DK2407485T3
(en)
|
2003-02-01 |
2016-03-21 |
Tanox Inc |
Anti-human IgE antibodies with high affinity
|
JP2007516157A
(ja)
|
2003-02-06 |
2007-06-21 |
トリペップ アクチ ボラゲット |
グリコシル化された抗原/抗体又はリガンド/受容体特異性交換体
|
US7335359B2
(en)
|
2003-02-06 |
2008-02-26 |
Tripep Ab |
Glycosylated specificity exchangers
|
US8021833B2
(en)
*
|
2003-02-12 |
2011-09-20 |
Functional Genetics, Inc. |
Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions
|
TW200427463A
(en)
*
|
2003-02-14 |
2004-12-16 |
Salmedix |
Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
|
GB0304515D0
(en)
*
|
2003-02-27 |
2003-04-02 |
Dakocytomation Denmark As |
Standard
|
US20040178714A1
(en)
*
|
2003-03-11 |
2004-09-16 |
Pan Wun Fang |
Decorative bulb of a series connected light string
|
US20040185446A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Jones Alison M. |
Cpn60 targets for quantification of microbial species
|
US20040185434A1
(en)
*
|
2003-03-21 |
2004-09-23 |
Robey W. Wade |
Detecting microbial contamination in animal by-products
|
US20040185454A1
(en)
*
|
2003-03-21 |
2004-09-23 |
Jones Alison M. |
Identification and quantification of microbial species in a sample
|
WO2004087758A2
(en)
*
|
2003-03-26 |
2004-10-14 |
Neopharm, Inc. |
Il 13 receptor alpha 2 antibody and methods of use
|
JP5392980B2
(ja)
*
|
2003-03-27 |
2014-01-22 |
チルドレンズ ホスピタル メディカル センター |
早発型の腎尿細管細胞障害を検出するための方法およびキット
|
US20070253964A1
(en)
*
|
2003-04-16 |
2007-11-01 |
Zlotnick Gary W |
Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7892745B2
(en)
*
|
2003-04-24 |
2011-02-22 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
KR100531760B1
(ko)
*
|
2003-04-28 |
2005-11-29 |
대한민국(관리부서 : 농림부 국립수의과학검역원) |
구제역 바이러스의 감염여부를 진단하는 방법 및 이를구현하기 위한 진단키트
|
US7892563B2
(en)
*
|
2003-05-20 |
2011-02-22 |
Wyeth Holdings Corporation |
Methods for treatment of severe acute respiratory syndrome (SARS)
|
US20050250094A1
(en)
*
|
2003-05-30 |
2005-11-10 |
Nanosphere, Inc. |
Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes
|
US20040241662A1
(en)
*
|
2003-05-30 |
2004-12-02 |
Robey W. Wade |
Detecting microbial contamination in grain and related products
|
EP1629014A2
(en)
*
|
2003-05-30 |
2006-03-01 |
Genentech, Inc. |
Polypeptides that bind an anti-tissue factor antibody and uses thereof
|
US7405274B2
(en)
|
2003-06-04 |
2008-07-29 |
Fibrogen, Inc. |
Connective tissue growth factor antibodies
|
WO2004110384A2
(en)
*
|
2003-06-12 |
2004-12-23 |
Vaxgen, Inc. |
Hiv-1 envelope glycoproteins having unusual disulfide structure
|
NZ544618A
(en)
|
2003-06-16 |
2009-02-28 |
Celltech R & D Inc |
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
IL156495A0
(en)
*
|
2003-06-17 |
2004-01-04 |
Prochon Biotech Ltd |
Use of fgfr3 antagonists for treating t cell mediated diseases
|
EP1668112A4
(en)
|
2003-06-20 |
2009-04-29 |
Protein Sciences Corp |
SARS IMMUNOGENOUS EXPRESSING VECTORS, SUCH VECTORS OR EXPRESSION PRODUCTS COMPRISING THOSE COMPOSITIONS, PROCESSES AND TESTS FOR THE PREPARATION AND USE THEREOF
|
CA2528529A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Amgen Inc. |
Gene amplification and overexpression in cancer
|
GB0315991D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Dakocytomation Denmark As |
Standard
|
DK1641822T3
(da)
|
2003-07-08 |
2013-07-22 |
Genentech Inc |
Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
|
US20050014734A1
(en)
*
|
2003-07-18 |
2005-01-20 |
Genovate Biotechnology Co., Ltd. |
Modulation of interleukin-10 by DHEA
|
ES2391975T3
(es)
*
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
EP2133362B1
(en)
|
2003-07-25 |
2012-04-18 |
Amgen, Inc |
Methods relating to LDCAM and CRTAM
|
GB0317592D0
(en)
*
|
2003-07-26 |
2003-08-27 |
Astrazeneca Ab |
Method
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
NZ619746A
(en)
|
2003-08-06 |
2014-05-30 |
Senomyx Inc |
Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US20080233119A2
(en)
|
2003-08-20 |
2008-09-25 |
University Of Miami |
Compositions and methods for treating inflammatory lung disease
|
US20050048589A1
(en)
*
|
2003-08-25 |
2005-03-03 |
Moncef Jendoubi |
Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer
|
US7517495B2
(en)
*
|
2003-08-25 |
2009-04-14 |
Inverness Medical Switzerland Gmbh |
Biological specimen collection and analysis system
|
ES2447423T3
(es)
|
2003-08-29 |
2014-03-12 |
Dyax Corp. |
Inhibidores de proteasa poli-pegilados
|
US7604994B2
(en)
*
|
2003-09-03 |
2009-10-20 |
Morphotek, Inc. |
Genetically altered antibody-producing cell lines with improved antibody characteristics
|
AU2004270721A1
(en)
*
|
2003-09-05 |
2005-03-17 |
The Scripps Research Institute |
Detection of cholesterol ozonation products
|
US20070111209A1
(en)
*
|
2003-09-19 |
2007-05-17 |
Soley Bjornsdottir |
Inversion on chromosome 8p23 is a risk factor for anxiety disorders, depression and bipolar disorders
|
US20050214279A1
(en)
*
|
2003-09-19 |
2005-09-29 |
Silverstein Samuel C |
Methods for stimulating human leukocytes to kill bacteria, yeast and fungi in biofilms that have formed in/on prosthetic devices, catheters, tissues and organs in vivo
|
US20050069958A1
(en)
*
|
2003-09-26 |
2005-03-31 |
Mills Rhonda A. |
Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
|
US20050069546A1
(en)
|
2003-09-30 |
2005-03-31 |
Yaron Ilan |
Educated NKT cells and their uses in the treatment of immune-related disorders
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
US7901880B2
(en)
|
2003-10-21 |
2011-03-08 |
Orion Genomics Llc |
Differential enzymatic fragmentation
|
WO2005052006A2
(en)
|
2003-11-25 |
2005-06-09 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services |
Mutated anti-cd22 antibodies and immunoconjugates
|
WO2005062048A1
(de)
*
|
2003-12-01 |
2005-07-07 |
Dade Behring Marburg Gmbh |
Homogenes nachweisverfahren
|
US20050118727A1
(en)
*
|
2003-12-01 |
2005-06-02 |
Carsten Schelp |
Conjugates and their use in detection methods
|
PT2805728T
(pt)
|
2003-12-23 |
2020-04-08 |
Genentech Inc |
Novos anticorpos anti-il13 e o uso dos mesmos
|
AU2004303448A1
(en)
|
2003-12-23 |
2005-07-07 |
Mount Sinai Hospital |
Methods for detecting markers associated with endometrial disease or phase
|
US7150995B2
(en)
*
|
2004-01-16 |
2006-12-19 |
Metrika, Inc. |
Methods and systems for point of care bodily fluid analysis
|
WO2005071058A2
(en)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
US20100216863A1
(en)
*
|
2004-01-30 |
2010-08-26 |
Decode Genetics Ehf. |
Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
|
US8158362B2
(en)
*
|
2005-03-30 |
2012-04-17 |
Decode Genetics Ehf. |
Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
|
CA2554537A1
(en)
*
|
2004-02-17 |
2005-09-01 |
Cancervax Corporation |
Method and composition for angiogenesis inhibition
|
ATE452147T1
(de)
|
2004-02-19 |
2010-01-15 |
Genentech Inc |
Antikörper mit korrigierten cdr
|
US7604956B2
(en)
*
|
2004-03-01 |
2009-10-20 |
Biotraces, Inc. |
Supersensitive immunoassays
|
JP4427541B2
(ja)
*
|
2004-03-05 |
2010-03-10 |
プリマハム株式会社 |
乳アレルゲンの検出方法
|
US20050227370A1
(en)
*
|
2004-03-08 |
2005-10-13 |
Ramel Urs A |
Body fluid analyte meter & cartridge system for performing combined general chemical and specific binding assays
|
JP5094384B2
(ja)
|
2004-03-12 |
2012-12-12 |
インターセプト ファーマシューティカルズ, インコーポレイテッド |
Fxrリガンドを使用する線維症の処置
|
JP2007529758A
(ja)
*
|
2004-03-19 |
2007-10-25 |
ユー.エス. ジェノミクス, インコーポレイテッド |
単一分子の検出のための組成物および方法
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
ES2482142T3
(es)
|
2004-04-15 |
2014-08-01 |
University Of Florida Research Foundation, Inc. |
Proteínas neurales como biomarcadores para lesiones del sistema nervioso y otros trastornos neurales
|
RU2006145450A
(ru)
*
|
2004-04-16 |
2008-06-27 |
Дженентек, Инк. (Us) |
Анализ на антитела
|
US7767417B2
(en)
*
|
2004-04-20 |
2010-08-03 |
New York University |
Prenyl-electrostatic switch, and methods of use
|
EA013071B1
(ru)
|
2004-04-23 |
2010-02-26 |
ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи |
Способ получения вируса репродуктивно-респираторного синдрома свиней (pprsv) и способ получения pprsv вакцины
|
ES2389047T3
(es)
|
2004-04-29 |
2012-10-22 |
Otsuka Pharmaceutical Co., Ltd. |
Anticuerpos específicos contra la glicoproteína VI y procedimientos de producción de estos anticuerpos
|
EP1753449A4
(en)
*
|
2004-04-30 |
2009-09-23 |
Corthera Inc |
METHOD AND COMPOSITIONS FOR CONTROLLING FEDERAL GROWTH BY RELAXIN MODULATION
|
US7939251B2
(en)
|
2004-05-06 |
2011-05-10 |
Roche Molecular Systems, Inc. |
SENP1 as a marker for cancer
|
US20050272101A1
(en)
*
|
2004-06-07 |
2005-12-08 |
Prasad Devarajan |
Method for the early detection of renal injury
|
UY28886A1
(es)
|
2004-05-10 |
2005-12-30 |
Boehringer Ingelheim Int |
Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
|
KR20120085921A
(ko)
|
2004-05-11 |
2012-08-01 |
압제노믹스 코오페라티에프 유.에이. |
T 세포 사멸 유도성 에피토프
|
AU2005246289A1
(en)
*
|
2004-05-15 |
2005-12-01 |
Genentech, Inc. |
Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
|
US7504205B2
(en)
*
|
2004-05-17 |
2009-03-17 |
The Burnham Institute |
Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy
|
US7604947B2
(en)
*
|
2004-06-09 |
2009-10-20 |
Cornell Research Foundation, Inc. |
Detection and modulation of cancer stem cells
|
US20060040876A1
(en)
|
2004-06-10 |
2006-02-23 |
Rong-Hwa Lin |
Modulation of peroxisome proliferator-activated receptors
|
EP2453024B1
(en)
|
2004-06-21 |
2017-12-06 |
The Board of Trustees of The Leland Stanford Junior University |
Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
|
US8034553B2
(en)
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
EP2287310B1
(en)
|
2004-07-22 |
2015-05-06 |
Five Prime Therapeutics, Inc. |
Compositions and methods using MGD-CSF in disease treatment
|
US7342093B2
(en)
|
2004-07-23 |
2008-03-11 |
University Of Massachusetts |
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
|
US20060024744A1
(en)
*
|
2004-07-28 |
2006-02-02 |
Mills Rhonda A |
Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
|
US7510858B2
(en)
*
|
2004-08-02 |
2009-03-31 |
Janssen Pharmaceutica N.V. |
IRAK 1c splice variant and its use
|
WO2006023312A2
(en)
*
|
2004-08-20 |
2006-03-02 |
Carl Deirmengian |
Diagnostic assay for source of inflammation
|
US7893197B2
(en)
*
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
CA2589602A1
(en)
*
|
2004-09-01 |
2006-04-13 |
Genvec, Inc. |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
US7645575B2
(en)
*
|
2004-09-08 |
2010-01-12 |
Xdx, Inc. |
Genes useful for diagnosing and monitoring inflammation related disorders
|
FI20041204A0
(fi)
|
2004-09-16 |
2004-09-16 |
Riikka Lund |
Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
AU2005294347A1
(en)
*
|
2004-10-05 |
2006-04-20 |
Oregon Health And Science University |
Compositions and methods for treating disease
|
PT1810026T
(pt)
|
2004-10-06 |
2018-06-11 |
Mayo Found Medical Education & Res |
B7-h1 e pd-1 no tratamento do carcinona de células renais
|
US8969291B2
(en)
|
2004-10-08 |
2015-03-03 |
Enzo Therapeutics, Inc. |
Methods for decreasing leptin levels or activity for treating inflammation
|
WO2006047417A2
(en)
|
2004-10-21 |
2006-05-04 |
University Of Florida Research Foundation, Inc. |
Detection of cannabinoid receptor biomarkers and uses thereof
|
DK2586456T3
(en)
|
2004-10-29 |
2016-03-21 |
Ratiopharm Gmbh |
Conversion and glycopegylation of fibroblast growth factor (FGF)
|
EP2302078B1
(en)
|
2004-11-03 |
2015-07-15 |
Iris Molecular Diagnostics, Inc. |
Microbubbles for affinity concentration
|
EP1842226B2
(en)
*
|
2004-11-03 |
2014-07-02 |
Iris International, Inc. |
Homogeneous analyte detection
|
US20090175866A1
(en)
*
|
2004-11-04 |
2009-07-09 |
Avner Yayon |
Treatment of b-cell malignancies
|
AU2005307765C1
(en)
|
2004-11-16 |
2012-07-05 |
Trustees Of Boston University |
Roles for Dual Endothelin-1/Angiotensin II Receptor (DEAR) in hypertension and angiogenesis
|
US20070207496A1
(en)
*
|
2004-11-19 |
2007-09-06 |
Larsen Oeistein |
Diagnostic control system
|
EP1814575A4
(en)
|
2004-11-24 |
2010-07-07 |
Neopro Labs Llc |
METHODS AND COMPOSITIONS FOR TREATING DISORDERS
|
WO2006060484A2
(en)
*
|
2004-12-01 |
2006-06-08 |
Gene Therapy Systems, Inc. |
Tuberculosis nucleic acids, polypeptides and immunogenic compositions
|
DE602005013288D1
(de)
*
|
2004-12-20 |
2010-05-06 |
Antibodyshop As |
M lipocalin (ngal) als diagnostischer marker für nierenerkrankungen
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
NZ588430A
(en)
|
2004-12-22 |
2012-10-26 |
Genentech Inc |
Methods for producing soluble multi-membrane-spanning proteins
|
CA2531616A1
(en)
*
|
2004-12-28 |
2006-06-28 |
Kabushiki Kaisha Kobe Seiko Sho (Kobe Steel, Ltd.) |
High strength thin steel sheet having high hydrogen embrittlement resisting property and high workability
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
CN101875692A
(zh)
|
2004-12-30 |
2010-11-03 |
新加坡科技研究局 |
中国仓鼠凋亡相关基因
|
US7700738B2
(en)
|
2005-01-27 |
2010-04-20 |
The Regents Of The University Of California |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
|
CA2597271A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Dana-Farber Cancer Institute |
Methods of detecting ovarian cancer
|
EP1856523A2
(en)
*
|
2005-03-10 |
2007-11-21 |
Hadasit Medical Research Services & Development Ltd. |
Antigen specific lymphocytes, compositions thereof, and methods for isolation and preparation thereof
|
EP1863531A1
(en)
|
2005-03-19 |
2007-12-12 |
Medical Research Council |
Improvements in or relating to treatment and prevention of viral infections
|
US20070092886A1
(en)
*
|
2005-03-22 |
2007-04-26 |
Raymond Tabibiazar |
Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease
|
EA015584B1
(ru)
|
2005-03-23 |
2011-10-31 |
Генмаб А/С |
Антитело к cd38 человека и его применение
|
EP2384767B1
(en)
|
2005-03-24 |
2016-03-09 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind OV064 and methods of use therefor
|
US20070037232A1
(en)
*
|
2005-03-31 |
2007-02-15 |
Barasch Jonathan M |
Detection of NGAL in chronic renal disease
|
US8048638B2
(en)
*
|
2005-04-01 |
2011-11-01 |
University Of Florida Research Foundation, Inc. |
Biomarkers of liver injury
|
CA2635198C
(en)
*
|
2005-04-01 |
2019-11-12 |
University Of Florida Research Foundation, Inc |
Biomarkers of liver injury
|
LT3264094T
(lt)
|
2005-04-04 |
2021-04-12 |
Biogen Ma Inc. |
Imuninio atsako į terapijos agentą įvertinimo būdai
|
WO2006121569A2
(en)
|
2005-04-08 |
2006-11-16 |
Neose Technologies, Inc. |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
EP2947145A1
(en)
|
2005-04-11 |
2015-11-25 |
Crealta Pharmaceuticals LLC |
Variant forms of urate oxidase and use thereof
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
WO2006119262A2
(en)
*
|
2005-05-02 |
2006-11-09 |
The Curators Of The University Of Missouri |
Detection of carbohydrate biomarkers
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
WO2006122295A2
(en)
*
|
2005-05-11 |
2006-11-16 |
Expression Diagnostics, Inc. |
Methods of monitoring functional status of transplants using gene panels
|
WO2006125021A2
(en)
*
|
2005-05-16 |
2006-11-23 |
Dana Farber Cancer Institute, Inc. |
Fibrinogen alpha and hemoglobin polypeptides as cancer markers
|
WO2006123369A1
(en)
|
2005-05-18 |
2006-11-23 |
Decode Genetics Ehf. |
Variants at chr8q24.21 confer risk of cancer
|
US7871781B2
(en)
*
|
2005-05-23 |
2011-01-18 |
Phadia Ab |
Two step lateral flow assay methods and devices
|
EP1888751A2
(en)
*
|
2005-05-25 |
2008-02-20 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
PL1907000T5
(pl)
|
2005-06-08 |
2020-11-16 |
Dana-Farber Cancer Institute |
Metody i kompozycje do leczenia infekcji przetrwałych
|
MX2007015848A
(es)
*
|
2005-06-20 |
2008-04-22 |
Decode Genetics Ehf |
Variantes geneticas en el gen tcf7l2 como marcadores de diagnostico para el riesgo de diabetes mellitus tipo 2.
|
US7482124B2
(en)
*
|
2005-07-08 |
2009-01-27 |
Bristol-Myers Squibb Company |
Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema
|
US7906297B2
(en)
|
2005-07-20 |
2011-03-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of phosphorylated ATR kinase (Ser 428) and uses thereof
|
AU2006278260B2
(en)
*
|
2005-08-08 |
2012-03-08 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US20070202512A1
(en)
*
|
2005-08-19 |
2007-08-30 |
Bristol-Myers Squibb Company |
Human single nucleotide polymorphisms associated with dose-dependent weight gain and methods of use thereof
|
ES2611307T3
(es)
|
2005-08-30 |
2017-05-08 |
University Of Miami |
Inmunomodulación de agonistas, antagonistas e inmunotoxinas del receptor del factor de necrosis tumoral 25 (TNFR25)
|
WO2007027906A2
(en)
*
|
2005-08-31 |
2007-03-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
EP2182057A1
(en)
|
2005-08-31 |
2010-05-05 |
Cell Signaling Technology, Inc. |
Antibody agains phosphorylated Tyrosine for the detection of protein phosphorylation in carcinoma signaling pathways
|
WO2007030560A2
(en)
*
|
2005-09-08 |
2007-03-15 |
Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine |
Identification of modulators of serine protease inhibitor kazal and their use as anti-cancer and anti-viral agents
|
EP1937305A4
(en)
*
|
2005-09-09 |
2008-10-08 |
Glycofi Inc |
IMMUNOGLOBULIN COMPRISING A MAN7GLCNAC2 OR MAN8GLCNAC2 PREDOMINANT GLYCOFORM
|
US7611834B2
(en)
*
|
2005-09-30 |
2009-11-03 |
Sandia Corporation |
Methods and devices for protein assays
|
IL172297A
(en)
|
2005-10-03 |
2016-03-31 |
Compugen Ltd |
Soluble vegfr-1 variants for the diagnosis of preeclampsia
|
JP2009511911A
(ja)
|
2005-10-11 |
2009-03-19 |
テシス バイオサイエンス, インコーポレイテッド |
糖尿病関連マーカおよびその使用
|
US8119358B2
(en)
*
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
US20080090304A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Barasch Jonathan Matthew |
Diagnosis and monitoring of chronic renal disease using ngal
|
US20090074720A1
(en)
*
|
2005-10-28 |
2009-03-19 |
Sabbadini Roger A |
Methods for decreasing immune response and treating immune conditions
|
US20090155850A1
(en)
*
|
2005-10-28 |
2009-06-18 |
The Florida International University Board Of Trustees |
Horse:Human Chimeric Antibodies
|
US20080213274A1
(en)
*
|
2005-10-28 |
2008-09-04 |
Sabbadini Roger A |
Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
|
AU2006308863A1
(en)
*
|
2005-10-31 |
2007-05-10 |
Janssen Pharmaceutica N.V. |
A polypeptide complex of TRPM8 and calmodulin and its uses thereof
|
WO2007051303A1
(en)
|
2005-11-02 |
2007-05-10 |
Protiva Biotherapeutics, Inc. |
MODIFIED siRNA MOLECULES AND USES THEREOF
|
MY151064A
(en)
|
2005-11-04 |
2014-03-31 |
Genentech Inc |
Use of complement pathway inhibitors to treat ocular diseases
|
ZA200804082B
(en)
|
2005-11-07 |
2010-02-24 |
Scripps Research Inst |
Compositions and methods for controlling tissue factor signaling specificity
|
WO2007056411A2
(en)
*
|
2005-11-08 |
2007-05-18 |
Genentech, Inc. |
Method of producing pan-specific antibodies
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
DK2564864T3
(en)
|
2005-11-12 |
2015-04-07 |
Trustees Of The Leland Board Of |
FGF-2 related methods for the diagnosis and treatment of depression
|
AU2006314528A1
(en)
|
2005-11-16 |
2007-05-24 |
Novartis Ag |
Biomarkers for anti-nogo-A antibody treatment in spinal cord injury
|
NZ568272A
(en)
|
2005-11-18 |
2012-02-24 |
Glenmark Pharmaceuticals Sa |
Anti-alpha2 integrin antibodies and their uses
|
EP2805971A1
(en)
|
2005-11-28 |
2014-11-26 |
ZymoGenetics, Inc. |
IL-21 antagonists
|
KR101472701B1
(ko)
|
2005-11-29 |
2014-12-15 |
캠브리지 엔터프라이즈 리미티드 |
유방암에 대한 마커
|
US7822474B2
(en)
*
|
2005-11-30 |
2010-10-26 |
Cedars-Sinai Medical Center |
Methods for the prediction of arrhythmias and prevention of sudden cardiac death
|
KR101453570B1
(ko)
|
2005-12-02 |
2014-10-22 |
제넨테크, 인크. |
Il-22 및 il-22r에 결합하는 항체를 포함하는,사이토카인 신호 전달과 관련된 질환 및 장애 치료용조성물 및 치료 방법
|
US20070134814A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
US20070178504A1
(en)
|
2005-12-22 |
2007-08-02 |
Tracey Colpitts |
Methods and marker combinations for screening for predisposition to lung cancer
|
US9347945B2
(en)
|
2005-12-22 |
2016-05-24 |
Abbott Molecular Inc. |
Methods and marker combinations for screening for predisposition to lung cancer
|
WO2007082144A2
(en)
*
|
2006-01-05 |
2007-07-19 |
Mayo Foundation For Medical Education And Research |
B7-h1 and survivin in cancer
|
US20090215084A1
(en)
*
|
2006-01-05 |
2009-08-27 |
Mayo Foundation For Medical Education And Research |
B7-h1 and b7-h4 in cancer
|
EP1982186A2
(en)
*
|
2006-01-12 |
2008-10-22 |
Janssen Pharmaceutica, N.V. |
Processing of slpi by chymase
|
WO2007084321A2
(en)
|
2006-01-12 |
2007-07-26 |
Alexion Pharmaceuticals, Inc. |
Antibodies to ox-2/cd200 and uses thereof
|
EP1973945A4
(en)
|
2006-01-16 |
2009-11-18 |
Compugen Ltd |
NEW NUCLEOTIDE AND AMINO ACID SEQUENCES AND METHOD FOR THEIR APPLICATION IN DIAGNOSIS
|
EP1973946B1
(en)
|
2006-01-20 |
2015-03-25 |
Cell Signaling Technology, Inc. |
Translocation and mutant ros kinase in human non-small cell lung carcinoma
|
US20120208824A1
(en)
|
2006-01-20 |
2012-08-16 |
Cell Signaling Technology, Inc. |
ROS Kinase in Lung Cancer
|
EP1991246B1
(en)
|
2006-02-22 |
2013-09-11 |
Zhenglun Zhu |
Treatment of development-related disorders
|
AU2007221321B2
(en)
*
|
2006-02-22 |
2012-06-28 |
The Texas A & M University System |
Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
|
SI2676967T1
(sl)
|
2006-02-28 |
2020-01-31 |
Biogen Ma Inc. |
Metode zdravljenja vnetne in avtoimunske bolezni z natalizumabom
|
US20070231319A1
(en)
|
2006-03-03 |
2007-10-04 |
Yednock Theodore A |
Methods of treating inflammatory and autoimmune diseases with natalizumab
|
PT2005185E
(pt)
|
2006-03-22 |
2011-01-27 |
Viral Logic Systems Technology Corp |
Métodos para a identificação de alvos polipeptídicos
|
US8129334B2
(en)
|
2006-03-31 |
2012-03-06 |
The Regents Of The University Of California |
Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
|
CA2648580A1
(en)
*
|
2006-04-07 |
2008-05-02 |
Xdx, Inc. |
Steroid responsive nucleic acid expression and prediction of disease activity
|
US8071323B2
(en)
*
|
2006-04-07 |
2011-12-06 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Human monoclonal antibodies that bind human insulin like growth factors and their use
|
KR101288027B1
(ko)
*
|
2006-04-12 |
2013-07-22 |
새비언트 파마수티컬즈 인크. |
양이온 계면활성제를 이용한 단백질 정제 방법
|
PT2450437T
(pt)
|
2006-04-14 |
2017-08-25 |
Cell Signaling Technology Inc |
Defeitos de genes e cinase alk mutante em tumores sólidos humanos
|
WO2007124361A2
(en)
*
|
2006-04-20 |
2007-11-01 |
Mayo Foundation For Medical Education And Research |
Soluble b7-h1
|
TWI425917B
(zh)
|
2006-04-21 |
2014-02-11 |
Senomyx Inc |
包含高度鮮味風味劑之可食用組合物及其製造方法
|
WO2007127335A2
(en)
*
|
2006-04-27 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways
|
NZ572178A
(en)
|
2006-05-04 |
2012-01-12 |
Genentech Inc |
Model systems and methods relating to zebrafish pro-apoptotic (zpa) polypeptides
|
CA2651847A1
(en)
*
|
2006-05-09 |
2007-11-22 |
Musc Foundation For Research Development |
Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
|
US8377448B2
(en)
*
|
2006-05-15 |
2013-02-19 |
The Board Of Trustees Of The Leland Standford Junior University |
CD47 related compositions and methods for treating immunological diseases and disorders
|
AU2007249709A1
(en)
*
|
2006-05-15 |
2007-11-22 |
Viral Logic Systems Technology Corp. |
CD47 related compositions and methods for treating immunological diseases and disorders
|
US7745584B2
(en)
*
|
2006-05-22 |
2010-06-29 |
California Institute Of Technology |
Antibodies to sulfated carbohydrates
|
WO2007137300A2
(en)
|
2006-05-23 |
2007-11-29 |
Bellicum Pharmaceuticals, Inc. |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
EP1862538A1
(en)
*
|
2006-05-29 |
2007-12-05 |
IMBA-Institut für Molekulare Biotechnologie GmbH |
siRNA kinase and methods of use
|
WO2007137584A1
(en)
|
2006-05-30 |
2007-12-06 |
Antibodyshop A/S |
Methods and devices for rapid assessment of severity of injury
|
US7862812B2
(en)
*
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
WO2007146229A2
(en)
|
2006-06-07 |
2007-12-21 |
Tethys Bioscience, Inc. |
Markers associated with arteriovascular events and methods of use thereof
|
CA2655504A1
(en)
*
|
2006-06-15 |
2007-12-21 |
Fibron Ltd. |
Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof
|
EP2377953A1
(en)
|
2006-06-23 |
2011-10-19 |
Myriad Genetics, Inc. |
DPYD gene variants and use thereof
|
CA2656221A1
(en)
|
2006-06-28 |
2008-01-03 |
Yeda Research And Development Co. Ltd. |
Caspase-8 and inflammation, infection and wound healing
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
EP2082059A4
(en)
*
|
2006-07-11 |
2009-11-11 |
Musc Found For Res Dev |
PREDICTION OF HEART FAILURE TO MYOCARDIN FARCT BY PROTEASE AND PROTEASE INHIBITOR PROFILE MANUFACTURE
|
MY150687A
(en)
|
2006-07-21 |
2014-02-28 |
Femalon S P R L |
Assay and kit for predicting implantation success in assisted fertilisation
|
EP1882697B1
(en)
|
2006-07-24 |
2010-04-21 |
Institut Pasteur |
Antibodies, antibody fragments and scFv binding to post-translationally modified neurotrophins
|
US20100210031A2
(en)
*
|
2006-08-07 |
2010-08-19 |
Antibodyshop A/S |
Diagnostic Test to Exclude Significant Renal Injury
|
US20110184747A1
(en)
*
|
2006-08-09 |
2011-07-28 |
Carmen Bozic |
Method for distribution of a drug
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
WO2008021431A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Xdx, Inc. |
Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
US20080300170A1
(en)
*
|
2006-09-01 |
2008-12-04 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment for type 2 diabetes
|
US20100267052A1
(en)
*
|
2006-09-01 |
2010-10-21 |
American Type Culture Collection |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
US20090203602A1
(en)
*
|
2006-09-01 |
2009-08-13 |
Cohava Gelber |
Compositions and methods for diagnosis and treatment of type 2 diabetes
|
US7569396B1
(en)
|
2006-09-08 |
2009-08-04 |
Purplecow Llc |
Caffeine detection using internally referenced competitive assays
|
US20100190689A1
(en)
|
2006-09-21 |
2010-07-29 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic distrophy
|
NZ576122A
(en)
|
2006-09-26 |
2012-09-28 |
Genmab As |
Anti-cd38 plus corticosteroids plus a non-corticosteroid chemotherapeutic for treating tumors
|
ES2584322T3
(es)
|
2006-10-04 |
2016-09-27 |
Genentech, Inc. |
ELISA para VEGF
|
WO2008066626A2
(en)
*
|
2006-10-25 |
2008-06-05 |
The Rockefeller University |
METHODS FOR THE TREATMENT OF Aβ RELATED DISORDERS AND COMPOSITIONS THEREFOR
|
CN101687031B
(zh)
|
2006-10-27 |
2014-05-14 |
勒帕斯公司 |
用于治疗眼疾和眼病的组合物及方法
|
PT2087002E
(pt)
*
|
2006-10-27 |
2014-11-26 |
Lpath Inc |
Composições e métodos para a ligação de esfingosina-1- fosfato
|
WO2008049239A1
(en)
|
2006-10-27 |
2008-05-02 |
Mount Sinai Hospital |
Endometrial biomarkers
|
US20080125368A1
(en)
*
|
2006-10-31 |
2008-05-29 |
Imperial Innovations Limited |
Methods
|
WO2008053486A1
(en)
*
|
2006-11-02 |
2008-05-08 |
Sylvie Luria |
Methods for screening for therapeutic molecules and use of the molecules therefrom
|
TWI472535B
(zh)
|
2006-11-02 |
2015-02-11 |
Genentech Inc |
人類化之抗-因子d抗體及其用途
|
WO2008140484A2
(en)
*
|
2006-11-09 |
2008-11-20 |
Xdx, Inc. |
Methods for diagnosing and monitoring the status of systemic lupus erythematosus
|
WO2008061013A2
(en)
*
|
2006-11-10 |
2008-05-22 |
Amgen Inc. |
Antibody-based diagnostics and therapeutics
|
WO2008133722A2
(en)
*
|
2006-11-10 |
2008-11-06 |
Ucb Pharma S.A. |
Anti human sclerostin antibodies
|
WO2008061130A2
(en)
*
|
2006-11-15 |
2008-05-22 |
Ucp Biosciences, Inc. |
An improved collecting and testing device and method of use
|
US20100104511A1
(en)
*
|
2006-11-22 |
2010-04-29 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions using chelator-antibody conjugates
|
JP2010510804A
(ja)
*
|
2006-11-30 |
2010-04-08 |
デコード・ジェネティクス・イーエイチエフ |
2型糖尿病の遺伝的感受性変異体
|
SG177225A1
(en)
|
2006-12-01 |
2012-01-30 |
Agency Science Tech & Res |
Cancer-related protein kinases
|
DK2121979T3
(en)
*
|
2006-12-05 |
2017-09-25 |
Decode Genetics Ehf |
Genetic markers for risk management of cardiac arrhythmia
|
US7935791B2
(en)
|
2006-12-18 |
2011-05-03 |
Genentech, Inc. |
Antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases
|
US20090186034A1
(en)
*
|
2006-12-19 |
2009-07-23 |
Genetech, Inc. |
Gene expression markers for inflammatory bowel disease
|
US20080171344A1
(en)
*
|
2006-12-22 |
2008-07-17 |
Kapsner Kenneth P |
Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase
|
AR064642A1
(es)
*
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
US20100129358A1
(en)
|
2006-12-22 |
2010-05-27 |
University Of Utah Research Foundation |
Method of detecting ocular diseases and pathologic conditions and treatment of same
|
EP2124998B8
(en)
*
|
2006-12-27 |
2015-05-06 |
The Johns Hopkins University |
Methods for detecting inflammation and auto-immune diseases
|
US7989173B2
(en)
*
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
US20090142342A1
(en)
*
|
2006-12-27 |
2009-06-04 |
Johns Hopkins University |
B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases
|
US8506499B2
(en)
*
|
2007-01-04 |
2013-08-13 |
Musc Foundation For Research Development |
Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
|
US8930178B2
(en)
|
2007-01-04 |
2015-01-06 |
Children's Hospital Medical Center |
Processing text with domain-specific spreading activation methods
|
AR065083A1
(es)
*
|
2007-02-02 |
2009-05-13 |
Amgen Inc |
Hepcidina, antagonistas de la hepcidina y metodos de uso
|
BRPI0807236A2
(pt)
|
2007-02-07 |
2019-09-24 |
Decode Genetics Ehf |
métodos para determinar uma suscetibilidade para câncer de próstata em um indivíduo humano, para identificar um marcador para uso em avaliação de suscetibilidade para câncer de próstata e para genotipificar uma amostra de ácido nucleico obtida de um indivíduo humano sob risco de, ou diagnosticado com, câncer de prostáta, para avaliar um indivíduo humano para probabiliade da resposta a um agente terapêutico para prevenir e/ou melhorar sintomas associados com câncer de próstata, para predizer prognóstico de um indivíduo diagnosticado com câncer e para monitorar progresso de um tratamento de um indivíduo sofrendo tratamento para câncer de próstata, kit para avaliar suscetibilidade para câncer de próstata em um indivíduo humano, uso de uma sonda de oligonucleotídeo, meio legível por computador, e , aparelho para determinar um indicador genético para câncer de próstata em um indivíduo humano.
|
SG178811A1
(en)
*
|
2007-02-21 |
2012-03-29 |
Decode Genetics Ehf |
Genetic susceptibility variants associated with cardiovascular disease
|
EP1972639A3
(en)
|
2007-03-07 |
2008-12-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
CN101680903A
(zh)
*
|
2007-03-21 |
2010-03-24 |
比奥波托诊断股份公司 |
肾损伤的诊断试验
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
US20090092631A1
(en)
*
|
2007-03-26 |
2009-04-09 |
Tripep Ab |
Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
|
NZ580490A
(en)
*
|
2007-03-26 |
2012-08-31 |
Decode Genetics Ehf |
Genetic variaints on CHR2 and CHR16 in linkage disequilibrium with rs 13387042 as markers for use in breast cancer assesment
|
EP1975184A3
(en)
|
2007-03-26 |
2008-11-26 |
Cell Signaling Technology, Inc. |
Serine or threonine phosphorylation sites
|
WO2008118324A2
(en)
|
2007-03-26 |
2008-10-02 |
Macrogenics, Inc. |
Composition and method of treating cancer with an anti-uroplakin ib antibody
|
ES2442919T3
(es)
|
2007-03-27 |
2014-02-14 |
Immunovia Ab |
Firma/marcadores de proteínas para la detección de adenocarcinoma
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
AU2008234530B2
(en)
|
2007-03-29 |
2013-03-28 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
DK2132339T3
(da)
*
|
2007-04-04 |
2011-06-27 |
Chimera Biotec Gmbh |
Fremgangsmåde til detektering af en analyt i en biologisk matrix
|
US20090182035A1
(en)
*
|
2007-04-11 |
2009-07-16 |
Alcon Research, Ltd. |
Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
|
JP2010523695A
(ja)
*
|
2007-04-11 |
2010-07-15 |
アルコン リサーチ, リミテッド |
アレルギー性鼻炎およびアレルギー性結膜炎を処置するためのTNFαのインヒビターおよび抗ヒスタミン薬の使用
|
AU2008242764B2
(en)
|
2007-04-18 |
2013-10-24 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
EP2145902A3
(en)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
WO2008132516A1
(en)
|
2007-04-26 |
2008-11-06 |
Opsona Therapeutics Limited |
Toll-like receptor binding epitope and compositions for binding thereto
|
US20090004677A1
(en)
*
|
2007-04-27 |
2009-01-01 |
The Board Of Trustees Of The University Of Illinois |
Quantitative determination of bcl10
|
BRPI0810775A2
(pt)
|
2007-05-01 |
2014-10-29 |
Hills Pet Nutrition Inc |
Método e kit para diagnosticar osteoartrite em um felino, composição, e, método para identificar um componente a ser testado para uma capacidade para tratar ou melhorar osteoartrite em um felino.
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
GB0709092D0
(en)
*
|
2007-05-11 |
2007-06-20 |
Borrebaeck Carl |
Diagnosis and method of disease
|
WO2008141318A1
(en)
*
|
2007-05-14 |
2008-11-20 |
Dr. Susan Love Research Foundation |
Device for determining risk of developing breast cancer and method thereof
|
JP2010527603A
(ja)
|
2007-05-25 |
2010-08-19 |
ディコーデ ジェネテクス イーエイチエフ |
乳癌のリスクアセスメント、診断、予後診断および治療における使用のためのマーカーとしてのCHR5p12および10q26上の遺伝的変異
|
US9163091B2
(en)
*
|
2007-05-30 |
2015-10-20 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
ES2585702T3
(es)
|
2007-05-30 |
2016-10-07 |
Lpath, Inc |
Composiciones y métodos para la unión al ácido lisofosfatídico
|
CN101971033A
(zh)
|
2007-06-04 |
2011-02-09 |
戴诺普雷克斯公司 |
用于结直肠癌的生物标志物组合
|
MX2009013269A
(es)
|
2007-06-05 |
2010-04-21 |
Univ Yale |
Inhibidores de receptor de cinasas de tirosina y metodos de uso de los mismos.
|
ES2583377T3
(es)
|
2007-06-08 |
2016-09-20 |
Genentech, Inc. |
Marcadores de expresión génica de la resistencia tumoral al tratamiento con inhibidor de HER2
|
AU2009258063B2
(en)
|
2007-06-21 |
2014-09-25 |
Macrogenics, Inc. |
BCR-complex-specific antibodies and methods of using same
|
US20100294665A1
(en)
*
|
2007-07-12 |
2010-11-25 |
Richard Allen |
Method and system for transferring and/or concentrating a sample
|
EP2170946A2
(en)
*
|
2007-07-13 |
2010-04-07 |
The Johns Hopkins University |
B7-dc variants
|
US8986684B2
(en)
*
|
2007-07-25 |
2015-03-24 |
Alexion Pharmaceuticals, Inc. |
Methods and compositions for treating autoimmune disease
|
US8734788B2
(en)
|
2007-08-03 |
2014-05-27 |
Opsona Therapeutics Ltd |
Composition and method for treatment of reperfusion injury and tissue damage
|
US8071561B2
(en)
*
|
2007-08-16 |
2011-12-06 |
Chrontech Pharma Ab |
Immunogen platform
|
US20090214593A1
(en)
*
|
2007-08-16 |
2009-08-27 |
Tripep Ab |
Immunogen platform
|
US8647622B2
(en)
|
2007-08-29 |
2014-02-11 |
Sanofi |
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
|
PL2769729T3
(pl)
|
2007-09-04 |
2019-09-30 |
Compugen Ltd. |
Polipeptydy i polinukleotydy i ich zastosowanie jako cel dla leków do wytwarzania leków i środków biologicznych
|
US20090111131A1
(en)
*
|
2007-09-13 |
2009-04-30 |
Seth Fishman |
Method of detecting protein losing enteropathy in animals
|
CL2008002775A1
(es)
*
|
2007-09-17 |
2008-11-07 |
Amgen Inc |
Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
|
EP3136103B1
(en)
|
2007-10-05 |
2018-08-29 |
Affymetrix, Inc. |
Highly multiplexed assays
|
US20100216655A1
(en)
*
|
2007-10-12 |
2010-08-26 |
Patrick Sulem |
Sequence variants for inferring human pigmentation patterns
|
EP2050764A1
(en)
|
2007-10-15 |
2009-04-22 |
sanofi-aventis |
Novel polyvalent bispecific antibody format and uses thereof
|
EP2203558B1
(en)
|
2007-10-18 |
2016-05-04 |
Cell Signaling Technology, Inc. |
Translocation and mutant ros kinase in human non-small cell lung carcinoma
|
BRPI0818881A2
(pt)
|
2007-10-23 |
2015-05-05 |
Cleveland Clinic Foundation |
Polipetídeo purificado, composição farmacêutica e métodos de de tratar distúrbios cardiovasculares, de promover efluxo de colesterol a partir de uma célula, de melhorar um ou mais sintomas de uma condição inflamatória em um indivíduo, de mitigar perda de oxidante mpo de função de efluxo de colesterol e de tratar dano de célula endotelial em um indivíduo
|
US8361465B2
(en)
*
|
2007-10-26 |
2013-01-29 |
Lpath, Inc. |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
|
RS57021B1
(sr)
|
2007-11-07 |
2018-05-31 |
Genentech Inc |
Il-22 za upotrebu u tretiranju mikrobnih poremećaja
|
WO2009062050A2
(en)
|
2007-11-08 |
2009-05-14 |
Neogenix Oncology, Inc. |
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
|
CN101910845A
(zh)
*
|
2007-11-15 |
2010-12-08 |
比奥波托诊断股份公司 |
个体分子形式的生物标志的诊断用途
|
EP2728017B1
(en)
|
2007-11-19 |
2016-08-24 |
Celera Corporation |
Lung cancer markers and uses thereof
|
EP2062920A3
(en)
|
2007-11-21 |
2009-06-17 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signalling pathways
|
US8912149B1
(en)
|
2007-11-28 |
2014-12-16 |
California Institute Of Technology |
Glycosaminoglycan mimetics
|
CN101970689A
(zh)
|
2007-11-29 |
2011-02-09 |
健泰科生物技术公司 |
炎性肠病的基因表达标志物
|
US8697360B2
(en)
|
2007-11-30 |
2014-04-15 |
Decode Genetics Ehf. |
Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
|
WO2010055366A2
(en)
|
2007-12-07 |
2010-05-20 |
Zymogenetics, Inc. |
Anti-human il-21 monoclonal antibodies
|
EP3327129A1
(en)
|
2007-12-13 |
2018-05-30 |
Philip Morris Products S.a.s. |
Plants modified for reduced cadmium transport, derivative products, and related methods
|
JP2011506483A
(ja)
*
|
2007-12-14 |
2011-03-03 |
アムジエン・インコーポレーテツド |
抗スクレロスチン抗体を用いた骨折の治療方法
|
ES2535419T3
(es)
|
2007-12-27 |
2015-05-11 |
Protiva Biotherapeutics Inc. |
Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
|
DE202008000834U1
(de)
|
2008-01-21 |
2008-05-29 |
Chin, Li-Te |
Zusammensetzung und Reagenz für CTLA-4 und Verwendungen derselben
|
ES2500066T3
(es)
|
2008-01-25 |
2014-09-30 |
Amgen, Inc |
Anticuerpos frente a ferroportina y métodos de uso
|
AU2009208607B2
(en)
*
|
2008-01-31 |
2013-08-01 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
CA2618163A1
(en)
|
2008-02-07 |
2009-08-07 |
K. W. Michael Siu |
Head and neck cancer biomarkers
|
AU2009213689B2
(en)
|
2008-02-14 |
2014-11-20 |
Decode Genetics Ehf. |
Susceptibility variants for lung cancer
|
AU2009215799B2
(en)
*
|
2008-02-21 |
2013-08-22 |
Iris International Inc. |
Method for early determination of recurrence after therapy for prostate cancer
|
US20110020325A1
(en)
*
|
2008-02-29 |
2011-01-27 |
Kwon Eugene D |
Methods for reducing granulomatous inflammation
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
US20110136166A1
(en)
|
2008-03-14 |
2011-06-09 |
Eastern Virginia Medical School |
Imaging Mass Spectrometry for Improved Prostrate Cancer Diagnostics
|
US8993231B2
(en)
*
|
2008-03-18 |
2015-03-31 |
Marshall University Research Corporation |
Methods for stem cell production and therapy
|
NZ588905A
(en)
|
2008-04-01 |
2012-08-31 |
Decode Genetics Ehf |
Genetic testing method for determining susceptibility to abdominal aortic aneurysm by assay for selected polymorphisms associated with the disease
|
PT2247304T
(pt)
|
2008-04-02 |
2016-08-29 |
Macrogenics Inc |
Anticorpos especificos de her2/neu e métodos de utilização dos mesmos
|
AU2009233708B2
(en)
|
2008-04-09 |
2015-06-04 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
WO2009126306A2
(en)
|
2008-04-10 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting egfr mutations in cancer
|
ES2638448T3
(es)
|
2008-04-15 |
2017-10-20 |
Protiva Biotherapeutics Inc. |
Novedosas formulaciones de lípidos para la administración de ácidos nucleicos
|
JP2011516094A
(ja)
|
2008-04-15 |
2011-05-26 |
プロチバ バイオセラピューティクス インコーポレイティッド |
干渉rnaを用いたcsn5遺伝子発現のサイレンシング方法
|
JP6106854B2
(ja)
|
2008-04-25 |
2017-04-05 |
ダイアックス、コープDyax Corp. |
FcRnに対する抗体及びその使用
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
AU2009246946B2
(en)
|
2008-05-01 |
2013-09-26 |
Amgen Inc. |
Anti-hepcidin antibodies and methods of use
|
WO2009137664A1
(en)
|
2008-05-07 |
2009-11-12 |
Eutropics Pharmaceuticals, Inc. |
Antibodies specific to heterodimers of bcl-2 family and uses thereof
|
EP2116261A1
(en)
|
2008-05-07 |
2009-11-11 |
Institut Pasteur |
Sub-region of a plasmodium protein with improved vaccine potential and medical uses thereof
|
SG157299A1
(en)
|
2008-05-09 |
2009-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
EP2599793A1
(en)
|
2008-05-29 |
2013-06-05 |
Nuclea Biotechnologies, Inc. |
Anti-phospho-akt antibodies
|
US20110081347A1
(en)
|
2008-06-04 |
2011-04-07 |
Macrogenics, Inc. |
Antibodies with Altered Binding to FcRn and Methods of Using Same
|
JOP20190083A1
(ar)
|
2008-06-04 |
2017-06-16 |
Amgen Inc |
بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها
|
US20110123542A1
(en)
*
|
2008-06-24 |
2011-05-26 |
Hadasit Medical Research Services And Development Ltd. |
Ccl20-specific antibodies for cancer therapy
|
EP2307457B2
(en)
|
2008-06-25 |
2022-06-22 |
Novartis AG |
Stable and soluble antibodies inhibiting tnf
|
KR101817284B1
(ko)
|
2008-06-25 |
2018-01-11 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
Vegf를 억제하는 안정하고 가용성인 항체
|
US20110182881A1
(en)
*
|
2008-06-26 |
2011-07-28 |
Dana-Farber Cancer Institute, Inc. |
Signature and determinants associated with metastasis and methods of use thereof
|
WO2009158432A2
(en)
|
2008-06-27 |
2009-12-30 |
Amgen Inc. |
Ang-2 inhibition to treat multiple sclerosis
|
NZ590832A
(en)
|
2008-07-04 |
2013-01-25 |
Decode Genetics Ehf |
Genetic variants for schizophrenia risk assessment
|
NZ590833A
(en)
|
2008-07-07 |
2013-01-25 |
Decode Genetics Ehf |
Genetic variants for breast cancer risk assessment
|
US20120009581A1
(en)
|
2008-07-08 |
2012-01-12 |
Bankaitis-Davis Danute M |
Gene Expression Profiling for Predicting the Survivability of Prostate Cancer Subjects
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
AU2009270682B2
(en)
|
2008-07-17 |
2016-04-21 |
Ikfe Lnstitut Fur Klinische Forschung Und Entwicklung Gmbh |
Biomarkers for insulin resistance and beta-cell dysfunction
|
EP2338051B1
(en)
|
2008-07-17 |
2013-11-20 |
IKFE Institut für klinische Forschung und Entwicklung GmbH |
Biomarkers for cardiodiabetes
|
US20100021472A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Geetha Srikrishna |
Methods for diagnosing and treating cancer
|
US8795981B2
(en)
|
2008-08-08 |
2014-08-05 |
Molecular Devices, Llc |
Cell detection
|
AU2009280807A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Decode Genetics Ehf |
Genetic variants useful for risk assessment of thyroid cancer
|
EP2329037B1
(en)
*
|
2008-08-15 |
2015-01-28 |
Decode Genetics EHF |
Genetic variants predictive of cancer risk
|
JP5628807B2
(ja)
|
2008-08-18 |
2014-11-19 |
ソウル ナショナル ユニバーシティー インダストリー ファウンデーション |
リジルtRNA合成酵素の細胞内水準を調節して癌転移又は癌細胞の移動を調節する方法
|
MX2011002252A
(es)
|
2008-08-25 |
2011-06-24 |
Amplimmune Inc |
Composiciones de antagonistas del pd-1 y metodos de uso.
|
KR20110074850A
(ko)
*
|
2008-08-25 |
2011-07-04 |
앰플리뮨, 인크. |
Pd-1 길항제 및 그의 사용 방법
|
CA2735433C
(en)
|
2008-09-07 |
2016-02-16 |
Glyconex Inc. |
Anti-extended type i glycosphingolipid antibody, derivatives thereof and use
|
AU2009291747B2
(en)
|
2008-09-10 |
2016-05-26 |
Genentech, Inc. |
Methods for inhibiting ocular angiogenesis
|
WO2010030167A2
(en)
|
2008-09-12 |
2010-03-18 |
Cancer Research Initiative Foundation |
Method of detection and diagnosis of oral and nasopharyngeal cancers
|
US8417011B2
(en)
|
2008-09-18 |
2013-04-09 |
Molecular Devices (New Milton) Ltd. |
Colony detection
|
US20110200525A1
(en)
*
|
2008-10-09 |
2011-08-18 |
Patz Jr Edward F |
Vhh antibody fragments for use in the detection and treatment of cancer
|
SG195542A1
(en)
|
2008-10-10 |
2013-12-30 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
US20110262446A1
(en)
|
2008-10-14 |
2011-10-27 |
Dyax Corp. |
Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis
|
US8147847B2
(en)
*
|
2008-10-21 |
2012-04-03 |
International Vaccine Institute |
Shigella protein antigens and methods
|
US8871202B2
(en)
|
2008-10-24 |
2014-10-28 |
Lpath, Inc. |
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
|
EP2356135B1
(en)
|
2008-11-05 |
2017-10-25 |
Wyeth LLC |
Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
|
CN109045296A
(zh)
|
2008-11-10 |
2018-12-21 |
阿雷克森制药公司 |
用于治疗补体相关障碍的方法和组合物
|
AT507604A1
(de)
|
2008-11-19 |
2010-06-15 |
Affiris Forschungs & Entwicklungs Gmbh |
Behandlung von atherosklerose
|
EP2189539B2
(en)
|
2008-11-21 |
2018-06-13 |
Chimera Biotec GmbH |
Conjugate complexes for analyte detection
|
WO2010062995A2
(en)
|
2008-11-26 |
2010-06-03 |
Five Prime Therapeutics, Inc. |
Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
|
WO2010061393A1
(en)
|
2008-11-30 |
2010-06-03 |
Compugen Ltd. |
He4 variant nucleotide and amino acid sequences, and methods of use thereof
|
JP2012510284A
(ja)
|
2008-12-03 |
2012-05-10 |
プロイェクト、デ、ビオメディシナ、シーマ、ソシエダッド、リミターダ |
ワクチンの開発のためのフェノール可溶性モジュリンの使用
|
CA2782776A1
(en)
|
2008-12-04 |
2010-06-10 |
Ikfe Gmbh |
Biomarkers for atherosclerosis
|
US8431775B2
(en)
|
2008-12-04 |
2013-04-30 |
Pioneer Hi Bred International Inc |
Methods and compositions for enhanced yield by targeted expression of knotted1
|
EP2385071A1
(en)
|
2008-12-04 |
2011-11-09 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
|
US20110311450A1
(en)
|
2008-12-08 |
2011-12-22 |
Zurit Levine |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
US20110118134A1
(en)
|
2008-12-11 |
2011-05-19 |
Ikfe Gmbh |
Biomarkers for insulin sensitizer drug response
|
WO2010076655A1
(en)
|
2008-12-30 |
2010-07-08 |
Ikfe Gmbh |
Biomarkers for adipose tissue activity
|
WO2010079428A2
(en)
|
2009-01-07 |
2010-07-15 |
Ikfe Gmbh |
Biomarkers for appetite regulation
|
WO2010087131A1
(ja)
|
2009-01-28 |
2010-08-05 |
学校法人東海大学 |
Hiv複製抑制剤、及びその利用
|
CA2748852C
(en)
|
2009-01-28 |
2019-05-28 |
Industrial Technology Research Institute |
Biomarkers associated with nephropathy
|
EP3301446B1
(en)
|
2009-02-11 |
2020-04-15 |
Caris MPI, Inc. |
Molecular profiling of tumors
|
WO2010093993A2
(en)
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
PL2881402T3
(pl)
|
2009-02-12 |
2017-10-31 |
Cell Signaling Technology Inc |
Ekspresja zmutowanej ROS w ludzkim raku wątroby
|
US8378068B2
(en)
|
2009-02-16 |
2013-02-19 |
Cerenis Therapeutics Holding Sa |
Apolipoprotein A-I mimics
|
US20100248265A1
(en)
*
|
2009-02-27 |
2010-09-30 |
The Salk Institute For Biological Studies |
Compositions and methods for diagnosis and treatment of cancer
|
US8772238B2
(en)
|
2009-03-18 |
2014-07-08 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
|
EP2233496A1
(en)
|
2009-03-26 |
2010-09-29 |
Ruhr-Universität Bochum |
Fluorescent proteins
|
AU2010241947B2
(en)
|
2009-03-27 |
2014-01-16 |
Gojo Industries, Inc. |
Compositions and methods for screening and using compounds antagonizing spore-surface interactions
|
WO2010112033A2
(en)
|
2009-03-31 |
2010-10-07 |
Østjysk Innovation A/S |
Method for estimating the risk of having or developing multiple sclerosis using sequence polymorphisms in a specific region of chromosome x
|
CN102449165B
(zh)
|
2009-04-03 |
2014-07-09 |
解码遗传学私营有限责任公司 |
用于心房颤动和中风的风险管理的遗传标志
|
AU2010246038A1
(en)
|
2009-05-05 |
2011-12-01 |
Amgen Inc. |
FGF21 mutants and uses thereof
|
CN107188950B
(zh)
*
|
2009-05-05 |
2021-09-28 |
安姆根有限公司 |
Fgf21突变体及其用途
|
US20110301093A1
(en)
|
2009-05-06 |
2011-12-08 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
|
AU2010245598A1
(en)
*
|
2009-05-08 |
2011-11-17 |
Decode Genetics Ehf |
Genetic variants contributing to risk of prostate cancer
|
MX2011013903A
(es)
*
|
2009-06-17 |
2012-05-08 |
Amgen Inc |
Polipeptidos quimericos y usos de los mismos.
|
RU2535038C2
(ru)
|
2009-06-25 |
2014-12-10 |
Криэлта Фармасьютикалз ЭлЭлСи |
Способы и наборы для прогнозирования риска инфузионных реакций и опосредованной антителами потери ответа при терапии пэгилированной уриказой с помощью мониторинга содержания мочевой кислоты в сыворотке крови
|
WO2011000805A1
(en)
|
2009-06-29 |
2011-01-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarkers of oocyte competency and method of use
|
IL199618A0
(en)
|
2009-06-29 |
2010-04-29 |
Two To Biotech Ltd |
Novel antibodies and their use in diagnostic methods
|
US8283333B2
(en)
|
2009-07-01 |
2012-10-09 |
Protiva Biotherapeutics, Inc. |
Lipid formulations for nucleic acid delivery
|
IE20090514A1
(en)
|
2009-07-06 |
2011-02-16 |
Opsona Therapeutics Ltd |
Humanised antibodies and uses therof
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
EP2451977A4
(en)
|
2009-07-10 |
2013-01-02 |
Decode Genetics Ehf |
GENETIC MARKERS FOR THE RISK OF DIABETES MELLITUS
|
SG177699A1
(en)
|
2009-07-20 |
2012-02-28 |
Genentech Inc |
Gene expression markers for crohn's disease
|
WO2011011447A1
(en)
|
2009-07-20 |
2011-01-27 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus gene expression
|
ES2581178T3
(es)
|
2009-07-29 |
2016-09-01 |
Pharnext |
Nuevas herramientas de diagnóstico para enfermedad de Alzheimer
|
IL200202A0
(en)
|
2009-08-02 |
2010-05-31 |
Orly Devary |
Novel proteins
|
SG178125A1
(en)
|
2009-08-03 |
2012-03-29 |
Univ Miami |
Method for in vivo expansion of t regulatory cells
|
EP2467398B1
(en)
|
2009-08-20 |
2019-10-09 |
Poseida Therapeutics, Inc. |
Trpc4 inhibitors and uses thereof
|
US20120183981A1
(en)
*
|
2009-08-28 |
2012-07-19 |
Inova Diagnostics, Inc. |
Methoed for detecting circulating cartilage oligomeric matrix protein in the diagnosis and monitoring of cirrhosis
|
CN102666581A
(zh)
|
2009-08-31 |
2012-09-12 |
艾普利穆恩公司 |
用于抑制移植物排斥的方法和组合物
|
WO2011034950A1
(en)
|
2009-09-16 |
2011-03-24 |
Vaxart, Inc. |
Immunization strategy to prevent h1n1 infection
|
EP2480668A2
(en)
|
2009-09-23 |
2012-08-01 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing genes expressed in cancer
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
US9885711B2
(en)
|
2009-09-25 |
2018-02-06 |
Xoma Technology Ltd. |
Screening methods
|
AU2010300421B2
(en)
*
|
2009-10-01 |
2014-01-23 |
Alcon Research, Ltd. |
Olopatadine compositions and uses thereof
|
CA2776756A1
(en)
|
2009-10-11 |
2011-04-14 |
Biogen Idec Ma Inc. |
Anti-vla-4 related assays
|
WO2011047358A1
(en)
|
2009-10-15 |
2011-04-21 |
Crescendo Bioscience |
Biomarkers and methods for measuring and monitoring inflammatory disease activity
|
EP2470564A1
(en)
|
2009-10-22 |
2012-07-04 |
Yeda Research and Development Co. Ltd. |
Compositions and methods for treating aspergillosis
|
SG10201407757XA
(en)
|
2009-10-23 |
2015-01-29 |
Millennium Pharm Inc |
Anti-gcc antibody molecules and related compositions and methods
|
KR101832510B1
(ko)
*
|
2009-10-26 |
2018-02-26 |
제넨테크, 인크. |
치료 항-ige 항체에 대해 특이적인 항체를 검출하기 위한 검정 및 아나필락시스에서의 이의 용도
|
WO2011056688A2
(en)
|
2009-10-27 |
2011-05-12 |
Caris Life Sciences, Inc. |
Molecular profiling for personalized medicine
|
WO2011059721A1
(en)
|
2009-10-29 |
2011-05-19 |
Tethys Bioscience, Inc. |
Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
|
WO2011059720A2
(en)
|
2009-10-29 |
2011-05-19 |
Tethys Bioscience, Inc. |
Method for determining risk of diabetes
|
WO2011058367A2
(en)
|
2009-11-13 |
2011-05-19 |
Astrazeneca Ab |
Diagnostic test for predicting responsiveness to treatment with poly(adp-ribose) polymerase (parp) inhibitor
|
US8592151B2
(en)
*
|
2009-11-17 |
2013-11-26 |
Musc Foundation For Research Development |
Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
|
US9428586B2
(en)
|
2009-12-01 |
2016-08-30 |
Compugen Ltd |
Heparanase splice variant
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
EP2679234A3
(en)
*
|
2009-12-02 |
2014-04-23 |
Amgen Inc. |
Binding proteins that bind to human FGFR1C, human beta-klotho and both human FGFR1C and human beta-klotho
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
SG10201408073XA
(en)
|
2009-12-07 |
2015-01-29 |
Pieris Ag |
Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target
|
WO2011078794A1
(en)
|
2009-12-22 |
2011-06-30 |
Agency For Science, Technology And Research |
Sers-based analyte detection
|
BR112012015740B1
(pt)
|
2009-12-23 |
2020-09-29 |
Synimmune Gmbh |
Anticorpo anti-flt3, seu uso,bem como composição compreendendo o referido anticorpo e molécula de ácido nucleico
|
LT2521568T
(lt)
|
2010-01-06 |
2018-12-10 |
Dyax Corp. |
Plazmos kalikreiną surišantys baltymai
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
PL2524060T3
(pl)
|
2010-01-11 |
2018-05-30 |
Biogen Ma Inc. |
Test wykrywający przeciwciała przeciwko wirusowi jc
|
AU2011203879A1
(en)
|
2010-01-11 |
2012-08-02 |
Alexion Pharmaceuticals, Inc. |
Biomarkers of immunomodulatory effects in humans treated with anti-CD200 antibodies
|
WO2011089211A1
(en)
|
2010-01-22 |
2011-07-28 |
Synimmune Gmbh |
Anti-cd133 antibodies and methods of using the same
|
US9682132B2
(en)
|
2010-01-26 |
2017-06-20 |
Banyan Biomarkers, Inc |
Compositions and methods relating to argininosucccinate synthetase
|
EP3216805A1
(en)
|
2010-01-27 |
2017-09-13 |
Yeda Research and Development Co. Ltd |
Antibodies that inhibit metalloproteins
|
US20130071408A1
(en)
|
2010-02-01 |
2013-03-21 |
Atul J. Butte |
Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
JP4686639B1
(ja)
*
|
2010-02-25 |
2011-05-25 |
田中貴金属工業株式会社 |
生豚肉検出法およびその検出キット
|
WO2011106738A2
(en)
|
2010-02-25 |
2011-09-01 |
Fred Hutchinson Cancer Research Center |
Use of tcr clonotypes as biomarkers for disease
|
US20110212088A1
(en)
*
|
2010-02-26 |
2011-09-01 |
Sabbadini Roger A |
Anti-paf antibodies
|
EP2544688B1
(en)
|
2010-03-02 |
2016-09-07 |
President and Fellows of Harvard College |
Methods and compositions for treatment of angelman syndrome
|
US20110237000A1
(en)
*
|
2010-03-11 |
2011-09-29 |
Agency For Science, Technology And Research |
Method for detecting an analyte molecule
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
AU2011230537C1
(en)
|
2010-03-26 |
2018-08-02 |
Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US20130190237A1
(en)
|
2010-04-07 |
2013-07-25 |
Imperial Innovations Limited |
Methods for categorising cancer such as breast cancer
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
EP3670534A3
(en)
|
2010-04-15 |
2020-09-09 |
Amgen Inc. |
Human fgf receptor and beta-klotho binding proteins
|
DK2560672T3
(en)
|
2010-04-19 |
2014-03-17 |
Res Dev Foundation |
RTEF-1 variants and their uses
|
EP2561363B1
(en)
|
2010-04-21 |
2021-07-14 |
Memed Diagnostics, Ltd. |
Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
|
MX340739B
(es)
|
2010-05-14 |
2016-07-22 |
Brookhaven Science Ass Llc |
Quimeras ospa y su uso en vacunas.
|
AU2011250920B2
(en)
|
2010-05-14 |
2015-05-21 |
Amgen Inc. |
High concentration antibody formulations
|
WO2011146479A1
(en)
|
2010-05-18 |
2011-11-24 |
The Texas A&M University System |
Method and composition for the diagnosis and monitoring of inflammatory diseases
|
WO2011146725A1
(en)
|
2010-05-19 |
2011-11-24 |
Bayer Healthcare Llc |
Biomarkers for a multikinase inhibitor
|
WO2011145085A2
(en)
|
2010-05-21 |
2011-11-24 |
Procognia (Israel) Ltd |
Novel antibodies and methods of use for the treatment and diagnosis of cancer
|
WO2011161545A2
(en)
|
2010-06-04 |
2011-12-29 |
The Netherlands Cancer Institute |
Non-hydrolyzable protein conjugates, methods and compositions related thereto
|
WO2011156715A2
(en)
|
2010-06-10 |
2011-12-15 |
The Regents Of The University Of Michigan |
Methods of treating metabolic disorders and cardiovascular diseases
|
GB201009798D0
(en)
|
2010-06-11 |
2010-07-21 |
Immunovia Ab |
Method,array and use thereof
|
WO2011163401A2
(en)
|
2010-06-22 |
2011-12-29 |
Neogenix Oncology, Inc. |
Colon and pancreas cancer specific antigens and antibodies
|
EP2593551B1
(en)
|
2010-07-15 |
2016-09-14 |
Technion Research & Development Foundation Ltd. |
Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides
|
EP2593480A2
(en)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
WO2012017208A1
(en)
|
2010-08-04 |
2012-02-09 |
Cizzle Biotechnology Limited |
Methods and compounds for the diagnosis and treatment of
|
US20120101108A1
(en)
|
2010-08-06 |
2012-04-26 |
Cell Signaling Technology, Inc. |
Anaplastic Lymphoma Kinase In Kidney Cancer
|
US8956859B1
(en)
|
2010-08-13 |
2015-02-17 |
Aviex Technologies Llc |
Compositions and methods for determining successful immunization by one or more vaccines
|
WO2012021969A1
(en)
|
2010-08-16 |
2012-02-23 |
Mount Sinai Hospital |
Markers of the male urogenital tract
|
US10865445B2
(en)
|
2010-08-18 |
2020-12-15 |
Fred Hutchinson Cancer Research Center |
Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
|
US10088490B2
(en)
|
2010-08-20 |
2018-10-02 |
Siemens Healthcare Diagnostics Inc. |
Assay for analytes using multiple receptors
|
PT3246044T
(pt)
|
2010-08-23 |
2021-02-15 |
Wyeth Llc |
Formulações estáveis de antigénios de rlp2086 de neisseria meningitidis
|
WO2012030738A2
(en)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Complex phosphoprotein activation profiles
|
WO2012071096A2
(en)
|
2010-09-03 |
2012-05-31 |
The Johns Hopkins University |
Arid1a and ppp2r1a mutations in cancer
|
GB201014837D0
(en)
|
2010-09-07 |
2010-10-20 |
Immunovia Ab |
Biomarker signatures and uses thereof
|
MX362802B
(es)
|
2010-09-10 |
2019-02-13 |
Wyeth Llc Star |
Variantes no lipidadas de antigenos orf2086 de neisseria meningitidis.
|
US8999335B2
(en)
|
2010-09-17 |
2015-04-07 |
Compugen Ltd. |
Compositions and methods for treatment of drug resistant multiple myeloma
|
WO2012038744A2
(en)
|
2010-09-22 |
2012-03-29 |
Genome Research Limited |
Detecting mutations
|
US9068014B2
(en)
|
2010-09-23 |
2015-06-30 |
Precision Biologics, Inc. |
Colon and pancreas cancer peptidomimetics
|
US8497138B2
(en)
|
2010-09-30 |
2013-07-30 |
Genetix Limited |
Method for cell selection
|
US9006458B2
(en)
|
2010-10-12 |
2015-04-14 |
Agency For Science, Technology And Research |
Surface Enhanced Raman Spectroscopy (SERS) compounds and methods of their preparation
|
WO2012054870A2
(en)
|
2010-10-21 |
2012-04-26 |
Vertex Pharmaceuticals Incorporated |
Biomarkers for hcv infected patients
|
EP2444084A1
(en)
|
2010-10-21 |
2012-04-25 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Use of PI3K inibitors for the treatment of obesity
|
AR083495A1
(es)
|
2010-10-22 |
2013-02-27 |
Esbatech Alcon Biomed Res Unit |
Anticuerpos estables y solubles
|
GB201018014D0
(en)
|
2010-10-26 |
2010-12-08 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
WO2012056455A1
(en)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
WO2012068355A2
(en)
|
2010-11-18 |
2012-05-24 |
Tufts Medical Center, Inc. |
Treating aortic aneurysm by modulating toll-like receptors
|
WO2012071561A2
(en)
|
2010-11-23 |
2012-05-31 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of anemia
|
WO2012071346A1
(en)
|
2010-11-23 |
2012-05-31 |
Pantheryx, Inc. |
Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
|
EP2477032A1
(en)
|
2011-01-18 |
2012-07-18 |
Baxter International Inc |
Measurement of anti-amyloid antibodies in human blood
|
KR20130139153A
(ko)
|
2011-01-18 |
2013-12-20 |
백스터 인터내셔널 인코포레이티드 |
인간 혈액 중 항-베타 아밀로이드 항체의 측정
|
AR085141A1
(es)
|
2011-02-03 |
2013-09-11 |
Alexion Pharma Inc |
Un metodo para prolongar la supervivencia de un aloinjerto renal, uso de un anticuerpo anti-cd200 para prolongar la supervivencia de aloinjertos
|
FR2971258B1
(fr)
|
2011-02-09 |
2020-12-04 |
Bio Rad Pasteur |
Combinaison de biomarqueurs pour le pronostic d'une reponse ou non-reponse a un traitement anti-vhc
|
FR2971256A1
(fr)
|
2011-02-09 |
2012-08-10 |
Bio Rad Pasteur |
Combinaison de biomarqueurs pour la detection et l'evaluation d'une fibrose hepatique
|
FR2971257B1
(fr)
|
2011-02-09 |
2020-12-04 |
Bio Rad Pasteur |
Combinaison de biomarqueurs pour le pronostic d'une reponse ou non-reponse a un traitement anti-vhc
|
AU2012217723A1
(en)
|
2011-02-15 |
2013-08-29 |
Immune Design Corp. |
Methods for enhancing immunogen specific immune responses by vectored vaccines
|
CN102675460B
(zh)
|
2011-02-28 |
2015-08-19 |
珠海市丽珠单抗生物技术有限公司 |
抗肿瘤坏死因子α的人源化抗体
|
US8658171B2
(en)
|
2011-02-28 |
2014-02-25 |
Livzon Mabpharm Inc. |
Humanized anti-TNFα antibodies
|
EP2681242B1
(en)
|
2011-03-01 |
2018-01-24 |
Amgen Inc. |
Sclerostin and dkk-1 bispecific binding agents
|
GB201103726D0
(en)
|
2011-03-04 |
2011-04-20 |
Immunovia Ab |
Method, array and use thereof
|
WO2012125623A2
(en)
|
2011-03-14 |
2012-09-20 |
Ludwig Institute For Cancer Research Ltd. |
Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
|
EP2686014A1
(en)
|
2011-03-16 |
2014-01-22 |
Sanofi |
Uses of a dual v region antibody-like protein
|
PE20140437A1
(es)
|
2011-03-25 |
2014-04-17 |
Amgen Inc |
Formulaciones de anticuerpos
|
CN103596586A
(zh)
|
2011-04-08 |
2014-02-19 |
免疫设计公司 |
免疫原性组合物及使用所述组合物诱导体液和细胞免疫反应的方法
|
EP2694975A1
(en)
|
2011-04-08 |
2014-02-12 |
Biogen Idec MA Inc. |
Biomarkers predictive of therapeutic responsiveness to ifnbeta and uses thereof
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
KR20140029446A
(ko)
|
2011-04-15 |
2014-03-10 |
컴퓨젠 엘티디. |
면역 관련 장애 및 암의 치료를 위한 폴리펩티드 및 폴리뉴클레오티드, 및 이들의 용도
|
CA2834552A1
(en)
|
2011-04-29 |
2012-11-01 |
Bristol-Myers Squibb Company |
Ip-10 antibody dosage escalation regimens
|
GB201114858D0
(en)
|
2011-08-29 |
2011-10-12 |
Nvip Pty Ltd |
Anti-nerve growth factor antibodies and methods of using the same
|
CN103732621B
(zh)
|
2011-05-06 |
2020-04-24 |
內克斯威特澳大利亚私人有限公司 |
抗神经生长因子抗体及其制备和使用方法
|
MY160884A
(en)
|
2011-05-06 |
2017-03-31 |
Nexvet Australia Pty Ltd |
Anti-nerve growth factor antibodies and methods of preparing and using the same
|
ES2905682T3
(es)
|
2011-05-06 |
2022-04-11 |
Zoetis Services Llc |
Anticuerpos anti-factor de crecimiento nervioso y métodos de preparación y uso de los mismos
|
CA2835094C
(en)
|
2011-05-06 |
2020-12-22 |
David Gearing |
Anti-nerve growth factor antibodies and methods of preparing and using the same
|
WO2012156825A1
(en)
|
2011-05-17 |
2012-11-22 |
Genoscience Pharma |
Peptide-based hiv pre-integration complex inhibitors
|
AU2012260601B2
(en)
|
2011-05-25 |
2018-02-01 |
Innate Pharma, S.A. |
Anti-KIR antibodies for the treatment of inflammatory disorders
|
JP6104897B2
(ja)
|
2011-06-02 |
2017-04-05 |
ダイアックス コーポレーション |
Fcレセプター結合タンパク質
|
JP2014527036A
(ja)
|
2011-06-27 |
2014-10-09 |
ザ ジャクソン ラボラトリー |
癌および自己免疫疾患の処置のための方法および組成物
|
US9428574B2
(en)
|
2011-06-30 |
2016-08-30 |
Compugen Ltd. |
Polypeptides and uses thereof for treatment of autoimmune disorders and infection
|
WO2013014669A1
(en)
|
2011-07-24 |
2013-01-31 |
Carmel-Haifa University Economic Corp. |
Lactoferrin fragments and use thereof
|
WO2013014485A1
(en)
|
2011-07-27 |
2013-01-31 |
Bio-Rad Innovations |
A2m fragments and applications thereof
|
US20160206608A1
(en)
|
2011-08-02 |
2016-07-21 |
Pfizer Inc. |
Crizotinib for use in the treatment of cancer
|
CN103975241B
(zh)
|
2011-08-03 |
2016-01-20 |
奎德尔公司 |
用于提高a型链球菌免疫测定法的特异性的n-乙酰基-d-葡糖胺
|
HUE039786T2
(hu)
|
2011-08-04 |
2019-02-28 |
Amgen Inc |
Csonthiány-defektusok kezelési módszere
|
WO2013028817A1
(en)
|
2011-08-23 |
2013-02-28 |
Foundation Medicine , Inc. |
Novel kif5b-ret fusion molecules and uses thereof
|
KR20140063752A
(ko)
|
2011-08-30 |
2014-05-27 |
엔브이아이피 피티와이 리미티드 |
견화(犬化) 종양 괴사 인자 항체 및 그의 이용방법
|
WO2013043012A2
(en)
*
|
2011-09-22 |
2013-03-28 |
Medicinal Bioconvergence Research Center |
Novel use of leucyl trna synthetase
|
WO2013045863A1
(fr)
|
2011-09-29 |
2013-04-04 |
Institut Pasteur |
Detection de souches e.coli de serotype o104
|
EP2581384A1
(en)
|
2011-10-11 |
2013-04-17 |
Institut Pasteur |
Products useful for the treatment of malignant neoplasms of the human nervous system
|
PL2766393T3
(pl)
|
2011-10-14 |
2018-11-30 |
F.Hoffmann-La Roche Ag |
PRZECIWCIAŁA PRZECIW HtrA1 I SPOSOBY ZASTOSOWANIA
|
AU2012325017A1
(en)
|
2011-10-17 |
2014-04-17 |
Westfaelische Wilhelms-Universitaet Muenster |
Assessment of PML risk and methods based thereon
|
RU2014123511A
(ru)
|
2011-11-10 |
2015-12-20 |
Дженентек, Инк |
Способы лечения, диагностики и мониторинга болезни альцгеймера
|
WO2013071066A1
(en)
|
2011-11-11 |
2013-05-16 |
The Broad Institute, Inc. |
Signatures associated with the response to cancer therapy
|
CN103917870B
(zh)
|
2011-11-16 |
2016-04-13 |
贝克顿·迪金森公司 |
用于检测样品中的分析物的方法和系统
|
US9554736B2
(en)
|
2011-11-29 |
2017-01-31 |
Teleflex Medical Incorporated |
Device with integrated allergy testing
|
WO2013082301A1
(en)
|
2011-11-29 |
2013-06-06 |
Teleflex Medical, Inc. |
Device with integrated allergy testing
|
EP2785874B1
(en)
|
2011-11-30 |
2018-09-26 |
Children's Hospital Medical Center |
Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support
|
WO2013081645A2
(en)
|
2011-11-30 |
2013-06-06 |
Genentech, Inc. |
Erbb3 mutations in cancer
|
SI2790687T1
(sl)
|
2011-12-16 |
2019-01-31 |
Poseida Therapeutics, Inc. |
TRPC4 modulatorji za uporabo pri zdravljenju ali preprečevanju bolečine
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
CA2858099C
(en)
|
2011-12-22 |
2020-12-15 |
Glycomimetics, Inc. |
E-selectin antagonist compounds, compositions, and methods of use
|
EP2797953B1
(en)
|
2011-12-28 |
2020-06-03 |
Amgen Inc. |
Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
|
CA2858336A1
(en)
|
2012-01-01 |
2013-07-04 |
Qbi Enterprises Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
EP2804878B1
(en)
|
2012-01-20 |
2018-08-22 |
Genzyme Corporation |
Anti-cxcr3 antibodies
|
US10139405B2
(en)
|
2012-01-24 |
2018-11-27 |
Cd Diagnostics, Inc. |
System for detecting infection in synovial fluid
|
RU2014111999A
(ru)
|
2012-02-01 |
2016-03-27 |
Компуджен Лтд. |
Антитела к C10RF32 и их применения для лечения рака
|
CN108802385B
(zh)
|
2012-02-09 |
2022-02-08 |
米密德诊断学有限公司 |
用于诊断感染的标记和决定因素和其使用方法
|
WO2013126803A1
(en)
|
2012-02-24 |
2013-08-29 |
Protiva Biotherapeutics Inc. |
Trialkyl cationic lipids and methods of use thereof
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
CA2865745C
(en)
|
2012-03-09 |
2018-01-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
WO2013142796A2
(en)
|
2012-03-23 |
2013-09-26 |
Bristol-Myers Squibb Company |
Methods of treatments using ctla4 antibodies
|
US9592289B2
(en)
|
2012-03-26 |
2017-03-14 |
Sanofi |
Stable IgG4 based binding agent formulations
|
KR20140138971A
(ko)
|
2012-03-28 |
2014-12-04 |
제넨테크, 인크. |
항-hcmv 이디오타입 항체 및 이들의 용도
|
EP2647995B8
(en)
|
2012-04-02 |
2015-02-18 |
Roche Diagnostics GmbH |
Methods and use for assessing chronic obstructive pulmonary disease (COPD) severity
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
ES2655842T3
(es)
|
2012-04-18 |
2018-02-21 |
Cell Signaling Technology, Inc. |
EGFR y ROS1 en el cáncer
|
GB201207297D0
(en)
|
2012-04-26 |
2012-06-06 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
WO2013170051A1
(en)
|
2012-05-09 |
2013-11-14 |
Advanced Animal Diagnostics, Inc. |
Sample cartridge and sample stage
|
US9265772B2
(en)
|
2012-05-11 |
2016-02-23 |
Reset Therapeutics, Inc. |
Carbazole-containing sulfonamides as cryptochrome modulators
|
SG11201406729TA
(en)
|
2012-05-31 |
2014-11-27 |
Agency Science Tech & Res |
Surface enhanced raman spectroscopy (sers) marker conjugates and methods of their preparation
|
US10155987B2
(en)
|
2012-06-12 |
2018-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of predicting resistance to JAK inhibitor therapy
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
BR112014032276A2
(pt)
|
2012-06-22 |
2017-11-28 |
King S College London |
construtos de vista-ig e o uso de vista-ig para o tratamento de distúrbios autoimunes, alérgicos e inflamatórios
|
JP6770312B2
(ja)
|
2012-07-05 |
2020-10-14 |
ユセベ ファルマ ソシエテ アノニム |
骨疾患の治療
|
DE202012012084U1
(de)
|
2012-07-09 |
2013-04-15 |
Schebo Biotech Ag |
Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
|
DE102012013888A1
(de)
|
2012-07-09 |
2014-05-22 |
Schebo Biotech Ag |
Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
|
WO2014011908A1
(en)
|
2012-07-11 |
2014-01-16 |
Esperion Therapeutics, Inc. |
Apolipoprotein mixtures
|
EP2687850A1
(en)
|
2012-07-19 |
2014-01-22 |
Roche Diagniostics GmbH |
Methods of stratifying for respiratory support therapy
|
WO2014015217A1
(en)
|
2012-07-19 |
2014-01-23 |
Vertex Pharmaceuticals Incorporated |
Biomarkers for hcv infected patients
|
WO2014018375A1
(en)
|
2012-07-23 |
2014-01-30 |
Xenon Pharmaceuticals Inc. |
Cyp8b1 and uses thereof in therapeutic and diagnostic methods
|
EP3682897A1
(en)
|
2012-07-27 |
2020-07-22 |
Baxalta GmbH |
Compositions comprising chimeric ospa molecules and methods of use thereof
|
EP4119676A1
(en)
|
2012-08-03 |
2023-01-18 |
Foundation Medicine, Inc. |
Human papilloma virus as predictor of cancer prognosis
|
WO2014027959A1
(en)
|
2012-08-14 |
2014-02-20 |
Nanyang Technological University |
Angiopoietin-like 4 antibody and a method of its use in cancer treatment
|
EP2885423B1
(en)
|
2012-08-15 |
2017-09-27 |
The Procter and Gamble Company |
Systems for identifying and evaluating skin-active agents effective for treating an array of skin disorders
|
CA2880701A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
AU2013312211B2
(en)
|
2012-09-07 |
2018-03-29 |
King's College London |
VISTA modulators for diagnosis and treatment of cancer
|
CA2884151A1
(en)
|
2012-09-10 |
2014-03-13 |
Westfaelische Wilhelms-Universitaet Muenster |
Methods and compounds for preventing, treating and diagnosing an inflammatory condition
|
US10288626B2
(en)
|
2012-09-14 |
2019-05-14 |
University Of Kentucky Research Foundation |
Secreted tumor-associated cytochrome as a blood-based biomarker for cancer
|
WO2014043633A1
(en)
|
2012-09-17 |
2014-03-20 |
Agios Pharmaceuticals, Inc. |
Use of e-cadherin and vimentin for selection of treatment responsive patients
|
WO2014047285A1
(en)
|
2012-09-19 |
2014-03-27 |
Paraskevi Giannakakou |
Identifying taxane sensitivity in prostate cancer patients
|
US11105809B2
(en)
|
2012-10-09 |
2021-08-31 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
WO2014063205A1
(en)
|
2012-10-26 |
2014-05-01 |
The University Of Queensland |
Use of endocytosis inhibitors and antibodies for cancer therapy
|
KR20150087270A
(ko)
|
2012-11-05 |
2015-07-29 |
프로나이 테라퓨틱스, 인코포레이티드 |
Bcl2 발현 조절에 의한 암치료용 바이오마커 이용 방법
|
AU2013337277B2
(en)
|
2012-11-05 |
2018-03-08 |
Foundation Medicine, Inc. |
Novel NTRK1 fusion molecules and uses thereof
|
KR20150085078A
(ko)
|
2012-11-21 |
2015-07-22 |
아지오스 파마슈티컬스 아이엔씨. |
글루타마제 억제제 및 사용 방법
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
WO2014079011A1
(en)
|
2012-11-22 |
2014-05-30 |
Agios Pharmaceuticals, Inc. |
Heterocyclic compounds for inhibiting glutaminase and their methods of use
|
ES2668045T3
(es)
|
2012-12-07 |
2018-05-16 |
Glycomimetics, Inc. |
Compuestos, composiciones y métodos que usan antagonistas de la E-selectina para la movilización de las células hematopoyéticas
|
GB201223053D0
(en)
|
2012-12-20 |
2013-02-06 |
Medical Res Council |
Receptor
|
US9938344B2
(en)
|
2012-12-28 |
2018-04-10 |
Precision Biologics, Inc. |
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
|
US20140234987A1
(en)
|
2013-01-02 |
2014-08-21 |
N-Dia, Inc. |
Methods for predicting time-to-delivery in pregnant women
|
KR20150136047A
(ko)
|
2013-01-09 |
2015-12-04 |
유니버시티 오브 마이애미 |
TL1A-Ig 융합 단백질을 사용한 T 조절 세포의 조절을 위한 조성물 및 방법
|
CA3150658A1
(en)
|
2013-01-18 |
2014-07-24 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
WO2014122166A1
(en)
|
2013-02-06 |
2014-08-14 |
Pieris Ag |
Novel lipocalin-mutein assays for measuring hepcidin concentration
|
JP6446377B2
(ja)
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
US9302005B2
(en)
|
2013-03-14 |
2016-04-05 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
US9052314B2
(en)
|
2013-03-14 |
2015-06-09 |
Silver Lake Research Corporation |
Biomarkers for detecting the presence of bacteria
|
US9151747B1
(en)
|
2013-03-14 |
2015-10-06 |
Mercyhurst University |
Sucralose antibody and immunoassay
|
PE20151873A1
(es)
|
2013-03-14 |
2016-01-06 |
Kasing Cheng |
Sistema de carcasa de tira de prueba
|
WO2014140197A1
(en)
|
2013-03-15 |
2014-09-18 |
Westfaelische Wilhelms-Universitaet Muenster |
Detection of acute renal allograft rejection
|
EP3449977A1
(en)
|
2013-03-15 |
2019-03-06 |
Velo Bio, LLC |
Method for treating eclampsia and preeclampsia
|
BR112015022971B1
(pt)
|
2013-03-15 |
2022-05-17 |
Janssen Biologics B.V. |
Métodos de fabricação para controlar o teor de lisina c-terminal, galactose e ácido siálico em proteínas recombinantes
|
CN105228641A
(zh)
|
2013-03-21 |
2016-01-06 |
密歇根大学董事会 |
治疗代谢紊乱的方法
|
GB201305940D0
(en)
|
2013-04-02 |
2013-05-15 |
Immunovia Ab |
Methods and arrays for use in the same
|
GB201306147D0
(en)
|
2013-04-05 |
2013-05-22 |
Univ Ha Il |
Novel biomarker signature and uses thereof
|
TW201515650A
(zh)
|
2013-05-06 |
2015-05-01 |
艾爾妮蘭製藥公司 |
遞送經脂質調配之核酸分子之劑量及方法
|
WO2014193804A1
(en)
|
2013-05-28 |
2014-12-04 |
Biogen Idec Ma Inc. |
Method of assessing risk of pml
|
KR20160013049A
(ko)
|
2013-06-03 |
2016-02-03 |
노파르티스 아게 |
항-pd-l1 항체 및 mek 억제제 및/또는 braf 억제제의 조합물
|
WO2014195899A1
(en)
*
|
2013-06-06 |
2014-12-11 |
Koninklijke Philips N.V. |
Reagents, methods and devices to prevent aggregation in particle based tests for the detection of multimeric target molecules
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
WO2015000014A1
(en)
|
2013-07-01 |
2015-01-08 |
Newsouth Innovations Pty Limited |
Diagnosis and treatment of autoimmune diseases
|
EP3022303B1
(en)
|
2013-07-17 |
2023-11-01 |
Foundation Medicine, Inc. |
Methods of treating urothelial carcinomas
|
US9770461B2
(en)
|
2013-08-02 |
2017-09-26 |
California Institute Of Technology |
Tailored glycopolymers as anticoagulant heparin mimetics
|
US10227370B2
(en)
|
2013-08-02 |
2019-03-12 |
California Institute Of Technology |
Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
|
WO2015035337A1
(en)
|
2013-09-06 |
2015-03-12 |
Academia Sinica |
HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS WITH ALTERED GLYCOSYL GROUPS
|
CN105917235A
(zh)
|
2013-09-06 |
2016-08-31 |
赛拉诺斯股份有限公司 |
用于检测感染性疾病的系统和方法
|
MX369534B
(es)
|
2013-09-08 |
2019-11-11 |
Pfizer |
Composiciones de neisseria meningitidis y sus metodos.
|
US20160216262A1
(en)
|
2013-09-12 |
2016-07-28 |
Institut National De La Sante Et De La Recherche Medicale |
Method for In Vitro Quantifying Allo-Antibodies, Auto-Antibodies and/or Therapeutic Antibodies
|
CA3174012A1
(en)
|
2013-09-13 |
2015-03-19 |
Genentech, Inc. |
Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
|
KR102571391B1
(ko)
|
2013-09-13 |
2023-08-29 |
제넨테크, 인크. |
정제된 재조합 폴리펩티드를 포함하는 방법 및 조성물
|
CN112552401B
(zh)
|
2013-09-13 |
2023-08-25 |
广州百济神州生物制药有限公司 |
抗pd1抗体及其作为治疗剂与诊断剂的用途
|
ES2714708T3
(es)
|
2013-10-01 |
2019-05-29 |
Mayo Found Medical Education & Res |
Procedimientos para el tratamiento de cáncer en pacientes con niveles elevados de Bim
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
WO2015051302A1
(en)
|
2013-10-04 |
2015-04-09 |
Aptose Biosciences Inc. |
Compositions and methods for treating cancers
|
WO2015063604A2
(en)
|
2013-11-01 |
2015-05-07 |
Imberti Luisa |
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNβ AND USES THEREOF
|
GB201319878D0
(en)
|
2013-11-11 |
2013-12-25 |
Immunovia Ab |
Method, Array and use thereof
|
BR112016011046A2
(pt)
|
2013-11-15 |
2019-01-29 |
Centre Nat Rech Scient |
método para genotipagem, método para a detecção de uma infecção, kit para detectar uma infecção e método para detectar em uma amostra biológica.
|
US20160289270A1
(en)
|
2013-11-18 |
2016-10-06 |
Westfaelische Wilhelms-Universitaet Muenster |
Methods, Peptides and Antibodies for Preventing, Treating and Diagnosing an Inflammatory Condition
|
NZ720311A
(en)
|
2013-12-02 |
2022-10-28 |
Baylor College Medicine |
Identification of a new polypeptide hormone for maintenance of optimal body weight and blood glucose
|
US9309314B2
(en)
|
2013-12-03 |
2016-04-12 |
Agency For Science, Technology And Research (A*Star) |
Polypeptides, nucleic acids and uses thereof
|
GB201322094D0
(en)
|
2013-12-13 |
2014-01-29 |
Electrophoretics Ltd |
Methods and compositions relating to alzheimers disease
|
EP3083670A2
(en)
|
2013-12-17 |
2016-10-26 |
Westfälische Wilhelms-Universität Münster |
Means and methods for treating a pruritus-like skin-disease
|
EP2960252A1
(en)
|
2014-06-26 |
2015-12-30 |
Institut Pasteur |
Phospholipase for treatment of immunosuppression
|
DK3087098T3
(da)
|
2013-12-24 |
2020-06-08 |
Janssen Pharmaceutica Nv |
Anti-Vista-antistoffer og -fragmenter
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EP3091999B1
(en)
|
2014-01-09 |
2021-10-20 |
Hadasit Medical Research Services and Development Ltd. |
Improved cell compositions and methods for cancer therapy
|
AU2015204566A1
(en)
|
2014-01-09 |
2016-08-25 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
CA2937123A1
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
AU2015207665B2
(en)
|
2014-01-17 |
2021-04-15 |
Minomic International Ltd. |
Cell surface prostate cancer antigen for diagnosis
|
MA39228A1
(fr)
|
2014-01-21 |
2017-06-30 |
Immune Design Corp |
Compositions à utiliser pour le traitement d'états allergiques
|
JP6581101B2
(ja)
|
2014-02-14 |
2019-09-25 |
イミューン デザイン コーポレイション |
局所免疫刺激及び全身免疫刺激の組み合わせによる癌の免疫療法
|
GB201403115D0
(en)
|
2014-02-21 |
2014-04-09 |
Qbd Qs Ip Ltd |
Red blood cell detection
|
CA2940422A1
(en)
|
2014-02-24 |
2015-08-27 |
Children's Hospital Medical Center |
Methods and compositions for personalized pain management
|
WO2015131078A1
(en)
|
2014-02-27 |
2015-09-03 |
Biogen Ma Inc. |
Method of assessing risk of pml
|
US10000479B2
(en)
|
2014-03-21 |
2018-06-19 |
Agios Pharmaceuticals, Inc. |
Compounds and their methods of use
|
WO2015148915A1
(en)
|
2014-03-27 |
2015-10-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
WO2015150900A2
(en)
|
2014-03-31 |
2015-10-08 |
Debiopharm International Sa |
Fgfr fusions
|
EP3126846A4
(en)
|
2014-04-02 |
2017-08-30 |
Crescendo Bioscience |
Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
|
TWI690521B
(zh)
|
2014-04-07 |
2020-04-11 |
美商同步製藥公司 |
作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
|
US9176113B1
(en)
|
2014-04-11 |
2015-11-03 |
Synapdx Corporation |
Methods and systems for determining autism spectrum disorder risk
|
EP3134439B1
(en)
|
2014-04-21 |
2018-12-26 |
Millennium Pharmaceuticals, Inc. |
Anti-psyk antibody molecules and use of same for syk-targeted therapy
|
US10247729B2
(en)
|
2014-05-05 |
2019-04-02 |
Microbplex, Inc. |
Media elaborated with newly synthesized antibodies (MENSA) and uses thereof
|
EP3169365A2
(en)
|
2014-05-07 |
2017-05-24 |
Westfälische Wilhelms-Universität Münster |
Compounds and methods for the treatment of itch
|
WO2015172083A1
(en)
|
2014-05-08 |
2015-11-12 |
Biogen Ma Inc. |
Dimethylfumarate and prodrugs for treatment of multiple sclerosis
|
US20170269075A1
(en)
|
2014-05-12 |
2017-09-21 |
Biogen Ma Inc. |
Biomarkers predictive of lupus progression and uses thereof
|
AU2015259516B2
(en)
|
2014-05-13 |
2020-05-28 |
Bavarian Nordic A/S |
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and a monoclonal antibody against TIM-3
|
US10302653B2
(en)
|
2014-05-22 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Distinguishing antagonistic and agonistic anti B7-H1 antibodies
|
TWI717319B
(zh)
|
2014-05-27 |
2021-02-01 |
中央研究院 |
得自類桿菌屬之岩藻糖苷酶及其用途
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
CN106573971A
(zh)
|
2014-05-27 |
2017-04-19 |
中央研究院 |
抗cd20醣抗体及其用途
|
CN106661099A
(zh)
|
2014-05-27 |
2017-05-10 |
中央研究院 |
抗her2醣抗体及其用途
|
AU2015267044A1
(en)
|
2014-05-28 |
2016-12-15 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
GB201410226D0
(en)
|
2014-06-09 |
2014-07-23 |
Immunovia Ab |
Methods and arrays for use in the same
|
EP3155439A4
(en)
|
2014-06-10 |
2018-03-14 |
Crescendo Bioscience |
Biomarkers and methods for measuring and monitoring axial spondyloarthritis disease activity
|
WO2015191881A2
(en)
|
2014-06-11 |
2015-12-17 |
Green Kathy A |
Use of vista agonists and antagonists to suppress or enhance humoral immunity
|
JP6587288B2
(ja)
|
2014-06-25 |
2019-10-09 |
テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド |
がん幹細胞の同定ならびに診断および処置のためのその使用
|
FR3023003B1
(fr)
|
2014-06-27 |
2016-07-15 |
Bio-Rad Innovations |
Combinaison synergique de biomarqueurs pour la detection et l'evaluation d'une fibrose hepatique
|
MX2017000630A
(es)
|
2014-07-15 |
2017-04-27 |
Immune Design Corp |
Regimenes de sensibilización-refuerzo con un adyuvante de agonista tlr4 y un vector lentiviral.
|
EP3171896A4
(en)
|
2014-07-23 |
2018-03-21 |
Mayo Foundation for Medical Education and Research |
Targeting dna-pkcs and b7-h1 to treat cancer
|
US10752668B2
(en)
|
2014-07-25 |
2020-08-25 |
Theravectys |
Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
|
US10422004B2
(en)
|
2014-08-08 |
2019-09-24 |
Children's Hospital Medical Center |
Diagnostic method for distinguishing forms of esophageal eosinophilia
|
CA3190715A1
(en)
|
2014-08-14 |
2016-02-18 |
Memed Diagnostics Ltd. |
Computational analysis of biological data using manifold and a hyperplane
|
WO2016026978A1
(en)
|
2014-08-22 |
2016-02-25 |
Universite Nice Sophia Antipolis |
Methods and pharmaceutical compositions for treating drug addiction
|
US9879042B2
(en)
|
2014-09-08 |
2018-01-30 |
Academia Sinica |
Human iNKT cell activation using glycolipids
|
JP6815992B2
(ja)
|
2014-10-08 |
2021-01-20 |
ノバルティス アーゲー |
キメラ抗原受容体療法に対する治療応答性を予測するバイオマーカーおよびその使用
|
DE102015220401B4
(de)
|
2014-10-20 |
2022-12-29 |
Gen-Probe Incorporated |
Erythrozyten-Lyselösung
|
US9107906B1
(en)
|
2014-10-28 |
2015-08-18 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
EP3221340A1
(en)
|
2014-11-19 |
2017-09-27 |
Koninklijke Philips N.V. |
Diagnostic method employing hnl
|
WO2016090347A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
MA41142A
(fr)
|
2014-12-12 |
2017-10-17 |
Amgen Inc |
Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
EP3789766A1
(en)
|
2015-01-24 |
2021-03-10 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
WO2016123329A2
(en)
|
2015-01-28 |
2016-08-04 |
Genentech, Inc. |
Gene expression markers and treatment of multiple sclerosis
|
RU2723045C2
(ru)
|
2015-02-19 |
2020-06-08 |
Пфайзер Инк. |
Композиции neisseria meningitidis и способы их получения
|
EP3636749B1
(en)
|
2015-03-06 |
2022-04-27 |
F. Hoffmann-La Roche AG |
Ultrapurified dsbc and methods of making and using the same
|
WO2016149537A1
(en)
|
2015-03-17 |
2016-09-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Bank vole prion protein as a broad-spectrum substrate for rt-quic-based detection and discrimination of prion strains
|
GB201504432D0
(en)
|
2015-03-17 |
2015-04-29 |
Electrophoretics Ltd |
Materials and methods for diagnosis and treatment of alzheimers disease
|
US11279768B1
(en)
|
2015-04-03 |
2022-03-22 |
Precision Biologics, Inc. |
Anti-cancer antibodies, combination therapies, and uses thereof
|
US9758575B2
(en)
|
2015-04-06 |
2017-09-12 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
|
EP3285811A1
(en)
|
2015-04-21 |
2018-02-28 |
Institut Gustave Roussy |
Therapeutic methods, products and compositions inhibiting znf555
|
US20180259516A1
(en)
|
2015-05-04 |
2018-09-13 |
Westfälische Wilhelms-Universität Münster |
Means and methods for diagnosing and treating inflammatory disorders
|
RU2727165C2
(ru)
|
2015-05-04 |
2020-07-21 |
ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ |
Слитый полипептид с противораковой активностью
|
WO2016181393A1
(en)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Citrin inhibitors for the treatment of cancer
|
JP6820278B2
(ja)
|
2015-05-22 |
2021-01-27 |
フアフイ ヘルス リミテッドHuahui Health Ltd. |
抗Pre−S1 HBV抗体
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
CN107922497B
(zh)
|
2015-06-24 |
2022-04-12 |
詹森药业有限公司 |
抗vista抗体和片段
|
ES2890073T3
(es)
|
2015-08-25 |
2022-01-17 |
Prothena Biosciences Ltd |
Métodos para detectar alfa-sinucleína fosforilada
|
EP3932953A1
(en)
|
2015-08-28 |
2022-01-05 |
F. Hoffmann-La Roche AG |
Anti-hypusine antibodies and uses thereof
|
CN108780084B
(zh)
|
2015-09-03 |
2022-07-22 |
诺华股份有限公司 |
预测细胞因子释放综合征的生物标志物
|
GB201516801D0
(en)
|
2015-09-22 |
2015-11-04 |
Immunovia Ab |
Method, array and use thereof
|
JP6959912B2
(ja)
|
2015-09-23 |
2021-11-05 |
ジェネンテック, インコーポレイテッド |
抗vegf抗体の最適化変異体
|
EP3356832A4
(en)
|
2015-09-29 |
2019-06-19 |
Sasso, Eric |
BIOMARKERS AND METHODS FOR ASSESSING THE ACTIVITY OF PSORIASTIC ARTHRITIS DISEASE
|
WO2017058999A2
(en)
|
2015-09-29 |
2017-04-06 |
Crescendo Bioscience |
Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
|
WO2017059371A1
(en)
|
2015-10-01 |
2017-04-06 |
Amgen Inc. |
Treatment of bile acid disorders
|
EP3362180B1
(en)
|
2015-10-15 |
2020-06-17 |
Inbios International Inc. |
Multiplexed lateral flow assay systems and methods for their use
|
WO2017075212A1
(en)
|
2015-10-30 |
2017-05-04 |
Genentech, Inc. |
Anti-htra1 antibodies and methods of use thereof
|
WO2017075045A2
(en)
|
2015-10-30 |
2017-05-04 |
Mayo Foundation For Medical Education And Research |
Antibodies to b7-h1
|
EP3368686A1
(en)
|
2015-10-30 |
2018-09-05 |
Exact Sciences Development Company, LLC |
Multiplex amplification detection assay and isolation and detection of dna from plasma
|
WO2017079215A1
(en)
|
2015-11-03 |
2017-05-11 |
Glycomimetics, Inc. |
Methods and compositions for the production of monoclonal antibodies, hematopoietic stem cells, and methods of using the same
|
JP2018533586A
(ja)
|
2015-11-03 |
2018-11-15 |
グリコミメティクス, インコーポレイテッド |
がん幹細胞を標的にし、そして侵襲性がんを処置するための抗体
|
GB201520258D0
(en)
|
2015-11-17 |
2015-12-30 |
Academisch Ziekenhuis Leiden |
Modulation of ciliogenesis
|
EP3391048B1
(en)
|
2015-12-15 |
2021-07-07 |
Case Western Reserve University |
Oral squamous cell carcinoma evaluation using beta defensin
|
WO2017123401A1
(en)
|
2016-01-13 |
2017-07-20 |
Children's Hospital Medical Center |
Compositions and methods for treating allergic inflammatory conditions
|
EP3410849B1
(en)
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
CN109069626A
(zh)
|
2016-02-12 |
2018-12-21 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
CA3015913A1
(en)
|
2016-02-29 |
2017-09-08 |
Foundation Medicine, Inc. |
Methods of treating cancer
|
EP3426693A4
(en)
|
2016-03-08 |
2019-11-13 |
Academia Sinica |
PROCESS FOR MODULAR SYNTHESIS OF N-GLYCANES AND ARRANGEMENTS THEREOF
|
GB201604124D0
(en)
|
2016-03-10 |
2016-04-27 |
Ucb Biopharma Sprl |
Pharmaceutical formulation
|
WO2017161357A1
(en)
|
2016-03-18 |
2017-09-21 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
GB201700138D0
(en)
|
2017-01-05 |
2017-02-22 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
JP7023857B2
(ja)
|
2016-03-23 |
2022-02-22 |
センソシェン アクティエ ボラーグ |
解析方法およびそれに用いるアレイ
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
WO2017181139A2
(en)
|
2016-04-15 |
2017-10-19 |
Michael Molloy |
Anti-human vista antibodies and use thereof
|
EP3446127A4
(en)
|
2016-04-20 |
2020-01-22 |
Crescendo Bioscience, Inc. |
BIOMARKER AND METHOD FOR CHECKING THE RESPONSE TO A THERAPY OF INFLAMMABLE DISEASES
|
US11162091B2
(en)
|
2016-04-27 |
2021-11-02 |
Gen-Probe Incorporated |
Blood cell lysis reagent
|
GB201608192D0
(en)
|
2016-05-10 |
2016-06-22 |
Immunovia Ab |
Method, array and use thereof
|
US11293017B2
(en)
|
2016-05-25 |
2022-04-05 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
GB201609951D0
(en)
|
2016-06-07 |
2016-07-20 |
Immunovia Ab |
Biomarkers signatures and uses thereof
|
GB201609950D0
(en)
|
2016-06-07 |
2016-07-20 |
Immunovia Ab |
Biomarkers signatures and uses thereof
|
DK3264087T3
(da)
|
2016-06-27 |
2020-07-20 |
Chimera Biotec Gmbh |
Fremgangsmåde og indretning til kvantificering af målmolekyler
|
US11125744B2
(en)
|
2016-06-30 |
2021-09-21 |
Siemens Healthineers Nederland B.V. |
Device, system and method for detecting an analyte in a body fluid sample containing a plurality of cells
|
EP3482200B1
(en)
|
2016-07-10 |
2022-05-04 |
Memed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
EP4184167A1
(en)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Early diagnosis of infections
|
EP3482202A4
(en)
|
2016-07-11 |
2020-03-18 |
Arizona Board of Regents on behalf of Arizona State University |
USE OF SWEAT AS A BIOFLUID FOR THE ANALYSIS AND IDENTIFICATION OF DISEASES
|
CN109844532B
(zh)
|
2016-08-10 |
2022-06-17 |
米密德诊断学有限公司 |
分析生物数据的系统和方法
|
ES2919927T3
(es)
|
2016-08-10 |
2022-07-29 |
Pasteur Institut |
Métodos y reactivos para la detección del paludismo por Plasmodium falciparum resistente a la piperaquina
|
WO2018033135A1
(en)
|
2016-08-19 |
2018-02-22 |
Beigene, Ltd. |
Use of a combination comprising a btk inhibitor for treating cancers
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
CN116655790A
(zh)
|
2016-08-26 |
2023-08-29 |
百济神州有限公司 |
抗tim-3抗体及其用途
|
WO2018045162A1
(en)
|
2016-09-01 |
2018-03-08 |
Biogen Ma Inc. |
Biomarkers predictive of primary progressive multiple sclerosis and uses thereof
|
EP3510047A1
(en)
|
2016-09-07 |
2019-07-17 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
WO2018075408A1
(en)
|
2016-10-17 |
2018-04-26 |
Alexion Pharmaceuticals, Inc. |
Methods of treating acute myeloid leukemia (aml) with combinations of anti-cd200 antibodies, cytarabine, and daunorubicin
|
WO2018102594A1
(en)
|
2016-12-01 |
2018-06-07 |
Alexion Pharmaceuticals, Inc. |
Methods of treating solid tumors with anti-cd200 antibodies
|
US10656164B2
(en)
|
2016-12-22 |
2020-05-19 |
Qiagen Sciences, Llc |
Screening asymptomatic pregnant woman for preterm birth
|
US10935555B2
(en)
|
2016-12-22 |
2021-03-02 |
Qiagen Sciences, Llc |
Determining candidate for induction of labor
|
KR20190104411A
(ko)
|
2017-01-18 |
2019-09-09 |
제넨테크, 인크. |
항-pd-l1 항체에 대한 이디오타입 항체 및 이의 용도
|
US11618924B2
(en)
|
2017-01-20 |
2023-04-04 |
Children's Hospital Medical Center |
Methods and compositions relating to OPRM1 DNA methylation for personalized pain management
|
US10183070B2
(en)
|
2017-01-31 |
2019-01-22 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
GB201701572D0
(en)
|
2017-01-31 |
2017-03-15 |
Immunovia Ab |
Methods, arrays and uses thereof
|
WO2018148180A2
(en)
|
2017-02-07 |
2018-08-16 |
Immune Design Corp. |
Materials and methods for identifying and treating cancer patients
|
US11061026B2
(en)
|
2017-02-17 |
2021-07-13 |
MFB Fertility, Inc. |
System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
AU2018258263A1
(en)
|
2017-04-24 |
2019-10-24 |
Genentech, Inc. |
ErbB2/Her2 mutations in the transmembrane or juxtamembrane domain
|
GB201706464D0
(en)
|
2017-04-24 |
2017-06-07 |
Senzagen Ab |
Analytical methods and arrays for use in the same
|
US20210156844A1
(en)
|
2017-05-02 |
2021-05-27 |
Bayer Aktiengesellschaft |
TMEM16A Modulation for Diagnostic or Therapeutic Use in Pulmonary Hypertension (PH)
|
CA3075518A1
(en)
|
2017-09-14 |
2019-03-21 |
Crescendo Bioscience, Inc. |
Biomarkers and methods for assessing myocardial infarction and serious infection risk in rheumatoid arthritis patients
|
GB201715445D0
(en)
|
2017-09-25 |
2017-11-08 |
Senzagen Ab |
Novel cell line and uses thereof
|
US20200225244A1
(en)
|
2017-09-26 |
2020-07-16 |
Sanford Burnham Prebys Medical Discovery Institute |
Compositions and methods for assessing painful demyelinating and nondemyelinating diseases
|
WO2019067499A1
(en)
|
2017-09-27 |
2019-04-04 |
Alexion Pharmaceuticals, Inc. |
BIOMARKER SIGNATURE FOR PREDICTING A TUMOR RESPONSE TO ANTI-CD200 THERAPY
|
EP3697809A1
(en)
|
2017-10-20 |
2020-08-26 |
Institut Curie |
Dap10/12 based cars adapted for rush
|
AU2018358804A1
(en)
|
2017-11-02 |
2020-04-09 |
Bayer Aktiengesellschaft |
Bispecific antibodies binding ALK-1 and BMPR-2
|
CN111587123A
(zh)
|
2017-11-09 |
2020-08-25 |
品通治疗有限公司 |
用于生成和使用人源化构象特异性磷酸化的τ抗体的方法和组合物
|
US20210087267A1
(en)
|
2017-12-20 |
2021-03-25 |
Alexion Pharmaceuticals, Inc. |
Liquid formulations of anti-cd200 antibodies
|
WO2019126536A1
(en)
|
2017-12-20 |
2019-06-27 |
Alexion Pharmaceuticals Inc. |
Humanized anti-cd200 antibodies and uses thereof
|
US20200384118A1
(en)
|
2017-12-21 |
2020-12-10 |
Friedrich-Alexander-Universitat Erlangen-Nurnberg |
Immunotoxin conjugates for use in therapy
|
CN111770936A
(zh)
|
2018-01-12 |
2020-10-13 |
百时美施贵宝公司 |
抗il-8抗体和抗pd-1抗体联合治疗用于治疗癌症
|
EP3752252A4
(en)
|
2018-02-12 |
2021-11-17 |
Hadasit Medical Research Services and Development Ltd. |
MODULATION OF SLAMF6 SPLICE VARIANTS FOR CANCER THERAPY
|
US11859250B1
(en)
|
2018-02-23 |
2024-01-02 |
Children's Hospital Medical Center |
Methods for treating eosinophilic esophagitis
|
EP3530282A1
(en)
|
2018-02-27 |
2019-08-28 |
Diaccurate |
Therapeutic methods
|
WO2019190877A1
(en)
|
2018-03-26 |
2019-10-03 |
Alexion Pharmaceuticals, Inc. |
High throughput method for measuring the protease activity of complement c3 convertase
|
WO2019191534A1
(en)
|
2018-03-30 |
2019-10-03 |
Amgen Inc. |
C-terminal antibody variants
|
EP3774916A2
(en)
|
2018-04-06 |
2021-02-17 |
Biolegend, Inc. |
Anti-tetraspanin 33 agents and compositions and methods for making and using the same
|
WO2019237119A1
(en)
|
2018-06-08 |
2019-12-12 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New compositions and detection methods for onchocerca volvulus infection
|
CN113164557A
(zh)
|
2018-07-23 |
2021-07-23 |
因柯利尔疗法公司 |
治疗神经性病症的方法
|
JP2022510573A
(ja)
|
2018-07-23 |
2022-01-27 |
エンクリアー セラピーズ, インク. |
神経障害の治療方法
|
WO2020043693A1
(en)
|
2018-08-29 |
2020-03-05 |
Westfälische Wilhelms-Universität Münster |
Diagnosis of multiple sclerosis
|
CA3113676A1
(en)
|
2018-09-21 |
2020-03-26 |
President And Fellows Of Harvard College |
Methods and compositions for treating diabetes, and methods for enriching mrna coding for secreted proteins
|
EP3856343A1
(en)
|
2018-09-25 |
2021-08-04 |
Biolegend, Inc. |
Anti-tlr9 agents and compositions and methods for making and using the same
|
DE102018124022A1
(de)
|
2018-09-28 |
2020-04-02 |
Rheinisch-Westfälische Technische Hochschule (Rwth) Aachen |
Hyaluronsäurestabilisator
|
WO2020070303A1
(en)
|
2018-10-05 |
2020-04-09 |
Bavarian Nordic A/S |
Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an immune checkpoint antagonist or agonist
|
EP3864166A1
(en)
|
2018-10-12 |
2021-08-18 |
Quidel Corporation |
Extraction reagent for use in an assay for detection of group a streptococcus
|
WO2020081493A1
(en)
|
2018-10-16 |
2020-04-23 |
Molecular Templates, Inc. |
Pd-l1 binding proteins
|
MX2021005560A
(es)
|
2018-11-20 |
2021-06-23 |
Bavarian Nordic As |
Terapia para el tratamiento del cancer con administracion intratumoral y/o intravenosa de un virus vaccinia ankara (mva) recombinante que codifica ligando 4-1bbl (cd137l) y/o ligando del cumulo o grupo de diferenciacion 40 (cd40l).
|
MX2021006234A
(es)
|
2018-11-30 |
2021-09-10 |
Caris Mpi Inc |
Perfilado molecular de proxima generacion.
|
WO2020118011A1
(en)
|
2018-12-06 |
2020-06-11 |
Alexion Pharmaceuticals, Inc. |
Anti-alk2 antibodies and uses thereof
|
AU2020205151A1
(en)
|
2019-01-03 |
2021-07-15 |
Senzagen Ab |
Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method
|
EP3917571A4
(en)
|
2019-01-31 |
2022-10-12 |
Agency For Science, Technology And Research |
CNX/ERP57 INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CANCER
|
EP3693063A1
(en)
|
2019-02-06 |
2020-08-12 |
Diaccurate |
Methods and compositions for treating cancer
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
EP3924379A4
(en)
|
2019-02-15 |
2022-12-21 |
Integral Molecular, Inc. |
COMMON LIGHT CHAIN ANTIBODIES AND THEIR USES
|
KR20210128443A
(ko)
|
2019-02-15 |
2021-10-26 |
인테그럴 몰큘러 인코포레이티드 |
클라우딘 6 항체 및 이의 용도
|
WO2020176637A1
(en)
|
2019-02-26 |
2020-09-03 |
Pantheryx, Inc. |
Compositions for management of disorders of the gastrointestinal tract
|
GB201904472D0
(en)
|
2019-03-29 |
2019-05-15 |
Immunovia Ab |
Methods, arrays and uses thereof
|
EP3952947A1
(en)
|
2019-04-11 |
2022-02-16 |
Enclear Therapies, Inc. |
Methods of amelioration of cerebrospinal fluid and devices and systems therefor
|
CN114599675A
(zh)
|
2019-05-28 |
2022-06-07 |
上海科技大学 |
用于治疗clouston型外胚层发育不良2的组合物和方法
|
WO2020261281A1
(en)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
IL292879A
(en)
|
2019-11-11 |
2022-07-01 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanoantibodies for insect control and their uses
|
WO2021099586A1
(en)
|
2019-11-20 |
2021-05-27 |
Bavarian Nordic A/S |
Recombinant mva viruses for intratumoral and/or intravenous administration for treating cancer
|
AU2020397802A1
(en)
|
2019-12-02 |
2022-06-16 |
Caris Mpi, Inc. |
Pan-cancer platinum response predictor
|
US20210188971A1
(en)
|
2019-12-19 |
2021-06-24 |
Quidel Corporation |
Monoclonal antibody fusions
|
WO2021146383A1
(en)
|
2020-01-17 |
2021-07-22 |
BioLegend, Inc. |
Anti-tlr7 agents and compositions and methods for making and using the same
|
US20210311054A1
(en)
|
2020-04-01 |
2021-10-07 |
Institut Pasteur |
Severe acute respiratory syndrome (sars) - associated coronavirus diagnostics
|
US11815513B2
(en)
|
2020-04-01 |
2023-11-14 |
Institut Pasteur |
Severe acute respiratory syndrome (SARS)-associated coronavirus diagnostics
|
WO2021209824A1
(en)
|
2020-04-17 |
2021-10-21 |
Institut Pasteur |
Methods and products for serological analysis of sars-cov-2 infection
|
BR112022022021A2
(pt)
|
2020-04-30 |
2022-12-13 |
Genentech Inc |
Anticorpos, ácido(s) nucleico(s), vetor, célula hospedeira, processo para produzir um anticorpo, métodos para rastrear um anticorpo, detectar kras-gdp, obter um inibidor, detectar a alquilação de kras, tratar um câncer, rastrear compostos, medir a ligação de uma proteína e medir o engajamento do alvo de um inibidor, kit, chaperona de cristalização, método de cristalização e superfície de biossensor
|
WO2021239666A1
(en)
|
2020-05-26 |
2021-12-02 |
Diaccurate |
Therapeutic methods
|
CA3182473A1
(en)
|
2020-06-01 |
2021-12-09 |
Genentech, Inc. |
Methods for making extracellular vesicles and uses thereof
|
TW202216771A
(zh)
|
2020-06-26 |
2022-05-01 |
德商拜耳廠股份有限公司 |
用於治療應用之ccr8抗體
|
US20230241171A1
(en)
|
2020-07-10 |
2023-08-03 |
Institut Pasteur |
Use of gdf11 to diagnose and treat anxiety and depression
|
GB202010970D0
(en)
|
2020-07-16 |
2020-09-02 |
Immunovia Ab |
Methods, arrays and uses thereof
|
US20240053339A1
(en)
|
2020-09-21 |
2024-02-15 |
Theravectys |
High throughput methods and products for sars-cov-2 sero-neutralization assay
|
WO2022093640A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2c agents and compositions and methods for making and using the same
|
WO2022093641A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2a agents and compositions and methods for making and using the same
|
US20240108766A1
(en)
|
2021-01-22 |
2024-04-04 |
Bayer Aktiengesellschaft |
Lrrc15 antibodies and conjugates thereof
|
EP4046652A1
(en)
|
2021-02-23 |
2022-08-24 |
Johann Wolfgang Goethe-Universität Frankfurt |
Compositions and methods for diagnosing, treating and preventing carrion's disease
|
WO2022180172A1
(en)
|
2021-02-26 |
2022-09-01 |
Bayer Aktiengesellschaft |
Inhibitors of il-11 or il-11ra for use in the treatment of abnormal uterine bleeding
|
GB202104422D0
(en)
|
2021-03-29 |
2021-05-12 |
Orre Lukas |
Methods
|
EP4314829A1
(en)
|
2021-03-30 |
2024-02-07 |
Westfälische Wilhelms-Universität Münster |
Classification of neurological or psychiatric disease manifestations using multi-dimensional cerebrospinal fluid analysis
|
EP4070814A1
(en)
|
2021-04-07 |
2022-10-12 |
Lama France |
Sars-cov-2 polypeptides and uses thereof
|
AR125344A1
(es)
|
2021-04-15 |
2023-07-05 |
Chugai Pharmaceutical Co Ltd |
Anticuerpo anti-c1s
|
WO2023118508A1
(en)
|
2021-12-23 |
2023-06-29 |
Bavarian Nordic A/S |
Recombinant mva viruses for intraperitoneal administration for treating cancer
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
WO2023192478A1
(en)
|
2022-04-01 |
2023-10-05 |
Bristol-Myers Squibb Company |
Combination therapy with anti-il-8 antibodies and anti-pd-1 antibodies for treating cancer
|
WO2023223092A1
(en)
|
2022-05-18 |
2023-11-23 |
Institut Pasteur |
Identification of a human circovirus
|
WO2024020051A1
(en)
|
2022-07-19 |
2024-01-25 |
BioLegend, Inc. |
Anti-cd157 antibodies, antigen-binding fragments thereof and compositions and methods for making and using the same
|
WO2024040114A2
(en)
|
2022-08-18 |
2024-02-22 |
BioLegend, Inc. |
Anti-axl antibodies, antigen-binding fragments thereof and methods for making and using the same
|
WO2024044675A1
(en)
|
2022-08-25 |
2024-02-29 |
Beigene, Ltd. |
Methods of cancer treatment using anti-pd1 antibodies in combination with anti-tim3 antibodies
|
WO2024052517A2
(en)
|
2022-09-09 |
2024-03-14 |
Bayer Aktiengesellschaft |
Medical use of ccr8 antibodies and dosing schedule
|
WO2024052922A1
(en)
|
2022-09-11 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Anti-klk4 antibodies and uses thereof
|